,ER Status qvalues,PR Status qvalues,HER2 Status qvalues,Triple Neg qvalues,ER-/PR-/HER2+ qvalues
RUNX1 regulates estrogen receptor mediated transcription,221.15581057792966,84.30819019604006,28.40201286248307,143.58454168098052,47.96500709642315
Activation of AMPK downstream of NMDARs,195.16055507527273,147.0069329395993,34.695045550090555,140.7555840924667,33.30264005757443
Transcriptional Regulation by MECP2,187.86315431192833,87.38457415005973,30.44311274894596,134.87487826784633,33.619615536354104
SLC-mediated transmembrane transport,185.87995960036417,80.25201443907544,19.738373786942468,145.6570935789032,23.547715339472408
DAG and IP3 signaling,185.87995960036417,99.79329111789436,25.32554459227405,141.7573210946757,25.860778161568028
PLC beta mediated events,184.35570199115168,99.08658624010535,19.032214059909347,143.41076730149496,23.696661336096223
G-protein mediated events,183.94699946337388,98.5085998928529,18.186083637857877,143.58454168098052,23.062480998545233
Caspase-mediated cleavage of cytoskeletal proteins,180.3770891317196,126.05278121883224,35.52182224661499,127.27998498315583,33.14733614931761
TFAP2 (AP-2) family regulates transcription of growth factors and their receptors,179.48926973961704,62.27944298091899,17.073204863392327,129.71276945465453,29.77200115991523
Cyclin D associated events in G1,173.0628190588355,101.18896388646925,24.016693925596574,129.86213832061327,26.944196032628025
G1 Phase,173.0628190588355,101.18896388646925,24.016693925596574,129.86213832061327,26.944196032628025
Estrogen-dependent nuclear events downstream of ESR-membrane signaling,170.0643721663573,74.47578833544351,15.823742180277927,129.5883745651088,22.566870724913127
Ion channel transport,169.81980346697853,69.0833095479931,13.097169450522031,135.81051518987704,20.614267735665475
Reversible hydration of carbon dioxide,169.80439998024258,74.59057400400145,14.147331114149292,126.60359359701668,26.381487484735302
Amino acid transport across the plasma membrane,169.80439998024258,75.65954902890273,19.54262278857237,137.3167242603276,20.385488660826795
Transport of inorganic cations/anions and amino acids/oligopeptides,168.20130197515135,74.75752026144288,15.952068274993282,135.8002021805609,20.18748187146567
PKA-mediated phosphorylation of CREB,167.2533720103421,93.15077721387833,13.451157843094464,137.36225398836055,18.156010657238465
Serine biosynthesis,167.1452105319361,82.48628572980951,21.865110266779013,114.38995141979571,33.388221627743164
Ca-dependent events,166.60107533730036,84.23281488570417,11.275733527310901,137.20627418726443,17.208603295595196
CaM pathway,166.45262542876387,83.59325652784439,11.034863568154783,137.05526165807896,17.21217325755882
Calmodulin induced events,166.45262542876387,83.59325652784439,11.034863568154783,137.05526165807896,17.21217325755882
Cardiac conduction,166.4026700185706,71.7052395411364,16.370975100261838,135.12833171852617,18.36374753243316
ABC transporters in lipid homeostasis,166.01227901580913,72.65215145244191,25.54647920818283,113.30308571155827,31.48421892801543
Post NMDA receptor activation events,161.4827656126498,105.22620481757467,26.53363092383119,119.60689564575198,24.213526008181223
Activation of NMDA receptors and postsynaptic events,161.2500909041007,102.9108591230393,27.378653435753844,118.71991606922923,24.697308012388152
Intraflagellar transport,159.00183960500058,102.9108591230393,16.08843326900602,127.02730921254562,18.904108970109654
Fatty acid metabolism,156.41167336319106,88.1411374541497,15.200884302387518,121.32648391288248,20.934591324544346
Signaling by ERBB4,155.15921521972774,73.0526098893734,11.903262753061833,117.90134250701072,20.13221906889416
"Transport of bile salts and organic acids, metal ions and amine compounds",154.3247728667264,59.33029282483628,8.821208591493072,130.8165884879276,14.436792941015476
MECP2 regulates neuronal receptors and channels,151.6788050131875,65.61753704893717,22.02729299478112,105.79509423590783,29.296843006724636
GAB1 signalosome,151.3709623081342,98.73706149120795,18.29901728791647,110.05012564994948,25.882912943064767
BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members,151.28965492289504,84.34934692135711,42.63156205899187,81.08693126639884,48.319614343766226
FBXW7 Mutants and NOTCH1 in Cancer,150.4666712130979,62.15173230152904,11.135994283879203,118.39679318373766,21.092803465998717
Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling,150.4666712130979,62.15173230152904,11.135994283879203,118.39679318373766,21.092803465998717
Purine catabolism,146.57984078409677,71.27296314535202,27.130728438539048,107.55814859353823,24.863526240459755
Sphingolipid metabolism,146.49645090178052,55.13354487062159,4.2034776113822465,134.31627651836408,8.712260238692068
Ubiquinol biosynthesis,145.41858522751468,77.54786866661664,26.08175919529925,103.10509750831143,27.067593884890584
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism,144.26901226203682,97.53638595254034,30.228083085931726,100.33428349145748,30.845385852693408
alpha-linolenic acid (ALA) metabolism,144.26901226203682,97.53638595254034,30.228083085931726,100.33428349145748,30.845385852693408
Keratinization,143.03306147243347,41.39456692847,11.152858801736336,107.7588347922406,20.385488660826795
Phase 4 - resting membrane potential,142.813310627463,75.52974637115885,18.142475042596516,107.65339458434958,20.691210617915786
Repression of WNT target genes,142.57624756077462,44.342863345190715,6.038727175571176,115.66217702961039,13.884843806446032
Negative regulation of MET activity,142.560103347765,94.85659951833522,10.083188525209284,123.51420776296251,12.54965098548936
Formation of the cornified envelope,141.95023555267585,38.67911302520631,11.356188082082953,105.3216097054186,21.028423135950447
Basigin interactions,138.12538656616456,70.67326574042455,23.42054988874303,102.89207649720981,23.828434881002995
"Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein",137.785844195432,59.45393691904533,4.75365279395506,127.85919036585479,8.777563846924716
Acyl chain remodelling of PE,137.77425284316632,68.19124828273883,3.129873907535429,116.68026274513035,12.742503378476792
Stimuli-sensing channels,137.56421144164025,57.80305083853835,6.779150658114004,119.39959292118813,11.212808061769406
Acyl chain remodelling of PC,137.13531831866374,66.3873959985274,3.3556244841706815,114.97484004441459,13.572777158938758
Metabolism of vitamins and cofactors,136.8787371891361,68.71312335045894,17.889532372609338,101.56694708267146,19.720578123565293
Tryptophan catabolism,136.5160723152897,85.42534377022508,47.39902314475045,75.72264009203451,45.59262317654566
Growth hormone receptor signaling,134.6609369743294,70.63745267482058,13.398747597137554,107.26798412605973,17.209793301646236
Carboxyterminal post-translational modifications of tubulin,133.96764289573332,81.25365015010262,20.926994862328694,100.64204972775693,19.473208230151556
Synthesis of substrates in N-glycan biosythesis,133.10161550620126,52.436438858725026,3.1472260171385797,128.0640966830465,6.645080850493624
Nucleotide salvage,131.98555412899995,85.74611012312752,25.321721126582947,97.7782971533238,23.407245294803683
Regulation of KIT signaling,131.3942171379484,58.46402397234158,7.022555343418087,108.05101457930164,13.251069560013246
Defective ABCC8 can cause hypoglycemias and hyperglycemias,131.34546770587392,63.67818153591196,8.417294475445727,106.26962748056248,14.768392156548147
Antimicrobial peptides,130.27236921693796,66.67199565994488,22.60794706128788,79.69164691253154,31.800888235150524
Organic cation transport,129.44880160984226,50.98857378654035,15.200884302387518,102.36770417529428,14.835407337449357
Purine salvage,129.14335350177288,90.51166349464076,20.524554049312748,95.82217908734992,22.690011085593778
Iron uptake and transport,129.07626178159663,54.90765684952599,16.343108465885763,90.8248958003919,27.822131560302324
Glycosphingolipid metabolism,128.2922720064066,46.448021959182825,3.905786198466403,119.39959292118813,7.64645921083926
Inositol phosphate metabolism,127.58728532026261,57.72679720701859,4.502325357211347,106.47804493444626,13.311760132138708
The NLRP1 inflammasome,127.58645448331919,49.651886960789895,13.162214468188495,98.53601775539232,17.201340344098558
Neurotransmitter clearance,127.51170553449212,69.68655634665272,18.726317154685688,92.44065213998395,21.668741967863898
Vitamin C (ascorbate) metabolism,127.34203972139994,74.25026498988643,2.9917846796538416,120.24469658885675,7.137186261284728
"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",127.33037299663118,64.54383081509243,9.704744093041327,101.1990125176039,15.097486973732535
Metabolism of nucleotides,127.2827009722844,73.85344587211662,21.240816961331795,99.14960671636658,17.803162866562126
BBSome-mediated cargo-targeting to cilium,126.71373595545018,75.35482820109245,21.359751980341596,89.87165505935431,21.73670504723723
Hydroxycarboxylic acid-binding receptors,126.58340365115485,44.19616580540261,15.583638286433377,97.95357134591623,19.33175353062262
Elevation of cytosolic Ca2+ levels,125.7782813589619,62.49973698514082,23.425409068009664,89.01752730607102,24.49086838393516
Synthesis of very long-chain fatty acyl-CoAs,125.41057537090667,40.32561075611121,6.807083961890797,102.94839785239456,15.16597185977607
Organic cation/anion/zwitterion transport,124.2654405427638,48.892564195011055,13.944260606885415,99.30917859553225,14.07932751587431
Neuronal System,124.15312391073223,54.03533695315531,7.546546991380282,104.3676531984934,11.124434627118925
EGFR interacts with phospholipase C-gamma,123.67623127996409,65.86940933994299,13.028697665032842,89.31154459758271,21.494213382484595
RUNX1 regulates transcription of genes involved in WNT signaling,123.32173540456652,63.02177360709018,17.36693290060818,75.47443986730924,30.845385852693408
Acyl chain remodelling of PG,123.08251718056468,52.46094313129278,1.9214825721848188,107.35102501264888,10.60157414657879
Amino acids regulate mTORC1,122.84346849321987,55.403116923307344,14.728512271654273,91.95980843659144,22.823213685075608
Negative regulation of the PI3K/AKT network,122.70044610149087,60.88116709310511,8.43823482598595,99.52999927870817,13.280141180862596
Release of Hh-Np from the secreting cell,122.68899071254724,68.58015065828401,17.464835054464608,98.01142703418232,13.505979490560144
Nucleobase catabolism,122.63893952525224,58.82384418685216,18.31996824157654,93.09089121501191,17.36658335074843
Linoleic acid (LA) metabolism,122.5268388584997,76.38202879043511,28.15624759720063,82.39169542449109,29.504674067650775
Prolactin receptor signaling,122.43538336248,51.588020492136295,6.740221736797024,105.452309441328,12.518404393511014
Synthesis of PC,121.812366809757,54.31206477558037,2.633273210654562,116.4838187995823,6.062286442622341
Sialic acid metabolism,121.03776849257837,41.22046336401481,1.794194769345776,120.68668887151479,4.753480626162118
Beta-oxidation of very long chain fatty acids,120.96818431559755,90.22560175735477,9.418907163728564,95.86110244307298,16.21200088522739
Transmission across Chemical Synapses,120.8892359265195,59.01966953242222,9.418663908991158,100.6356038416316,11.797834542780823
Signaling by Overexpressed Wild-Type EGFR in Cancer,120.79092263498492,64.43827099702098,8.395563062012815,91.45371945962245,18.5026655594859
Inhibition of Signaling by Overexpressed EGFR,120.79092263498492,64.43827099702098,8.395563062012815,91.45371945962245,18.5026655594859
Interleukin-37 signaling,120.40354763662278,51.65710547986903,6.779126556715353,100.58146549846248,11.315170308828359
Acyl chain remodelling of PS,119.36706333055227,54.652791009033756,1.7175784053939036,107.92192245531321,8.33610752851985
CLEC7A (Dectin-1) induces NFAT activation,119.31342378164571,64.84145012925656,23.25979113563139,83.11614815438274,25.009587306454097
Metabolism of folate and pterines,119.05787245850642,65.02098085897674,30.58345458759317,78.46300911613407,29.205879099961546
RAB geranylgeranylation,118.69901844511662,53.689444741242326,4.697193648959763,111.19674129382774,6.404495206929048
Peroxisomal lipid metabolism,118.31483250579672,80.48603523305422,10.58569779004538,99.68483979703373,12.341949338610167
Oncogene Induced Senescence,118.25941118212603,70.41118502949477,15.546288108372769,88.23015944709412,20.309988949079955
Ephrin signaling,117.2587020159849,50.13403213207764,4.9982801853418986,86.66573249149474,14.429609183036833
Cytochrome P450 - arranged by substrate type,116.31894369641059,70.13051645515546,4.3415726367918435,101.9864416980558,8.847204739845516
Amine Oxidase reactions,116.20445112341795,47.91229673178567,22.119049632993725,74.83125869111961,28.456686155455497
Manipulation of host energy metabolism,115.4529279315075,51.58321655071134,31.473778123974974,70.83927804421876,30.572905234759336
Activation of C3 and C5,115.32786366492381,82.49224607487018,12.209552500497525,90.4017022649689,17.823585614217762
Phase I - Functionalization of compounds,114.34682429106533,62.03161591893361,6.266552700089216,92.54751686119327,11.896589594803949
Visual phototransduction,113.74506944667502,76.6702768774341,35.701463290976264,66.76240507916664,33.13151154935562
Signaling by Insulin receptor,113.19450808368606,51.662917635346574,17.34538277483295,77.56285531661375,26.631323475271124
RUNX3 regulates WNT signaling,112.26838908880474,37.73322277428482,1.2846301493523098,105.4803299998851,4.8312909254379175
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6,112.17897757557553,52.11681511738166,3.5969503772222957,107.87448074238691,5.726385259199029
Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects,112.17897757557553,52.11681511738166,3.5969503772222957,107.87448074238691,5.726385259199029
Diseases of Cellular Senescence,112.17897757557553,52.11681511738166,3.5969503772222957,107.87448074238691,5.726385259199029
Evasion of Oncogene Induced Senescence Due to p16INK4A Defects,112.17897757557553,52.11681511738166,3.5969503772222957,107.87448074238691,5.726385259199029
Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6,112.17897757557553,52.11681511738166,3.5969503772222957,107.87448074238691,5.726385259199029
Enzymatic degradation of dopamine by COMT,112.16614379708454,60.740051319736736,14.803713630429447,90.02009648462881,13.172339875589042
Dopamine clearance from the synaptic cleft,112.16614379708454,60.740051319736736,14.803713630429447,90.02009648462881,13.172339875589042
Regulation of RUNX1 Expression and Activity,111.38189026059086,61.68490423989446,5.918083021079261,89.58535509096697,13.62011865874271
Metabolism of lipids,110.99046652543858,44.93594244440245,2.6882504725749192,104.2535599738995,5.3909800810869495
RET signaling,110.1124059892203,52.94344782527751,0.4522687967427661,118.95675737859521,2.1242426108664016
RHO GTPases Activate Rhotekin and Rhophilins,109.78981975610655,29.78648715275483,0.6173071945687245,115.94795560454186,2.530580411988668
Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane,109.45703814539841,90.74596882162652,21.55136933360276,79.3423852792342,18.86734917381675
Constitutive Signaling by Aberrant PI3K in Cancer,108.76892046664396,57.816763628966264,13.796548522162174,77.01535669275184,18.36374753243316
SLC transporter disorders,108.65852731676708,51.662917635346574,11.811187688269248,91.69596136588575,10.70270419125974
Diseases associated with glycosylation precursor biosynthesis,108.06720180844648,35.22953178665245,1.1601865921367047,109.9658062964461,3.7971559926882628
ROS and RNS production in phagocytes,107.74224891316165,51.24769956565592,12.895306086403016,80.47526109776283,20.320963088977575
PI3K/AKT Signaling in Cancer,105.94638028504863,54.38006511716855,12.063895943056483,77.55604266332107,15.65538788189375
Signaling by SCF-KIT,105.45826601476823,48.199540784571894,5.0581508043550745,89.87616019288512,8.916884958088978
NOD1/2 Signaling Pathway,105.45826601476823,39.997929716808564,7.999938055035588,83.33197738755699,12.130194800926194
Cellular hexose transport,105.21634018537681,49.4739421974829,11.825245378469187,88.12797518123132,13.01896247660482
ATP sensitive Potassium channels,104.99812949477409,56.460455534972716,6.945740487313858,80.9054861728882,13.214075241755744
HHAT G278V abrogates palmitoylation of Hh-Np,104.91382803069213,49.4382814042437,5.235238840014929,86.1653292978882,10.73897266553608
JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,104.5788007291927,55.4639695986098,8.24613454483231,86.94491336913083,11.63159355044482
Signaling by ERBB2,104.38891130918559,35.00046940367502,1.7188447259131903,99.82294701334534,4.565435701887629
Metabolism of steroid hormones,104.1983088658221,65.0513593317879,2.698632379506551,89.37316100120819,8.22086288482519
Netrin-1 signaling,104.11424232403348,53.69054517363709,8.95835773443657,85.8119782438136,10.60972240930107
"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",104.0275928728152,41.527384328361755,8.95776986098025,80.02305961011945,13.804856470454643
Glycerophospholipid biosynthesis,103.72843247375816,33.15810750720853,0.3337283669927169,107.88938555688428,2.4871793900615917
Defective NEU1 causes sialidosis,103.63845067023317,32.16456056319172,1.0769549335612723,106.09699096768752,3.495802949904097
Interconversion of polyamines,103.17785532790168,39.99274492210292,10.647022787929387,65.3828635107035,24.067403829258424
Transport of small molecules,103.02524910998935,42.70395211024616,7.024593168584208,91.18200542652619,7.592536670020912
Glucose metabolism,102.98368903523524,50.30347049278575,17.152422299106743,79.04828917086179,13.870079217654544
Transport of connexons to the plasma membrane,102.86557747542123,79.85950384000537,20.257291562414924,76.57583819488394,16.157877870809386
PTK6 Regulates Cell Cycle,102.85065779533724,44.78600604048606,10.833743371750641,81.5770384645002,11.636547306218416
Activation of PPARGC1A (PGC-1alpha) by phosphorylation,102.56338299644449,48.089002174972016,3.4794328327619173,84.7502222926271,11.974662767496321
The activation of arylsulfatases,102.29964505110917,48.199540784571894,13.586782069068967,80.80193216784356,12.134698859911072
RHO GTPases Activate NADPH Oxidases,102.28299473720027,52.11681511738166,15.595219557168159,69.49386799402507,18.695143520175044
Caspase activation via Dependence Receptors in the absence of ligand,101.36865989990912,65.90740252501381,29.048023142838716,69.6994836405149,21.73814664548321
Phospholipid metabolism,101.36865989990912,32.015680894789966,0.34436312863507024,104.9525572312838,2.3915906888282796
Signaling by EGFR,101.19507463502853,46.76669456901916,4.646982155408105,88.34261680632804,7.255554802631907
N-glycan antennae elongation in the medial/trans-Golgi,99.50063752566516,63.46468824910002,24.400878265208622,62.42938049596648,26.81963367892742
Androgen biosynthesis,99.42244601665554,28.452809219762244,15.222617599712645,68.81918789214441,20.76801104165021
p75NTR signals via NF-kB,99.2403771309987,43.86994647118713,5.8177335037486,82.54284953242707,10.80048927868085
Miscellaneous transport and binding events,99.1386216607534,53.8430650138431,5.422607281354744,93.21524504757294,5.243804047162374
Aflatoxin activation and detoxification,99.0951136680566,53.791328959227606,8.554003740927023,88.32680209263752,7.7885641135651325
Reactions specific to the complex N-glycan synthesis pathway,98.9900257328424,49.115710837486375,21.98157565444749,55.79086573507004,33.392806584556915
Biological oxidations,98.94567240923313,48.66933264781426,6.2796846640677595,85.8369566125304,7.672492897786212
Neurotransmitter receptors and postsynaptic signal transmission,98.86591240521003,52.828524050430225,10.085831303835901,79.51120024988673,11.532385376473286
Endogenous sterols,98.14109624563743,59.393807230194206,2.0717379987733033,89.75749559026082,5.805718801125423
Metal sequestration by antimicrobial proteins,97.99282731299992,44.399335513294986,28.996196940941182,51.67927465016542,33.14733614931761
NOSTRIN mediated eNOS trafficking,97.70386220557823,72.22227619134422,17.246998739806532,68.69199077401257,20.934591324544346
RHO GTPase Effectors,96.91405352108131,59.120600427794834,21.976523789883107,73.83021983235905,15.357977393964184
MAP3K8 (TPL2)-dependent MAPK1/3 activation,96.6974991726169,47.3576408051685,11.246456101169743,74.40803755122766,15.532649245387674
Gastrin-CREB signalling pathway via PKC and MAPK,95.85866347880692,36.66645986913688,2.423143530504997,87.81543010775631,5.939150071669783
p75NTR recruits signalling complexes,95.71147345673165,41.1062791853505,5.79190459500591,76.84830162700257,12.623879368100694
Gap junction assembly,95.71147345673165,67.2609121311564,15.988064446414812,76.0366078595122,11.873637173110781
Ion transport by P-type ATPases,95.44985609407733,33.73204745131029,4.267677392384703,80.98685493755512,8.353420648041707
Gluconeogenesis,94.59172818043784,47.11632955374827,21.57745418875892,67.82303980827398,15.58810510683575
Calcitonin-like ligand receptors,94.56718658669101,48.40617275702859,23.25979113563139,66.78539194651019,18.573314509295454
CDC6 association with the ORC:origin complex,94.47919569615458,61.0418272603848,28.067190235893545,59.97902201415367,24.47813564079752
Glycolysis,94.44146183862448,48.98552041483962,16.903046069647683,73.19576873199316,12.878041941390197
Signal attenuation,94.35926415564485,45.349814689848856,8.087758978414962,73.15253368399766,13.660544902324023
Glutamate Neurotransmitter Release Cycle,93.30131090334493,39.78318820031913,21.493101585368105,67.99580088722252,16.79927244011451
Metabolic disorders of biological oxidation enzymes,92.94162857382014,60.42221843975712,0.9141675208322183,89.89562781992306,3.839983985490705
Metabolism of cofactors,92.8829298599295,50.20018643401404,24.78250626829345,59.74717737510279,21.16098284799768
HS-GAG biosynthesis,92.72629312395145,29.61088218900675,14.995198409165011,69.19129326482587,15.365702106767639
Cell-Cell communication,92.71169071730378,32.23858468567268,3.2270794437777597,77.2877032870565,8.313100998285817
HS-GAG degradation,92.22775427236095,32.61116618515041,15.451585823186665,65.93457760933137,16.388236038673117
Signaling by Rho GTPases,92.18794677523749,56.064110652578286,19.519592360743747,72.10664468493997,13.21804363581538
Phosphate bond hydrolysis by NUDT proteins,92.1725378411324,41.11242177537063,24.219656712376516,63.51460185921085,19.638850056633725
RHO GTPases Activate Formins,91.5756314498642,57.39886999794609,21.5677982368666,69.01536866398892,15.908007326663943
Diseases of metabolism,90.98713167954625,51.95116170234346,2.4287070072008428,84.6589760133396,4.806004588863914
Interleukin-12 family signaling,90.9217002103252,51.422820608810795,8.90384490108001,73.93826469314806,10.40520269477225
Factors involved in megakaryocyte development and platelet production,90.10031031672611,59.585389605534544,23.217035234133885,65.60344652216074,17.13783983399025
Mitotic G2-G2/M phases,89.64809648222855,52.57818940418053,24.697932308272673,63.7100696603971,17.24039501221972
Signaling by Interleukins,89.38916848078553,45.49375956451209,6.94140910337792,75.34490354777076,8.509407004324702
DCC mediated attractive signaling,88.82611370309982,45.1155014391334,12.463835735346285,65.9261036875204,13.481778932088414
Sphingolipid de novo biosynthesis,88.79815240144664,36.74179188094564,3.231128310531847,74.3219398573904,6.773210817844855
Ovarian tumor domain proteases,88.64968955801818,48.24254359207388,14.236149086118967,66.23837761836467,16.685078726413927
Erythropoietin activates RAS,88.24886627496346,40.455333566414126,2.423143530504997,79.23352602301337,5.875383326549776
Phenylalanine and tyrosine metabolism,88.22733256142878,49.920457774976526,4.9606996953558875,86.1655386974715,4.405731982434786
G2 Phase,88.04831732330778,43.245217109798595,15.483019050522495,68.44235002562966,12.637553954802364
Platelet calcium homeostasis,87.94731924619151,39.15975934991186,10.947787179311312,71.73548550678316,12.582368650990139
Activation of SMO,87.71699103174284,22.03229373910849,1.3077279503991008,84.21458133770732,3.557464877703465
Class I peroxisomal membrane protein import,87.30955366759213,48.774318189118844,17.616500027786124,51.94888660184216,23.716110480364442
Pentose phosphate pathway,87.22557197627783,28.544888195463756,5.839687164517375,80.54937046851596,6.31883842575201
Estrogen biosynthesis,86.83190210474416,27.875195731816042,25.754572276204176,38.14988372849239,37.85002605830238
Phenylalanine metabolism,86.56754740031609,48.69927956088704,16.68653817939579,65.0721480473097,13.84670328002657
Interleukin-12 signaling,86.53747934408426,44.853898083754245,9.353973214238579,71.06677201291069,9.403989230446934
Cytosolic tRNA aminoacylation,86.30425000019022,51.662917635346574,20.645167009706743,57.34246120973104,23.383222711436197
"Cell Cycle, Mitotic",85.79021164331061,54.895990553185925,21.57745418875892,63.44958323399029,15.195821941449354
Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,85.47181867216642,55.1813771815584,16.46273646412853,64.71369860014426,12.972907938166177
Immune System,85.37419692817737,47.24670393778072,9.475849862421917,67.56967486139786,10.713251833615292
G alpha (i) signalling events,85.19529067350747,47.479971914955094,9.449283249810831,66.02481264082775,11.482158159949659
Glucocorticoid biosynthesis,84.75161718610633,58.28683328313347,1.1700638873504443,78.86588900669472,4.552993342887458
Assembly and cell surface presentation of NMDA receptors,84.45616178009689,57.505879849452185,24.016693925596574,57.04931176568708,17.514882932642006
Mitotic Prometaphase,84.36026360799391,53.497165432344055,21.060360231377803,62.03283707675437,15.812383162913198
Phase 0 - rapid depolarisation,84.31106966566152,40.35289828110785,23.46948590162764,60.7829906484236,18.586614134713425
G2/M Transition,84.2370025754778,48.70637821359367,22.49944818019261,61.04789397507816,15.164179599840333
The phototransduction cascade,84.16140545049777,30.802854081815884,5.406245046661987,72.1932217959561,6.724488683829702
Erythropoietin activates Phospholipase C gamma (PLCG),84.13710190650207,37.12002304286245,0.8182872979041377,83.9595989754883,2.8997884047433793
Synthesis of IP3 and IP4 in the cytosol,84.04444911660697,38.011585246806916,3.8808437866085215,67.94134541392313,9.85059538100645
Innate Immune System,84.02169693810791,44.07475457815312,8.872598195954025,67.95148676282192,9.462278850993771
EML4 and NUDC in mitotic spindle formation,83.59732792759705,53.37213922945511,20.683647985063693,62.939283024303236,14.756190221173082
Acetylation,83.50959696227804,64.3766319480085,9.557468467000648,61.9376146663169,12.328314503068208
M Phase,83.41958381004319,52.245177402756674,21.59037559708675,61.994150655354595,14.318067022416697
NOTCH1 Intracellular Domain Regulates Transcription,83.07082124736321,27.46689345311435,9.623650458293257,64.93241469028561,9.817610938459643
COPI-dependent Golgi-to-ER retrograde traffic,82.82989207254214,56.880674529025505,21.972960536734128,61.00487164073883,16.009129226936086
Regulation of TLR by endogenous ligand,82.59469701422738,42.96276543796835,18.867218925116173,48.56230615566422,23.050424084357275
Binding of TCF/LEF:CTNNB1 to target gene promoters,82.55901207413889,25.931000946908245,0.3056972786561963,86.18774207553534,1.7283428618574108
Alternative complement activation,82.52794234207927,55.795711451377926,9.436569566660163,54.31643872973745,17.42916592702198
GRB2 events in EGFR signaling,82.35278580778683,34.305796177652184,1.633461477834774,75.72264009203451,5.511104361409356
Transferrin endocytosis and recycling,82.35278580778683,35.92584304814958,10.231299067824953,60.78673738295104,17.066004823038302
Rho GTPase cycle,81.98247012717002,41.47119798009219,4.113400964456029,65.63989234644158,9.597961389532504
Diseases of glycosylation,81.42108121798672,27.39410461749452,1.5940758562366886,80.15239900559449,3.071534512455185
Cell Cycle,81.3993646783191,51.588020492136295,20.196854485916205,60.88037301359343,13.881532708344617
Signaling by GPCR,81.25470099081326,41.8989145590328,7.213510893146385,64.45888757361199,9.85212631140776
Mitotic G1 phase and G1/S transition,81.05221085653793,47.4292920949014,17.5723454161241,63.8753126410499,10.689793582376863
SHC1 events in ERBB2 signaling,80.93222193719302,25.407476421772248,0.6914187500752159,77.59488555322706,3.561249001512728
DNA Replication,80.92730048668683,49.24657459954917,19.94740354457232,60.58895284632877,12.997670956240885
Interleukin-4 and Interleukin-13 signaling,80.75563928268973,34.65916697105187,3.5868687001862622,69.66955183876128,6.760356118535401
Activation of the phototransduction cascade,80.70506052247079,34.68322258783551,6.144586772247522,52.567196189032224,18.462606487974373
HDL remodeling,80.70012344416685,43.56877258184193,10.56963512828133,60.89718937130205,11.618729161202811
SHC1 events in EGFR signaling,80.646505600109,33.86223856616154,1.4649613148750618,74.83125869111961,5.148046445863993
Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET),80.4941114713216,49.640787781746894,25.112898506763397,42.95215721257258,25.882912943064767
Peptide ligand-binding receptors,80.44282766571496,46.60698160047324,8.321314877346953,62.59360703551736,10.5321849919784
GPCR downstream signalling,80.34525089208515,41.367432396004055,7.355366741063446,63.22938120627752,10.017479710673749
Cargo trafficking to the periciliary membrane,80.29627746744512,41.92060604418376,5.797002145321447,66.30029231289755,7.906441992291389
Signaling by FGFR2 in disease,80.25641399694537,47.6796079366662,8.861235399945675,71.05989600369628,7.939798661187044
Glutathione conjugation,80.17560986701965,42.85390777570369,16.467272456059046,58.831009935248105,14.632006532607434
SUMO E3 ligases SUMOylate target proteins,79.81170174889286,46.100852809705586,9.86790734317985,68.34241810559345,7.553356920204382
TP53 Regulates Transcription of Death Receptors and Ligands,79.58980546873615,32.35216103575065,2.865542919210817,72.24794329976963,4.843177822688142
Signaling by Erythropoietin,79.17524276888263,38.29944956719424,2.3598876034319645,70.54185679254802,5.329622011539298
Neutrophil degranulation,78.89030092532548,39.36495671293733,6.360931966870965,68.0637354974391,7.036376760303364
Insulin receptor recycling,78.75606561837056,34.077004100775106,10.572660530972538,57.115635830779524,17.230803719494897
Defective CYP21A2 causes Adrenal hyperplasia 3 (AH3),78.34294047921641,52.792142183675416,0.9110536347274645,73.62615684300512,3.9610003737636093
CTLA4 inhibitory signaling,78.29828324309831,38.909495428732846,5.319414185156206,71.35944451066547,5.018463150696425
Separation of Sister Chromatids,78.24914237874897,48.674430114755815,19.221212099882244,60.644846597721845,11.839697957635662
Pyrimidine salvage,78.06793338217453,45.84016364554847,19.655404876963203,57.774078244160805,14.848454218393762
Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,77.97688564112732,49.86902096289677,19.072184987884672,59.696251859378975,13.280141180862596
Amplification of signal from the kinetochores,77.97688564112732,49.86902096289677,19.072184987884672,59.696251859378975,13.280141180862596
Resolution of Sister Chromatid Cohesion,77.88448548482643,49.55497574509403,19.50390015862486,59.32282837183042,13.268252323146228
Protein-protein interactions at synapses,77.71226529946233,22.910695544086632,0.3404163339437789,80.10850621972291,2.3960901088784907
Signal Transduction,77.54097825828275,33.777791205948816,4.419569133304001,68.25070680661447,5.631922602444933
Mitotic Metaphase and Anaphase,77.23070160340868,48.13141264723591,19.243316170076284,59.732737062183915,11.769969801173811
Mineralocorticoid biosynthesis,77.11048072787119,52.667571890024504,0.8687657527906536,72.58170854516642,3.85632602027869
Beta-oxidation of pristanoyl-CoA,77.05275252137453,46.73270308497224,0.35746321195041775,94.50412844377564,0.6423507509256512
Toll Like Receptor 2 (TLR2) Cascade,77.01309516199888,32.65085259097923,3.108419170841678,69.25647980083288,4.991730959416686
Toll Like Receptor TLR1:TLR2 Cascade,77.01309516199888,32.65085259097923,3.108419170841678,69.25647980083288,4.991730959416686
Toll Like Receptor TLR6:TLR2 Cascade,76.9600562199419,32.574382421724216,2.8791568543755943,69.80940493197323,4.7481980334620255
MyD88:MAL(TIRAP) cascade initiated on plasma membrane,76.9600562199419,32.574382421724216,2.8791568543755943,69.80940493197323,4.7481980334620255
Mitotic Anaphase,76.94467136549001,47.65740871003951,19.07182512981697,59.51891148735631,11.699450927068963
Activation of ATR in response to replication stress,76.92705465424304,47.803667175785115,18.526674974295545,55.62667124166872,14.081543068967033
Cell Cycle Checkpoints,76.7506649838458,47.255890939093796,19.45627396671136,57.97583596903031,12.56291936021015
G1/S-Specific Transcription,76.65226516138452,51.541339213011085,18.262888613881817,60.58825547478538,11.36547429225396
S Phase,76.44732115205393,45.380435309478116,16.57627566323456,60.33916362285771,10.129936325232288
Antiviral mechanism by IFN-stimulated genes,76.4275222460726,37.92779907884174,14.192770914740942,61.82382948496276,9.62408643514469
mRNA Splicing - Minor Pathway,76.31970527771914,41.26246598220214,11.801563251275821,62.458834224613504,8.828967795666491
Synthesis of pyrophosphates in the cytosol,76.18905720521165,36.84973782854687,1.479908824276579,66.2757629577716,7.287234492381841
Mitotic Spindle Checkpoint,76.14194853572675,49.516247124551136,19.01148230251697,58.51005313935619,12.823541811485754
Dissolution of Fibrin Clot,76.0867283312208,27.95084817016318,6.2147448980204665,66.65397371351725,7.351775837650389
Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA,76.08540498042409,31.34733724241205,1.4068828884034768,81.31086525113899,1.8488668280124887
SUMOylation of DNA replication proteins,76.03831270441604,43.6664618678227,15.140025509015961,60.81739543048323,10.7538046628253
Recycling pathway of L1,75.92632074559154,34.56214395309289,2.824798829963455,73.84137743473764,2.7709317472044495
Regulation of signaling by CBL,75.50596382625996,43.90450815619128,5.343997226310612,60.365149872097064,8.580052859144606
Neurotransmitter release cycle,75.26068025710349,25.197920017891803,11.074393494434942,57.2379484936867,11.144561698071554
Mitotic Metaphase/Anaphase Transition,75.20355644976956,53.33324484280935,17.330750248466824,59.696251859378975,10.980794106401143
Golgi Cisternae Pericentriolar Stack Reorganization,75.1735958416139,47.31699515243171,25.12611489964641,53.10961736461599,15.596376299849597
RUNX2 regulates osteoblast differentiation,75.009449009553,17.90059007981038,1.909577774715573,75.51993667287543,2.410850500402465
Reelin signalling pathway,74.66475458270162,37.056839976246685,2.8722562459006538,62.92791594082014,5.921797838915123
Kinesins,74.59030169317937,51.04274709416581,18.487986902018747,56.99641789248215,12.807590336783147
Regulation of MECP2 expression and activity,74.55168027537756,31.78720054266407,17.889532372609338,51.634986393542086,14.691999836360988
Synthesis of PI,74.53873090626914,31.681615420017692,12.895306086403016,49.67862273800429,14.364402324034561
Toll-like Receptor Cascades,74.53873090626914,34.67311482045379,5.358013346584917,62.937907189473286,6.8003551342399025
SUMOylation,74.22937978280841,42.521140864934225,8.596573323881715,65.07902010736109,6.41553924821308
"Inactivation, recovery and regulation of the phototransduction cascade",73.83703175815582,25.341845139849486,3.983701338102799,65.46715889699185,4.966967003866942
Nucleobase biosynthesis,73.56543142054512,38.54358833303125,7.045466732330477,60.60423062198102,9.845886314913223
CD209 (DC-SIGN) signaling,73.4081111307827,34.52917291414487,2.3127017195389756,66.81886223283038,4.897312816230156
Cyclin A/B1/B2 associated events during G2/M transition,73.31832347284644,45.29037186204556,19.27588593740773,54.92658415744687,13.128310408763234
Synthesis of PG,73.15040761711597,24.131525534089615,11.79159729362486,45.79467742766686,18.717868136310646
Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes,72.97256324152576,40.318453991788445,17.990404340936788,56.35738794935342,11.00154101638803
Nuclear signaling by ERBB4,72.8743663995002,30.981217830091122,5.306359047385108,50.56934537337997,11.28453015161554
Regulation of TP53 Activity through Phosphorylation,72.75097133288754,45.49375956451209,11.227909794037284,61.884979152412164,8.22086288482519
Cytokine Signaling in Immune system,72.46552908796615,38.98070308754889,7.005482388695233,59.61173726026457,7.831069846875054
Ca2+ activated K+ channels,72.33240334020242,15.814631272564748,3.7579159829983464,54.85129258690306,9.246379304459388
Hemostasis,72.30331908380595,34.07624160732658,7.196342523706388,53.49268077799889,10.006572038538481
Signaling by FGFR in disease,72.16350882277717,44.510323280781705,12.483638437901508,58.169674336433836,10.401320461387776
Synthesis of DNA,71.92370216523322,43.50513524578633,16.903046069647683,55.96715259732033,10.077836845400247
Circadian Clock,71.79823585557791,27.883747603354955,4.216135452066182,66.09183382736937,4.450502755750558
Response of EIF2AK1 (HRI) to heme deficiency,70.84300820422443,50.57976308667535,28.83781960047775,41.04188895967462,25.860778161568028
Unwinding of DNA,70.75407161730841,49.30616324158754,14.433365068154002,54.58909664898952,10.854663502064845
RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs),70.70288527116607,45.99270984882362,9.568561068609347,53.99870400722443,9.994296701569793
Transport and synthesis of PAPS,70.63109323915381,26.298812901357252,0.39928694832763595,79.79195033403018,1.300071035710505
Nectin/Necl  trans heterodimerization,70.5302016041096,20.80206110675266,1.8439991060462795,57.50684750504543,7.229739344206238
Alpha-oxidation of phytanate,70.40666243829507,39.074802913887225,27.12972989700515,37.90369232385923,20.450795749505502
GPCR ligand binding,70.35913653691253,37.378541430768976,7.159601615053266,53.950797352771346,9.70596785108625
Downregulation of ERBB2 signaling,70.35702901434998,25.322359564594823,0.34964271796770063,75.20604609456417,1.2646169085439327
TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest,70.32369934004493,41.90131148909251,14.433365068154002,55.830761378154286,9.729957514238446
Norepinephrine Neurotransmitter Release Cycle,70.14789006889029,27.709087831389983,13.666651023056849,57.6475022018413,8.481820942526852
Class I MHC mediated antigen processing & presentation,70.13939750044361,38.42871983462591,7.874276555077972,60.70391145059033,6.050705352719914
Branched-chain amino acid catabolism,70.0034448916801,50.509284585574896,19.231432644479177,50.347128344781986,13.37803306124045
Regulation of PLK1 Activity at G2/M Transition,69.65989887997137,39.78318820031913,20.057517222910622,44.93865767220086,18.573314509295454
Metabolism of fat-soluble vitamins,69.55827109218069,51.65710547986903,28.408266379627335,37.40212577233276,24.87688084156309
Acetylcholine regulates insulin secretion,69.5293459946424,32.31635364098567,0.6480501837243609,73.96129544268477,1.8044054413090824
Pentose phosphate pathway disease,69.30663299915457,31.5566506013027,4.2275858614612725,65.21969790668616,6.256935982503509
Ion homeostasis,68.8910731027658,33.616235495115234,5.033108307063517,57.385039166922745,6.324824331837526
Defective CP causes aceruloplasminemia (ACERULOP),68.8770084374488,44.416412205474835,7.45975546927416,55.381183233321295,10.566930470900184
Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages),68.8770084374488,44.416412205474835,7.45975546927416,55.381183233321295,10.566930470900184
Intrinsic Pathway for Apoptosis,68.85242271745028,29.252896256824627,5.257898002984389,64.28260833278658,4.342466398586115
EGFR Transactivation by Gastrin,68.76960720794247,25.48643739238064,1.004435000360692,64.49348853551004,3.8763779667430667
Activation of RAC1,68.50610260701386,29.818947663849293,1.7766861865673849,63.07534307452682,3.921073557704543
Extra-nuclear estrogen signaling,68.14183085168676,24.452241097756318,1.3159849830378907,63.11040428742175,3.2850809203655076
Class A/1 (Rhodopsin-like receptors),68.02037279866269,37.96911656479951,7.1566706162964016,51.3037567508497,9.754047876164105
Transfer of LPS from LBP carrier to CD14,67.97221872088352,33.90045189004183,11.542810754545608,41.68944814386969,17.569726936377926
"Activation of NIMA Kinases NEK9, NEK6, NEK7",67.968696974327,41.48714244097856,21.037980908576422,48.807381459535584,13.444788519603236
Phosphorylation of Emi1,67.85574648103396,42.910460564471926,20.247070760915715,51.094284523299216,11.878113548786901
PAOs oxidise polyamines to amines,67.70947943268094,19.284294092022428,4.774360441810409,44.54071960579145,14.375450872411447
Retinoid metabolism and transport,67.69969165233657,50.451226961653475,27.77790385297426,36.190093804079325,24.486398363610746
Fcgamma receptor (FCGR) dependent phagocytosis,67.67668077333568,40.1476944356503,13.758529838435358,44.740642081884545,14.494759846467463
Nuclear Envelope Breakdown,67.44861765703085,34.464411913554926,11.789256327760333,55.815968150238284,7.766347060550347
Abacavir metabolism,67.43050550426815,32.23568163445521,20.334561912224526,45.60810444069395,17.956745330295465
Other interleukin signaling,67.28885221290459,31.588401934768974,4.093721163102245,60.26570464662427,5.130304489942636
Eicosanoids,67.16328668219505,34.47408936996708,11.858429314961278,56.35437909879427,8.291843556806644
tRNA Aminoacylation,66.84548515525807,38.5707986118002,11.961899639307372,49.01585290014423,15.091466326196342
Carnitine metabolism,66.56224442716209,27.18327887729977,0.5334538124297945,77.38922903322354,0.7652738624495359
Activation of the pre-replicative complex,66.25551453819082,42.9936882918248,16.785755496127965,48.259136721443866,12.28719254965895
ISG15 antiviral mechanism,66.23824089510971,30.104025223659914,10.894796754521524,54.728651975721235,7.323555041194282
G1/S Transition,66.19413114798606,36.99352748419444,13.752473418445632,53.87384096740567,7.5768077487539305
Formyl peptide receptors bind formyl peptides and many other ligands,65.98782052283137,33.113536589934505,6.006854316144395,53.313496841254675,8.320059455991558
Interaction between PHLDA1 and AURKA,65.80240974677116,39.69848109367564,5.107195769044035,59.9447094083933,4.998403537640666
Activation of BAD and translocation to mitochondria ,65.74815460942835,32.29287898670052,12.155806241716892,49.136401563266546,10.234689469418997
Purine ribonucleoside monophosphate biosynthesis,65.59149767135659,32.1871667494783,5.107518084408379,56.93722276532057,7.563303865551032
Diseases associated with surfactant metabolism,65.51644863643908,39.50716006105329,10.977791267404491,45.09314248592214,12.50010967746608
Vpr-mediated nuclear import of PICs,65.1670929871633,31.130546006748403,9.305562503224243,54.57285733687428,7.4536299445384975
RUNX3 Regulates Immune Response and Cell Migration,65.025108148985,31.315692364813064,5.993105799321562,53.78261846610406,6.930165196725065
Golgi-to-ER retrograde transport,64.96707768765904,45.86010527171418,17.574431654630008,47.48802393212461,13.918004312549659
"Interleukin-3, Interleukin-5 and GM-CSF signaling",64.8893170713437,34.962907402717086,4.500315148631739,51.239144805429554,7.78226972066036
RNA Polymerase III Transcription Termination,64.88786069273658,44.73854360003872,7.24318040174153,55.42463206294136,7.5009912827565035
Signaling by EGFR in Cancer,64.83601082750573,23.722130072798144,0.6014758810175119,64.87545673719796,2.620338224649427
Transport of Mature mRNA Derived from an Intronless Transcript,64.61551755305554,29.658205756609544,7.789831968189689,56.28479230087527,6.160555705007957
Interleukin-35 Signalling,64.55018683392343,31.40505748976032,4.952428256593283,50.236661354727545,8.596990249785259
Viral Messenger RNA Synthesis,64.05786668999639,33.54957436775826,7.809644819991656,55.62667124166872,6.323790123083095
Signaling by Hedgehog,63.86978651832763,33.86301490867896,9.613891307439824,53.587269993782314,6.160555705007957
Defective EXT2 causes exostoses 2,63.80415831425313,20.30192242864164,13.008275874085397,45.43614375478734,14.437326869681375
"Defective EXT1 causes exostoses 1, TRPS2 and CHDS",63.79999847546474,20.30473148913482,13.008275874085397,45.43579248913099,14.437326869681375
Regulation of Complement cascade,63.6203878799432,45.197773916744076,14.576561352691803,41.36567879252282,15.031320731987032
ERBB2 Regulates Cell Motility,63.392557899051596,38.705461387674475,10.302095096945648,46.989444358126484,11.727735754314851
Pyrimidine catabolism,63.18932940298389,31.35347867265712,12.935524886732756,39.923746122281145,13.698332778236242
Adaptive Immune System,63.13009045245046,37.089309243710005,7.38590849758473,50.34338524540821,7.834557226095045
APOBEC3G mediated resistance to HIV-1 infection,63.089005569289945,43.1274613006954,15.928916049043101,45.571892115403536,10.627774709783209
NS1 Mediated Effects on Host Pathways,63.04726022499241,28.86444389738456,9.756213822990924,53.405936329408,6.946724467621031
Host Interactions with Influenza Factors,63.046464725864176,28.86495899622458,9.756213822990924,53.4043356909541,6.946724467621031
FGFR2 mutant receptor activation,62.95508342622226,43.547723255788625,10.205284188620952,54.65922295896997,7.5544331425922
Interactions of Vpr with host cellular proteins,62.82690901959805,30.04278690443275,9.434645273181394,52.23628938995052,7.138162733627721
DNA Replication Pre-Initiation,62.63930641729479,35.38763888966031,13.77917595778936,49.523040161817136,8.068082525443776
Signaling by FGFR2 IIIa TM,62.57295679357172,43.62191947511685,9.55655634622057,54.7059596123941,7.323266362531392
Transport of the SLBP independent Mature mRNA,62.501962320322555,30.04684290600732,8.206914247628461,54.57369872831484,5.900650466079151
Complement cascade,62.455053047501934,43.9294570879633,13.955636448159016,40.843853382273316,14.468212825519217
Mitotic Telophase/Cytokinesis,62.18465727306042,39.305684691835935,13.863380046023536,52.40696276968511,7.926152119384892
RUNX3 regulates YAP1-mediated transcription,62.18384906308973,11.58195481268323,1.1111489486772066,58.885464218350585,2.8359490288055964
Regulation of IFNG signaling,61.96526829840709,23.20934320189369,2.537308579292218,52.78222660505405,6.017821148096448
AURKA Activation by TPX2,61.939841144201324,36.15079640914373,18.753213856342537,39.859807448269244,16.78065687546487
Signaling by the B Cell Receptor (BCR),61.853243560568465,35.66248908154634,10.085831303835901,45.78435101288047,9.564020406263017
G2/M Checkpoints,61.48470787803248,35.49154222871179,15.172546829957838,47.61862976498959,8.500348235316396
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,61.36664427749889,27.505116188580512,2.8601441207411513,54.59793935232299,4.161033943711909
Synthesis of wybutosine at G37 of tRNA(Phe),61.07683248026711,34.543530109019514,4.2923369944707295,47.98924037264624,10.062081266276294
Noncanonical activation of NOTCH3,60.82923327963105,32.25052320410522,3.1159966420073197,48.04887063399625,6.757131555418123
CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling,60.748028820528184,24.16002955288404,6.291464234685486,47.684072282750655,7.322976003379409
Platelet Aggregation (Plug Formation),60.57935631629618,41.09036791885255,13.810640715652115,36.616780272628446,15.164179599840333
CREB3 factors activate genes,60.323584838271465,28.818137693399724,1.9060929471195551,75.86190334211989,0.3103214150361287
Export of Viral Ribonucleoproteins from Nucleus,60.276176741701605,26.63168200031016,6.435000625144474,53.152155511247564,5.430433309015252
Phase 2 - plateau phase,60.06427189325211,39.011665965824314,23.42054988874303,35.31777850347991,19.23949411482554
Signaling by BRAF and RAF fusions,59.8847839644087,21.601645244873335,6.39784399987215,50.86975808165427,5.7471181194147
SHC-related events triggered by IGF1R,59.47202083639864,22.1728835208579,3.3039025032918303,48.25884551726469,6.264059303669543
MicroRNA (miRNA) biogenesis,59.39498471418916,35.39180038993754,4.7014935561110915,50.09038712042306,7.2074418826943605
Transport of Mature mRNAs Derived from Intronless Transcripts,59.30563153260723,27.17819028353103,6.116692951699378,53.89567550183293,4.58517093516634
MyD88 dependent cascade initiated on endosome,59.237640824673605,26.285784060511556,2.549510609598689,52.99087523932389,3.8605236713373188
Toll Like Receptor 7/8 (TLR7/8) Cascade,59.237640824673605,26.285784060511556,2.549510609598689,52.99087523932389,3.8605236713373188
Erythropoietin activates Phosphoinositide-3-kinase (PI3K),59.202356288807,25.90359762786515,2.0464492040099027,53.668372039109094,4.097417732543944
DNA strand elongation,59.12613702473741,40.4582052525947,11.152961314918663,47.19063431336159,8.378078843511384
TYSND1 cleaves peroxisomal proteins,59.11491849605809,38.905235105988595,8.952258796864896,47.45517125277953,8.364911571716389
E2F-enabled inhibition of pre-replication complex formation,58.85839047490276,38.38179304080711,21.03187361534156,38.85189336842018,14.63694744208683
Post-translational modification: synthesis of GPI-anchored proteins,58.79405272325072,25.631397028991515,4.677935870853845,51.07786641906086,6.0310898572795715
SUMOylation of ubiquitinylation proteins,58.77055211108692,29.27099656382955,8.517613058932017,49.13474504231611,6.469625846215888
Wax biosynthesis,58.75223512483793,24.642906463690533,17.05222996235559,28.286528089162047,22.027938745527123
Sulfur amino acid metabolism,58.704781410041136,37.97918445352898,15.15499427706096,36.94238742277919,15.52009830779819
Nuclear Pore Complex (NPC) Disassembly,58.67223022309819,28.313812759905385,9.260521222527755,50.577992400558365,6.01953874843333
"Synthesis of IP2, IP, and Ins in the cytosol",58.62739283475854,32.22661477003138,0.39993253827680175,63.42701436504172,1.4635759784744198
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,58.541188284984614,37.63021797163162,8.169385027050621,45.230083967469255,8.123624411399867
Fructose biosynthesis,58.34527782426947,28.37203414782652,0.4329112585651733,63.69455876433937,0.8926528901776795
Metabolism of steroids,58.308303964562725,33.20560302231252,2.596138248367326,54.32600618608679,3.3576419232309136
Switching of origins to a post-replicative state,58.194613889775376,32.6918010741591,12.16806929710688,47.81971028512574,6.33914533553124
Aspartate and asparagine metabolism,58.17250523901509,36.010838582505755,21.308838831788584,34.18492034218367,20.189506889839134
Transport of the SLBP Dependant Mature mRNA,58.08534402465727,27.964371837191845,6.690988315055522,52.697630295316785,4.521495314293953
PIWI-interacting RNA (piRNA) biogenesis,57.544237112680676,33.652257652264225,4.677382871274216,51.26263260749892,5.604195856420102
Lipophagy,57.302039304991915,24.321193478508746,6.996497918579315,44.27521387378203,7.398312797829063
Intestinal absorption,57.07375880531355,24.081460261289234,3.2536309448533225,47.433849711805635,6.4108741947628305
Choline catabolism,56.96319919867028,42.410492482191074,26.095571239903176,28.07432786795359,23.008024619748745
Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC),56.94048467359559,25.430993707300367,6.567791947360885,50.30725387656493,5.242845688635174
Regulation of Glucokinase by Glucokinase Regulatory Protein,56.94048467359559,25.430993707300367,6.567791947360885,50.30725387656493,5.242845688635174
Insulin effects increased synthesis of Xylulose-5-Phosphate,56.74919973712833,22.177566558991373,12.534828631894737,44.74824523049063,9.116250727123337
Activation of BH3-only proteins,56.60462672139364,27.41791687273114,5.328821283917198,51.07247239937324,4.647467429894946
Surfactant metabolism,56.580907650547346,31.52978679577834,5.701484625431491,42.33930227891275,8.097418452958891
Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1,56.50066403745649,34.17453819788755,8.732359099362881,51.36253911832991,5.057727389554263
PTK6 promotes HIF1A stabilization,56.31392762122284,25.030911309833225,1.6579902880975128,51.67128851422504,3.760656224451995
Astrocytic Glutamate-Glutamine Uptake And Metabolism,55.89906677170405,38.053830258045835,11.400099563182449,41.86974959556391,8.472307448521686
Neurotransmitter uptake and metabolism In glial cells,55.89906677170405,38.053830258045835,11.400099563182449,41.86974959556391,8.472307448521686
Gap junction trafficking,55.65324482595029,32.08370654454313,7.20939483049533,50.802819853949416,3.245647789055181
"Gamma carboxylation, hypusine formation and arylsulfatase activation",55.65324482595029,20.633679758506016,5.964575765137111,39.85131893281277,7.355854640587603
Molybdenum cofactor biosynthesis,55.644210666749466,34.306124827923696,12.140087019351961,42.140964196234556,10.539848914780963
Apoptotic cleavage of cellular proteins,55.45135786511444,21.891028051839935,1.0373209510223724,57.31407434694651,1.1156314781709176
Na+/Cl- dependent neurotransmitter transporters,55.42158452146291,17.241842786489368,0.3614547335258213,52.53059020641506,3.4526750441300886
Loss of function of MECP2 in Rett syndrome,55.35661929262886,33.16393527244845,19.25907152977475,30.975857386791496,19.74098267472845
Pervasive developmental disorders,55.350116069064164,33.171844270229954,19.25907152977475,30.970486722613582,19.74098267472845
Apoptotic execution phase,55.1295521712421,21.79858442999099,0.9280634649068369,57.54723608211077,0.9994785176373273
CaMK IV-mediated phosphorylation of CREB,55.08230681215121,27.02329388161313,11.502360094180345,47.20275820328528,7.315003606747021
Trafficking of myristoylated proteins to the cilium,54.77911073521065,33.90045189004183,19.901441204879287,29.757238607422586,21.850956755068644
Initial triggering of complement,54.74201364214206,40.32272624393298,13.554050247456512,35.11975445033759,13.709209903491606
Activation of caspases through apoptosome-mediated cleavage,54.72616838462946,46.82155086865476,29.68518856729149,29.498423792866586,19.900932783880037
Chemokine receptors bind chemokines,54.67721939867713,33.30657277077892,6.09870117311445,42.78827011103468,7.202519747168424
Rev-mediated nuclear export of HIV RNA,54.650765211412526,24.593389530683208,7.108243958911051,47.97667331638776,4.959994914146982
mRNA decay by 5' to 3' exoribonuclease,54.621818870550435,23.240609040071362,5.371720817685434,48.47289013247856,4.393145581571565
Toll Like Receptor 9 (TLR9) Cascade,54.56043487266159,23.925493585581986,2.229572548670959,50.100410082617344,3.1885641288399134
Cell junction organization,54.248120622948896,13.204823966131254,1.4097898028840083,43.815514363213026,4.996179465426756
Signaling by Nuclear Receptors,54.05182213016362,19.81538677703735,0.8144214361140394,56.255899112241266,1.3029013865276953
Transport of Ribonucleoproteins into the Host Nucleus,53.953846291012404,23.505482612655783,6.123514006165834,48.41231638850179,4.643152732709156
Interleukin receptor SHC signaling,53.897799652272454,28.149853950401877,4.161210573983554,41.71587673339662,7.080002245424918
RHO GTPases Activate WASPs and WAVEs,53.881445830459,25.564149364594474,6.4017722103146975,46.24518903670584,4.488636215961199
activated TAK1 mediates p38 MAPK activation,53.87686891233617,17.57562765376312,1.0632734196171922,54.52834434270247,1.7358559084311365
Interleukin-2 family signaling,53.865472253920935,31.363263077147437,5.804978057891322,40.98358217960047,7.573477955665225
Detoxification of Reactive Oxygen Species,53.75992145836074,25.01622768446365,4.132464501672398,49.3549795030267,4.038806418605499
Post-transcriptional silencing by small RNAs,53.69530588538163,29.701232963251964,1.2294905726705072,48.33467008637419,5.540536816719615
Regulation of actin dynamics for phagocytic cup formation,53.68577986341856,33.497220386823486,13.719961323722575,32.86293928004716,13.834706858481416
Programmed Cell Death,53.51984747881502,26.792756632068475,5.391306105272147,49.46181981630776,3.2927465467381816
APC/C-mediated degradation of cell cycle proteins,53.372431264591185,30.369763900694046,12.13899675467321,44.04749886495777,5.995968568965081
Regulation of mitotic cell cycle,53.372431264591185,30.369763900694046,12.13899675467321,44.04749886495777,5.995968568965081
TP53 Regulates Transcription of Cell Death Genes,53.354910108002215,17.896665665830508,2.9132577418038603,47.340053816604254,4.233316111680802
Dectin-2 family,53.2547887960619,33.2439667497185,2.646139223610991,47.23958686166071,4.101155352626445
DAP12 signaling,52.766418827315015,34.50417951852,6.733401109061485,40.33703044750335,6.879253123729498
Polo-like kinase mediated events,52.73305477207093,38.21226403475746,14.192770914740942,42.22690758033969,9.19093077410758
Presynaptic depolarization and calcium channel opening,52.676410898479965,13.379224032462595,3.809446423636109,76.89845990298218,1.8191910472279913
Metabolism of carbohydrates,52.55183552816984,17.42502880708211,1.4504729388485376,52.393934247502024,1.869077888721114
Fc epsilon receptor (FCERI) signaling,52.518536156126686,30.437711641970264,9.208016730911213,39.11810070270633,7.791243050127716
Interleukin-20 family signaling,52.508491556415926,30.17237967408725,5.6401281743298695,40.32725569856867,7.349150062444482
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers,52.46235998126717,33.39597611761441,12.131338350735062,31.911824778510514,13.565144090945733
L1CAM interactions,52.413802553499465,21.68896984825537,1.5730637545443071,50.27278225661592,1.8635004282543872
TNFR2 non-canonical NF-kB pathway,52.36037908867869,29.47815828646408,6.577072858610975,41.94602595323786,6.882943044821108
Transport of glycerol from adipocytes to the liver by Aquaporins,52.2312958824697,25.27423594966776,14.702222770654323,38.83677187738541,9.367059328944455
Membrane binding and targetting of GAG proteins,52.20114060444616,10.825043066582651,0.4329112585651733,51.44607451597472,2.0108469952176855
"Synthesis And Processing Of GAG, GAGPOL Polyproteins",52.200876223289534,10.825043066582651,0.4329112585651733,51.44607451597472,2.010823873423484
G0 and Early G1,52.16218991025346,31.953860225151328,11.744984167651305,45.32345440714946,5.23013682298773
Anchoring of the basal body to the plasma membrane,52.13509766256334,29.194977430691136,15.769038382692287,32.891497028644544,15.066191966647589
TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway,52.09704236300554,31.494755729474683,11.034863568154783,33.61146002500925,12.448424728600619
Presynaptic phase of homologous DNA pairing and strand exchange,51.956112503972875,27.396940248397186,11.806541544256289,41.839060942069295,7.685795566755241
Interleukin-27 signaling,51.953406732418316,26.88648280228126,3.2015575562263363,41.730248639320806,6.6167706883930055
Muscle contraction,51.94461467619722,15.250368163954796,1.7242723191326346,44.42752916048808,3.5029389460187685
Orc1 removal from chromatin,51.89020450475711,28.4449537618875,9.689138618336592,43.713003468807564,5.088807705473846
Signaling by NTRK2 (TRKB),51.77567068206629,20.614464088080755,3.4465646138011086,40.16830942986856,6.362199065028071
Loss of proteins required for interphase microtubule organization from the centrosome,51.750212758532584,29.229989171230287,16.12767947041873,32.1216013988887,15.365702106767639
Loss of Nlp from mitotic centrosomes,51.750212758532584,29.229989171230287,16.12767947041873,32.1216013988887,15.365702106767639
tRNA modification in the nucleus and cytosol,51.70472207201317,26.739632167166583,3.5867507444544144,42.0251545552292,8.952254763857114
CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde,51.70472207201317,28.57012677829034,13.570312799686873,40.309994930973616,8.784199961316595
Interleukin-1 family signaling,51.57462895346142,24.088446815715116,4.914308849764552,46.63067794541023,3.5280404603275994
APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway,51.51192502894688,23.908308607522883,10.658655545032298,35.74483094742701,8.629392798387792
Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4,51.489543135337286,25.093607140991804,2.023855199797528,51.538370292518536,2.275312600256242
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4,51.489543135337286,25.093607140991804,2.023855199797528,51.538370292518536,2.275312600256242
"Antigen Presentation: Folding, assembly and peptide loading of class I MHC",51.434757078288754,29.453328419187454,4.543157889625427,46.96012346991896,3.5593403227287785
DAP12 interactions,51.33765691058161,32.86580946012277,5.983887966841776,40.48733770409031,6.036674345491203
Mismatch Repair,51.32889833233324,31.505977125226153,5.983887966841776,43.200714580789914,6.821105208029486
NEP/NS2 Interacts with the Cellular Export Machinery,51.232501696422005,22.1326290306897,5.793538225615078,46.52828050966994,4.195217406485091
Apoptosis,51.12653960044484,25.51313980951878,5.085046506114406,47.6300998758657,3.0196766455178787
Regulation of gene expression by Hypoxia-inducible Factor,50.99898701838379,33.65104033474418,13.638311327828138,38.111250107826514,12.723627562404632
O-linked glycosylation,50.76991283786617,19.49006312894323,3.301542682226895,40.27153540769713,4.647467429894946
Signal regulatory protein family interactions,50.641609291808834,25.845201232893924,4.509387442378992,42.27522144390751,5.645113798590016
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex,50.640112656331475,27.053524038625557,16.44830114813492,35.446492804878524,10.23130164858514
PECAM1 interactions,50.60979103885356,29.28206076276971,5.15624681170401,36.518981561626745,8.182643881946333
CD28 co-stimulation,50.57467566527491,27.326125545677755,2.9917846796538416,47.61862976498959,2.6309862224411256
Gap junction trafficking and regulation,50.41665346607788,27.829509945431248,6.502458434320853,46.22010338164572,2.8061096544691315
Antigen processing-Cross presentation,50.27862626709242,28.719305698277097,4.760894161713404,46.09076717667403,3.391445722247741
TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest,50.25080352588976,34.730879308010145,10.587801864906531,45.252933499052645,4.626008371687846
Homologous DNA Pairing and Strand Exchange,50.21282074060136,26.614863661431635,10.212141745426425,41.91253334536134,6.517305283292087
Scavenging by Class F Receptors,49.88952967243401,12.144879435974778,10.58569779004538,30.725443604798603,14.454970168723374
Ca2+ pathway,49.8320247489691,33.756809655589194,10.161613025769105,34.52185243650305,13.334254162385974
Disorders of transmembrane transporters,49.73705254442957,25.54508115662097,6.065912940902873,45.53866350451804,3.3142002714777377
Small interfering RNA (siRNA) biogenesis,49.701643923328305,30.943317547526792,2.392578365815464,41.52254367365779,6.409523431437138
Integrin signaling,49.54975717034877,33.315322921517954,12.062370401633826,29.276728448470163,12.982672170929112
Signaling by FGFR3,49.51975846123753,12.759371717452975,0.6401888589218353,46.36401283554233,2.322342942659264
Transcriptional regulation by RUNX2,49.37586029215889,22.318284579277798,6.062863551858868,44.23362603133115,3.4571522370596237
Assembly of the pre-replicative complex,49.24342319247791,27.836533910508617,9.82888846155301,40.74302608057612,5.1813881898719
Unfolded Protein Response (UPR),49.20108640356423,23.925493585581986,6.780593633355958,41.955333858808636,5.448706406553368
Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB,49.087801371446986,27.633802780658804,19.221212099882244,27.663906130718292,18.22106597677987
Interactions of Rev with host cellular proteins,49.0177621058819,21.105922630534995,5.824609911648087,44.6084347820603,3.812892778424793
Activated NTRK3 signals through PI3K,48.943640616318305,55.255694007129364,27.794879459789104,24.110480574886168,24.583866700165768
Proton/oligopeptide cotransporters,48.88963127252909,32.298242918673935,17.473917162106662,26.632939219482555,16.97687113879116
RNA Polymerase III Transcription Initiation From Type 1 Promoter,48.86277718608616,18.097504452015723,0.9560742237031398,54.374073852484244,1.225791744622568
Signaling by Non-Receptor Tyrosine Kinases,48.844184168005235,17.484332473834503,1.0424113571818212,45.12491181449099,2.3667128005005433
Signaling by PTK6,48.8367952664142,17.481952781855984,1.0422961098434658,45.12058800984103,2.3662640847420784
E2F mediated regulation of DNA replication,48.82527851140952,33.90045189004183,13.334742828531393,37.01013047537138,8.992020377795738
SUMOylation of DNA damage response and repair proteins,48.80963548949919,24.0652823652291,2.2674227368513904,50.7773151428661,1.6715198086765524
Recruitment of NuMA to mitotic centrosomes,48.80637037664232,30.709738233400234,15.798466206118837,30.114597184111567,14.909854810432401
Regulation of beta-cell development,48.73711514253157,24.63942542313702,1.397232978151613,46.417951531923634,2.540338874740238
Cell surface interactions at the vascular wall,48.62730702836937,27.336508946288372,7.623320103857762,32.26735181024287,9.852746699365216
Synaptic adhesion-like molecules,48.54759794311903,13.742893301194481,0.6546005886407876,52.69244084792945,1.3108240326214968
The role of Nef in HIV-1 replication and disease pathogenesis,48.53375765374847,25.84690219463034,3.745581693010043,39.48126250465504,5.104232788295723
Interleukin-10 signaling,48.447078097511294,28.04441158190781,1.930636791550928,46.94024773573446,2.9671193555913074
tRNA processing,48.39333509256771,32.11694675048453,5.807133831121959,46.29336724274482,4.041949199886721
Signaling by ERBB2 in Cancer,48.19661478713539,15.730446354341941,0.633954616340053,48.76790803096843,1.7160677180179542
RNA Polymerase III Transcription Initiation From Type 2 Promoter,48.02777264887814,17.671327701141937,0.9137059240076035,53.66822680965641,1.1683564141471972
Toll Like Receptor 4 (TLR4) Cascade,48.00465211629047,18.735442098981075,1.4324170662494093,45.98729236224046,2.2161154031716217
Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta),47.94881947231422,28.795126671736647,5.984799898459662,40.52026526207663,6.335587726141442
Trafficking and processing of endosomal TLR,47.92279608923708,34.09594062433649,6.5356410522735215,39.161972357250086,5.84395161270592
G2/M DNA replication checkpoint,47.92013324740702,29.222051505513193,19.484260886246474,32.854168275606284,11.124434627118925
Acetylcholine Neurotransmitter Release Cycle,47.911046061606825,18.161894783385815,5.664591724666254,45.06834497584917,3.399504390465931
p75 NTR receptor-mediated signalling,47.810926782180104,26.549317022580407,12.254628504186215,32.29599450020131,9.190283534582678
ER-Phagosome pathway,47.633706353929675,27.004705776005043,4.564453106759553,43.60788571021327,3.2443665260193115
Signaling by ERBB2 KD Mutants,47.633706353929675,15.748912693563994,0.32666712111486845,50.03759896153014,1.2895207954760008
Hedgehog 'off' state,47.62813563004169,26.361974707225095,8.276593216376426,40.06562191671288,4.700004923657644
SUMOylation of chromatin organization proteins,47.612086929224,23.311596026140432,3.2112683665180444,44.09759597657486,4.046513879244967
Nef and signal transduction,47.580329408288975,31.115143497879913,7.441262154138334,32.28329029192118,9.581654608904994
Resolution of Abasic Sites (AP sites),47.57533947823367,29.84480830407468,8.976016904000664,37.570820342769665,7.080002245424918
SUMOylation of SUMOylation proteins,47.49998389777617,19.641297262023482,4.500395435925582,45.22509666056979,3.050733427652592
Diseases of Immune System,47.37441160906144,22.21277256481022,1.8171382216801628,43.88764306754235,3.2157531482330532
Diseases associated with the TLR signaling cascade,47.37441160906144,22.21277256481022,1.8171382216801628,43.88764306754235,3.2157531482330532
Triglyceride biosynthesis,47.148522559229534,24.755911003797827,0.6647440034786273,51.07247239937324,1.3397809921190271
Metabolism of ingested H2SeO4 and H2SeO3 into H2Se,47.09376346737797,25.160149264426,27.066743568426265,21.686514055726548,19.114183098453736
Autointegration results in viral DNA circles,47.091926620399434,28.238221388878614,14.94010117322842,31.654221009727543,9.959721506871867
Integration of viral DNA into host genomic DNA,47.091926620399434,28.238221388878614,14.94010117322842,31.654221009727543,9.959721506871867
Vitamin B2 (riboflavin) metabolism,46.90830076680887,30.981217830091122,23.896508940977874,26.067030973168364,17.50283874684383
Cross-presentation of particulate exogenous antigens (phagosomes),46.7982787320983,28.573744867158446,5.003288433374569,39.34085722600903,4.773020790449549
Interleukin-2 signaling,46.5168267360736,28.6109713531262,5.322241415921713,34.471403723196055,6.688958513941054
Defective Mismatch Repair Associated With MSH3,46.46128802226221,22.59354710437355,1.2544554877346623,44.138467797676114,2.9864459092714317
Caspase activation via extrinsic apoptotic signalling pathway,46.38165757880427,27.4727555022427,5.08276845342293,39.60361433424007,4.781411118750731
Cysteine formation from homocysteine,46.33423529673722,27.171218971117785,3.3091580643059286,42.77502181280758,3.3935335518309553
Signaling by FGFR3 fusions in cancer,46.30232849251662,16.528666621157623,1.5337491145363957,41.82085850347401,3.2337157334190527
Interleukin-15 signaling,46.21538165060317,21.538873111211796,2.15183046334819,39.152324443368464,3.79827605581132
Assembly of the ORC complex at the origin of replication,46.06210577467149,30.638772176771806,12.068863018011681,29.01903494584888,13.933256928477899
Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK),45.923372183683746,35.46580916728074,24.959475799865533,27.83419949141582,13.238123276169674
Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha),45.908174079844336,28.680713187806617,5.368632866455128,39.05565152175992,5.964235335317195
"Defective ABCC9 causes dilated cardiomyopathy 10, familial atrial fibrillation 12 and hypertrichotic osteochondrodysplasia",45.84386478641566,24.482449047946652,3.3071088823927393,33.37300800934027,6.7858417052758115
Tyrosine catabolism,45.76248676563411,25.56391283686833,0.8930781545843188,62.0583188153615,0.7885180511244001
"FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes",45.68574077621457,16.766957939694016,1.0751116194446193,46.24518903670584,1.9774138380303643
VEGFR2 mediated cell proliferation,45.64608022112105,19.149687649139484,0.847935883235195,45.571545425648225,1.4215999864435098
Metabolism of amine-derived hormones,45.63946811121282,28.764372604138774,68.61433029563214,7.957955610430474,48.27830080042057
C-type lectin receptors (CLRs),45.59071664641678,22.94752293363602,3.8131036008993857,42.35504369307164,2.7560085130645833
TNFs bind their physiological receptors,45.46464059259713,29.83168027985569,7.7986661565169415,31.499398068657207,9.53747848029758
mTORC1-mediated signalling,45.37621785600697,33.43234894582311,19.13296499554178,27.94091680544619,15.952997458330362
Polymerase switching on the C-strand of the telomere,45.33201644097075,27.691301950932793,4.874179583764061,40.39799723622758,4.703091939950137
Polymerase switching,45.33201644097075,27.691301950932793,4.874179583764061,40.39799723622758,4.703091939950137
Leading Strand Synthesis,45.33201644097075,27.691301950932793,4.874179583764061,40.39799723622758,4.703091939950137
HDR through Homologous Recombination (HRR),45.261303863199565,25.723368509413618,9.257259349967471,37.52466195722292,6.246634917779182
Tie2 Signaling,45.1946140625766,18.735442098981075,0.7725725090943006,45.740085929002284,1.6440453330697153
Catecholamine biosynthesis,45.17839281975615,25.590647142199025,59.83833107722334,7.596683714886162,47.35223829165648
PI3K events in ERBB2 signaling,45.099873417398776,10.02226588167692,1.1327465695395562,47.202443766464796,1.0453946235877452
HDR through Single Strand Annealing (SSA),45.09725409157435,25.093607140991804,10.611018704835327,37.136978528947836,6.52420481954443
Transport of nucleotide sugars,45.02729015306733,12.898667777973783,0.35542450885864335,46.043021074609435,2.255937846896468
Centrosome maturation,44.56898416738587,27.107065158750657,13.955636448159016,27.784837581801927,13.411224164283865
Recruitment of mitotic centrosome proteins and complexes,44.56898416738587,27.107065158750657,13.955636448159016,27.784837581801927,13.411224164283865
Regulation of PAK-2p34 activity by PS-GAP/RHG10,44.56863069522635,23.54620778647475,8.808576593610704,18.639637118008615,21.799684700785132
Endosomal/Vacuolar pathway,44.568275867238484,26.61694365635246,4.231445376272891,39.878644249798846,3.260673073932588
Nuclear import of Rev protein,44.54822535767519,18.490301142276014,4.268001619714732,42.49693974455371,2.8411308571586216
Fructose metabolism,44.54111683690751,20.54013345247336,0.6319505884589949,46.74731517528949,0.9271248133931179
GRB2 events in ERBB2 signaling,44.45922254060131,14.81570103823893,0.3697973144589644,43.85170564723214,1.9273494367622963
G alpha (z) signalling events,44.447623450836474,20.982280914800562,2.0469075388647413,37.571255953614795,3.50002768590808
Downregulation of TGF-beta receptor signaling,44.43714855204689,12.037806972378604,5.628654806661791,36.59376801064994,4.88771767936977
WNT ligand biogenesis and trafficking,44.29474160385317,14.991623931610498,18.106922511904806,20.371951080719263,16.59570631909615
Synthesis of IPs in the nucleus,44.230451795872455,30.824210387827954,8.174673718680962,28.169101616155316,14.81366069107226
Serotonin clearance from the synaptic cleft,44.193100734794626,19.041178587768115,8.685636297121132,38.465483658128726,4.643152732709156
FCERI mediated Ca+2 mobilization,44.076268159134855,29.544735162794698,11.628883771408255,25.70593656860162,12.62633280625437
Nicotinate metabolism,43.614362211837644,16.883947323504533,6.663880715296597,30.814391987476153,7.041247195410974
Regulation of PTEN mRNA translation,43.31839667779848,30.864851673141075,1.8557946557198937,37.45121426117169,5.662749756145878
Toll Like Receptor 5 (TLR5) Cascade,43.30401721392709,16.803367117850105,1.7242723191326346,38.25167224074978,2.7560085130645833
MyD88 cascade initiated on plasma membrane,43.30401721392709,16.803367117850105,1.7242723191326346,38.25167224074978,2.7560085130645833
Toll Like Receptor 10 (TLR10) Cascade,43.30401721392709,16.803367117850105,1.7242723191326346,38.25167224074978,2.7560085130645833
RUNX2 regulates bone development,43.26373771955803,7.340719233479534,0.38574166997933496,50.085239713469,0.3912495204891879
RUNX3 regulates RUNX1-mediated transcription,43.143174734986296,19.122697721760826,3.7348202872460665,37.011172551908935,5.3694918601713955
Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes,43.06977985509831,25.958785582023875,12.849199610180177,31.560752107912467,7.573477955665225
Downstream signal transduction,43.01413257163205,13.905747628383619,0.3409316055115237,50.4872067526712,0.3817859995981336
RNA Polymerase III Chain Elongation,42.83736977644923,29.501819266187233,4.9894926888171325,38.02179676491534,5.1257983648631065
Intracellular signaling by second messengers,42.837286715606304,20.517378290962327,3.2296750122190634,40.08656634992636,2.472057663740726
N-Glycan antennae elongation,42.81983070442779,35.31499826535387,12.111780987739833,31.518559684161215,8.9252864336136
TP53 Regulates Transcription of Genes Involved in Cytochrome C Release,42.76159029029942,37.46567772743911,7.001423266862325,40.138630783188304,4.598255269562407
Defective Mismatch Repair Associated With MSH2,42.34950646126808,18.798693555187864,3.0954562036986415,33.36349096007002,6.536547107070018
FCERI mediated MAPK activation,42.34421399399174,27.169514108326698,10.589743340986546,25.278549911054885,11.495451044381346
Competing endogenous RNAs (ceRNAs) regulate PTEN translation,42.31096325322305,26.79142482459224,2.1011658969803406,36.21593538689781,5.890958310238677
AMPK inhibits chREBP transcriptional activation activity,42.25526527321809,20.689203109385005,6.452461971183545,22.45959886345954,12.723627562404632
SUMOylation of RNA binding proteins,42.245594607258894,20.206288705813627,1.7172502923609438,42.30629724286829,2.691262717391045
IRS activation,42.23647158121211,33.86103694968884,31.342355598190593,18.1690091838793,25.321696843217822
Resolution of AP sites via the multiple-nucleotide patch replacement pathway,42.157294156502296,26.283706807283878,6.67799129659424,35.209217640135925,5.32502577315685
Cholesterol biosynthesis,42.09458983829759,33.780680708500185,35.28193112772972,16.677423358508655,27.582978463365652
"Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3",42.09094723309646,25.161849648564317,10.120448654097437,24.757698074174574,10.83012135605699
ERBB2 Activates PTK6 Signaling,42.061071059858435,12.14286766200942,2.8568243021481665,51.156475900533835,0.3817859995981336
mRNA Editing,42.00990481574006,26.48332931902565,3.261502161691638,41.86298923359732,2.601443002887415
Formation of tubulin folding intermediates by CCT/TriC,41.76035528167336,27.262946725704058,10.234644420986324,31.582133593543688,5.964235335317195
Dopamine Neurotransmitter Release Cycle,41.39927568549823,11.364110292054837,3.129873907535429,40.02914139364036,2.2719534906932948
Host Interactions of HIV factors,41.3176484574328,20.055835918914685,5.0596937947243505,37.18214580256144,2.8206684424227584
Arachidonic acid metabolism,41.31728865581638,17.10700738099395,3.45193645659905,33.60929989146896,4.379187313595859
Loss of MECP2 binding ability to 5mC-DNA,41.24602176135873,19.764314783419323,15.017336552559282,21.22941078605055,18.4627979825444
Fatty acids,41.17427642478578,19.745829630364174,13.215213084502098,31.658447458917053,8.882228214047347
Constitutive Signaling by EGFRvIII,40.76843688202191,13.466132341160852,0.5545951153857226,41.48098227852851,1.4714494705715087
Signaling by EGFRvIII in Cancer,40.753021311982494,13.460355099105758,0.5534243837763597,41.4793062539623,1.4682343216394969
Formation of the Editosome,40.74585114218888,27.660558652782868,2.9909924690263847,38.09765070139635,3.242813111432951
mRNA Editing: C to U Conversion,40.74585114218888,27.660558652782868,2.9909924690263847,38.09765070139635,3.242813111432951
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,40.735812961004314,12.711187198856493,0.5391234445876828,48.884715871108,0.4450509459695362
MyD88 deficiency (TLR2/4),40.725506294236226,20.929215432460037,1.3252023129935022,41.20646158176707,1.9380095291018375
DNA Double-Strand Break Repair,40.701226864866065,23.15781649471318,7.913860229705837,35.380647084522664,3.8388575086953867
Interferon Signaling,40.64177436191813,23.62581689476544,4.794230297909402,34.654285278980055,4.034813387021609
Response to elevated platelet cytosolic Ca2+,40.61215111181351,16.9500875509317,3.601976942618852,29.33197580312217,4.92836549952902
FCGR activation,40.53694231780094,27.702458285587678,11.800743181832301,23.147441437479493,12.351566971378455
Cilium Assembly,40.46475079862468,20.797525848509387,1.7914567536918509,39.55702628896903,1.9716472693890068
VxPx cargo-targeting to cilium,40.46009990457358,18.658207338668483,1.3150380428698194,36.49540338452312,2.5629948451130735
Interleukin-1 signaling,40.43937852494042,19.65049169979661,4.525288919535499,37.15297701300456,2.639784187182532
IRAK4 deficiency (TLR2/4),40.342127583085464,20.72482305436928,1.313513614234237,40.92531670048899,1.8939515280442365
GRB2:SOS provides linkage to MAPK signaling for Integrins ,40.28881940653262,17.224886717817082,21.266142505183016,16.051211869587572,20.397540184090733
PCNA-Dependent Long Patch Base Excision Repair,40.254246666899164,24.265873489499196,5.410351065269167,35.614078732846366,3.964953674681469
Processing of Intronless Pre-mRNAs,40.03030337045102,22.102900642464284,8.10081193308262,31.91947705456537,6.9106066058421485
Regulation of cortical dendrite branching,40.01501958002384,15.779625842360282,3.2715171024588163,31.016974858796516,5.291227411645958
EPHB-mediated forward signaling,39.99494436798373,18.40585633765972,7.994084521646955,29.294146041606375,5.965224862426522
Metabolism of water-soluble vitamins and cofactors,39.96369266338989,16.01804848998094,2.02894298819562,35.97313448084248,2.4290575462836235
Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA),39.925002729769425,22.68426445836231,10.806103268767435,31.93045212748211,6.4943296530181716
Role of phospholipids in phagocytosis,39.86346492829453,27.505116188580512,12.50259747204331,22.13620145994606,12.704092828041103
Lagging Strand Synthesis,39.83704726919158,25.865107284962157,5.835953009295475,34.64286315328771,4.4517154553367355
Oncogenic MAPK signaling,39.69966724007014,13.215991496986224,3.514066555652956,36.57016873727399,2.845613317912868
Regulation of TP53 Activity through Association with Co-factors,39.6690610135249,15.29512913956833,2.3241463267292635,61.63874127823848,2.179976010541766
Hydrolysis of LPC,39.595004767133474,20.1514808402408,0.5935942175103153,53.23351518234094,0.7311526376693159
Glutamate and glutamine metabolism,39.58297882035521,12.507339116104811,0.6271076492796305,36.91867656399508,1.8197823560095847
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,39.544473398442655,11.864653913745824,1.217850714434355,43.858602365394475,0.8940138221753499
Interleukin-18 signaling,39.50175255819934,19.81538677703735,4.0371793997259635,30.596983607846347,5.72765917610678
Activation of PUMA and translocation to mitochondria,39.45429444282435,12.823411506280898,0.9584725495152356,57.13951345595438,0.7671700674175322
Adherens junctions interactions,39.442816229193305,19.520807139379986,8.519482084529646,25.63814680675954,11.75555544138325
Diseases of carbohydrate metabolism,39.42287951405532,17.864259752901898,2.4574134448793794,35.67356500519761,3.123257222373568
Signaling by Receptor Tyrosine Kinases,39.42039089784857,12.734876133625935,1.4845541743999577,36.054264394624106,2.006901317276939
Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template,39.39570179939195,24.356655352232742,7.63206612546673,32.64904631345579,5.034086756523985
Selective autophagy,39.3910983719692,26.369977277262276,1.0329230099432731,44.81113408120079,0.6415992752419196
Free fatty acids regulate insulin secretion,39.05798688592256,9.809839896742329,0.37070501981849174,47.02754477166743,0.8216244511793511
Regulation of cytoskeletal remodeling and cell spreading by IPP complex components,38.98293252464092,22.457407629475778,3.862088388571812,36.18373796984246,3.2331713713030177
Butyrophilin (BTN) family interactions,38.87434876296011,11.952925516622026,0.8489769869683884,36.17856210242184,2.4390017535682156
Removal of the Flap Intermediate from the C-strand,38.84825923500232,20.943144978553985,6.296418922322992,32.8619260457496,4.60465881937092
Transcriptional  activation of  cell cycle inhibitor p21 ,38.82285285397259,18.778245051203953,0.4249916394403177,43.712224130519196,0.9214804187910656
Transcriptional activation of p53 responsive genes  ,38.82285285397259,18.778245051203953,0.4249916394403177,43.712224130519196,0.9214804187910656
Cholesterol biosynthesis via desmosterol,38.66489854841239,25.47466500889623,21.25779548521141,17.916126333288098,20.31127809276409
Cholesterol biosynthesis via lathosterol,38.66489854841239,25.47466500889623,21.25779548521141,17.916126333288098,20.31127809276409
Serotonin Neurotransmitter Release Cycle,38.656148386257335,13.677278948929727,3.7727631308488268,37.101248721076786,2.156875064922275
Diseases of signal transduction,38.64111847944599,16.02435727163704,2.63338085569606,37.46907883628556,1.8306314747122319
Homology Directed Repair,38.61196584074637,24.142058095865597,7.707443417594438,33.37300800934027,3.9107213288836227
Striated Muscle Contraction,38.41568128874901,12.987679339094237,0.5236532395069738,38.981600734217615,1.6077120383425219
FCERI mediated NF-kB activation,38.370970357198544,22.478498951215023,7.777339915363295,28.40930082330473,5.8664045183389355
RUNX1 regulates transcription of genes involved in differentiation of keratinocytes,38.22889759936048,23.463743502792784,4.792490465919363,31.77662795948906,4.519369749192239
Regulation of APC/C activators between G1/S and early anaphase,38.22435879925878,20.889037195319244,8.161594475856964,32.795301439345636,3.5910895820052158
Phosphorylation of the APC/C,37.96214855182289,26.84793057972099,14.196526427218696,30.91607710746431,5.31747219518166
"Platelet activation, signaling and aggregation",37.92807317682513,16.12342485696833,2.481432856255462,29.96600063020994,3.615455940944243
Agmatine biosynthesis,37.91266794172791,25.884051704338045,7.346478310460758,25.418619347365293,8.906331696735732
SOS-mediated signalling,37.89260193963487,14.102591859875547,0.6708347005405554,36.83254576947569,1.8782267147052678
Ligand-receptor interactions,37.880828719930015,12.064645638848372,0.34342988807307173,41.53371776078112,0.35900440077026763
RUNX3 regulates CDKN1A transcription,37.78778321942492,1.1466078033991474,4.211399502442016,50.25786239398408,0.6600309873475727
Telomere C-strand (Lagging Strand) Synthesis,37.74395999771029,24.863426043824727,6.160334162679918,32.091712869934405,4.694457050074726
Activation of RAS in B cells,37.66038169909176,13.03313955326581,1.0952523289943543,35.4597984732999,2.133453930202214
Signaling by FGFR,37.66000525092744,11.663114301187912,0.4529537749776326,39.64898883836589,0.9981030271216204
Signaling by FGFR2,37.562593118229124,11.131727254432285,0.9240029433869171,37.26044606792177,1.5728278859789846
Ras activation upon Ca2+ influx through NMDA receptor,37.52818114533533,15.748912693563994,6.62503444493166,25.843778260003216,7.3104343638763485
Activated NTRK2 signals through FYN,37.51027677756417,19.262254110621978,0.32579708341890484,42.57618950805536,0.623747203027855
APC/C:Cdc20 mediated degradation of Cyclin B,37.49855998122281,26.82846686687873,14.820250048965061,29.457632837568283,6.118751967304433
snRNP Assembly,37.260098487279066,16.703635155564218,3.732334985725918,36.56452150497703,2.3210393224201664
Metabolism of non-coding RNA,37.260098487279066,16.703635155564218,3.732334985725918,36.56452150497703,2.3210393224201664
CD28 dependent Vav1 pathway,37.086815833526806,25.896761086877305,7.506093937299376,26.31186270562795,6.891907350696125
Sodium/Proton exchangers,37.08080273210842,12.392551129047934,0.6329005208054869,44.07632532212022,0.5367497319770607
Interferon gamma signaling,36.961130082631335,21.23695895353682,3.882841262533422,31.047996324961,3.9064960861874996
AXIN missense mutants destabilize the destruction complex,36.8857441014375,17.265660687427673,14.192770914740942,22.347621477766573,13.01896247660482
Truncations of AMER1 destabilize the destruction complex,36.8857441014375,17.265660687427673,14.192770914740942,22.347621477766573,13.01896247660482
AMER1 mutants destabilize the destruction complex,36.8857441014375,17.265660687427673,14.192770914740942,22.347621477766573,13.01896247660482
APC truncation mutants have impaired AXIN binding,36.8857441014375,17.265660687427673,14.192770914740942,22.347621477766573,13.01896247660482
truncated APC mutants destabilize the destruction complex,36.8857441014375,17.265660687427673,14.192770914740942,22.347621477766573,13.01896247660482
"AXIN mutants destabilize the destruction complex, activating WNT signaling",36.8857441014375,17.265660687427673,14.192770914740942,22.347621477766573,13.01896247660482
G1/S DNA Damage Checkpoints,36.73833774482169,18.648309477290177,5.514358194008507,33.146029682963615,2.658857613729098
Platelet degranulation ,36.63246812214767,15.375005996042418,3.68310340134965,25.72472332988521,4.834732611258957
Bile acid and bile salt metabolism,36.612231343375576,14.857029829662327,0.637991616867368,33.77630183048559,2.3815673649892326
Interleukin-21 signaling,36.5843658090389,24.645312837273508,6.39784399987215,25.004078844839384,6.634426197463473
SHC-mediated cascade:FGFR3,36.53769129537915,12.41994683161137,0.944797267893987,34.09702195464301,2.0955122826098975
Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins,36.45395553458763,20.512220527938275,8.333561830148565,31.08987081418356,3.5607017045165676
Sema4D mediated inhibition of cell attachment and migration,36.445955980853924,7.828278291507404,0.5458680055936294,37.50077337622678,1.6469725447168038
Activated NTRK3 signals through RAS,36.43237043038366,13.259377580027227,0.9790245581931343,34.250778386157705,2.181413650240747
Signaling by Ligand-Responsive EGFR Variants in Cancer,36.28386305577058,11.246329141918794,0.46673144507438363,37.75184913404073,1.13205443546903
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,36.27182788766992,11.231732738618685,0.4656160669626226,37.75650800353779,1.1283914628352227
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1,36.25067624674033,20.241484014259516,7.180081954448264,31.66827915969903,3.105473031698301
Heparan sulfate/heparin (HS-GAG) metabolism,36.24573557598768,10.913912498907616,5.626268867128497,27.41578386520731,5.296793226115886
Termination of translesion DNA synthesis,36.078413268846575,22.381797520678607,5.342418019631906,31.69741825577642,3.858286212637988
Regulation of RUNX2 expression and activity,35.99571865937644,18.67772684357256,5.3077665764268085,31.72601860514281,2.823729867917261
Plasma lipoprotein clearance,35.90707148987131,13.998100063548973,4.4901644238341865,27.881535881408226,4.474184891927364
SHC1 events in ERBB4 signaling,35.84320783076254,12.241532628181556,0.5985494792076033,34.67321702789001,1.81401816501906
The role of GTSE1 in G2/M progression after G2 checkpoint,35.77235814295366,19.014966079088524,7.246417444339218,30.480231118013823,3.3419008637373913
IKK complex recruitment mediated by RIP1,35.67444502666277,15.606597257315437,1.1079482424585394,34.296231173268886,1.8818393881822644
Peroxisomal protein import,35.63639551487108,23.874933118364435,1.1688646465556591,34.46864726218179,2.529432705498734
SCF(Skp2)-mediated degradation of p27/p21,35.56826198597499,18.1035882685238,5.625169839322292,31.85216054030088,2.5875681322513433
MAPK3 (ERK1) activation,35.53026961081399,9.721321828990613,1.4916451378898419,31.738067268945553,2.4190625188043127
Constitutive Signaling by Overexpressed ERBB2,35.4622391399676,12.6748299369472,1.0910138617769267,35.6910149734936,1.5134524387264208
Spry regulation of FGF signaling,35.4403246475158,4.93442741311998,0.7597500106657902,36.94238742277919,0.7532633475622338
FLT3 Signaling,35.43643842309533,15.123218318930872,2.3250341792127207,33.99642421858029,1.6996371168725044
Gap-filling DNA repair synthesis and ligation in GG-NER,35.408024494582435,23.57095420232831,4.226600749478034,30.423560640909344,4.477799869282719
Activated NTRK2 signals through RAS,35.31111989332258,12.463739659142826,0.7624904587123214,33.82978061269802,1.9538628008767478
Gap junction degradation,35.299743817137596,26.048404461598235,2.5756737422482634,24.558000288332135,8.313100998285817
Signaling by NOTCH1,35.26039711644066,10.83752888266812,5.414458107983213,27.789887040255426,3.995435566979203
Signaling by FGFR1,35.11733482255422,9.818996204647709,0.4269672377224148,34.94336851050286,1.111597775799749
Class B/2 (Secretin family receptors),35.01735243532732,12.37921815648053,3.7914989338987306,26.012212933881404,4.393145581571565
Diseases of Mismatch Repair (MMR),34.898634629672166,16.8400996424459,2.191298957211951,32.25743436695884,2.872181549307712
HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA),34.69834247363998,21.05115185986221,6.3595226877435564,31.0528235584153,3.0162584607942997
UNC93B1 deficiency - HSE,34.57374850536377,22.580953854320075,10.762614107507265,20.341678174377385,11.668721711048587
Creation of C4 and C2 activators,34.55211387455992,24.161709964912276,11.08733636574246,19.060023578700964,11.247993024685687
Cyclin A:Cdk2-associated events at S phase entry,34.52752101964371,16.839221804623453,4.478658304995415,32.43418545064809,1.9454422269771126
Abacavir transport and metabolism,34.41557093229841,16.022636371703054,12.768139680392187,26.512635867125454,8.952892844919049
G alpha (q) signalling events,34.347648933647875,14.322747284322828,1.212355163359917,30.19672130862025,2.2613936835341892
Signaling by FGFR3 in disease,34.31524866289736,11.381255937071652,0.8024844636677928,32.54449337799228,1.8154919087432215
Signaling by FGFR3 point mutants in cancer,34.30846796890631,11.380505015488659,0.8027157224573458,32.53285905968859,1.8160595568653153
Defective SLC7A7 causes lysinuric protein intolerance (LPI),34.257382905051884,28.510786828423083,6.757532972607623,34.11065126265663,2.5565282131420455
Intra-Golgi traffic,34.02709165025986,15.252889757944512,3.4465646138011086,24.542072006140714,6.231694023130819
CLEC7A (Dectin-1) signaling,34.01445581437775,16.904240200384276,4.128764760631285,31.116009475073135,2.248867230343636
FasL/ CD95L signaling,33.98956696125494,16.88746900535494,3.10606031954183,26.62239465531679,4.874207691394263
RAF/MAP kinase cascade,33.96297212184105,14.417328197832058,2.536287750251706,31.83317949251731,1.8249407237297621
Wax and plasmalogen biosynthesis,33.893792704534995,5.6174348730953705,4.432685617160289,26.591176794730703,4.803507789273888
Role of LAT2/NTAL/LAB on calcium mobilization,33.79755500130126,23.114239497058346,10.2976864018856,18.693792734781294,10.845488348160766
Activated NTRK2 signals through FRS2 and FRS3,33.79082470826796,11.663083536949191,1.8553071820911329,28.883940328561007,3.137405825433283
Downregulation of ERBB2:ERBB3 signaling,33.72597348390091,9.941798544585689,0.5438652243370629,44.58704761232462,0.6873048220391098
APC/C:Cdc20 mediated degradation of mitotic proteins,33.543749101477836,18.68856288919753,7.702600043703656,28.841937569559697,3.1757859618929176
Interleukin-23 signaling,33.52536215947774,18.46316742340856,3.275090731246702,24.240708935065015,5.511104361409356
mRNA Capping,33.51573883194941,13.647687079282637,1.7931687780010686,32.25364053126622,2.61986526637146
Interconversion of 2-oxoglutarate and 2-hydroxyglutarate,33.4798467929828,27.891154607489465,12.969956117164072,23.305329998336692,8.493394621750856
Fatty acyl-CoA biosynthesis,33.478983015511155,15.379782248038913,5.305778785907621,17.99966029823487,12.313091389016375
Zinc efflux and compartmentalization by the SLC30 family,33.42901499201208,28.706974525345064,11.62129493466745,13.215917950049077,18.469238246859973
Cytosolic iron-sulfur cluster assembly,33.15752931482155,27.5092661143604,5.993105799321562,23.194819598462725,6.672401839911659
Endosomal Sorting Complex Required For Transport (ESCRT),33.12425185684582,20.920883121385916,13.480955691470216,16.118001910932993,15.532415252078753
MAPK1/MAPK3 signaling,33.11807197361075,13.932680745484598,2.512526694160265,31.12138669382736,1.7730603027651615
RNA Polymerase II Transcription Elongation,32.94198131240571,16.740852769252765,2.828628232548652,29.74617140330621,4.07133588970071
Formation of RNA Pol II elongation complex ,32.94198131240571,16.740852769252765,2.828628232548652,29.74617140330621,4.07133588970071
Suppression of autophagy,32.88760343886901,26.571850684230384,3.2140475107909463,33.2673929300393,2.294709134586045
CD22 mediated BCR regulation,32.874698617565834,22.73463634140343,11.808866779879507,16.63783621192448,12.373431842768394
TRP channels,32.83000692649975,23.224540002961504,5.649030334820989,24.066542832076713,7.091683192451434
FRS-mediated FGFR3 signaling,32.82492108647587,10.679795666350147,1.9759848829959472,27.13868522947599,3.195110204292274
Cyclin E associated events during G1/S transition ,32.82492108647587,15.951902160006735,4.272770123312202,30.998050261697177,1.8184414519731444
RAS signaling downstream of NF1 loss-of-function variants,32.73408911126201,10.491744196536386,0.4394250755335063,35.312659638374505,0.9540168443421088
TP53 Regulates Transcription of DNA Repair Genes,32.673640470005125,17.970146190554882,3.1177903082709344,31.260277775884017,2.747640971544628
Signaling by VEGF,32.66798031557793,13.41403072881673,0.5069376172954021,35.67076728468705,0.45175197334920597
Classical antibody-mediated complement activation,32.658478021026994,23.177504777931738,11.15091437864465,17.54888799403742,11.1710564404412
Transcriptional regulation by RUNX3,32.65329806528891,13.410600849004553,2.9844916453677923,31.01433128881452,1.7661615087305653
SLBP independent Processing of Histone Pre-mRNAs,32.63563528527147,18.25529689776291,10.053357298126189,23.92556788480382,6.742289748621713
Resolution of D-loop Structures through Holliday Junction Intermediates,32.60885912674433,19.24243290571793,9.871562904383248,26.256781949555904,5.416494779792716
Resolution of D-Loop Structures,32.49629469837538,19.21352697010908,9.896484621045305,26.108421108724865,5.431086829294768
PP2A-mediated dephosphorylation of key metabolic factors,32.49352119847748,11.294613020427017,2.1505303754922456,32.13250908399877,1.2571705599580765
MET interacts with TNS proteins,32.43473386409164,13.570955221168457,1.5095538533342916,28.356767483243647,3.285097824572703
GDP-fucose biosynthesis,32.39417084173418,13.025912976430178,21.747607702314347,12.66027830812628,21.027841172692987
Signaling downstream of RAS mutants,32.34359791421978,11.385454839416749,4.646982155408105,24.17313250211609,4.259285383750343
Paradoxical activation of RAF signaling by kinase inactive BRAF,32.34102425735475,11.38419548174125,4.646982155408105,24.17181143930755,4.259285383750343
Signaling by moderate kinase activity BRAF mutants,32.34102425735475,11.38419548174125,4.646982155408105,24.17181143930755,4.259285383750343
Signaling by RAS mutants,32.34102425735475,11.384164722721694,4.646982155408105,24.17181143930755,4.259285383750343
Ion influx/efflux at host-pathogen interface,32.28380893721986,13.565142375692277,0.6362845790668108,39.86457393459418,0.5265764219004737
APC-Cdc20 mediated degradation of Nek2A,32.171819597869025,24.817538750955162,11.825286096409712,26.72227543060527,5.043028824499577
Downstream signaling of activated FGFR3,32.05622310028996,10.518248864527864,1.6723805120434738,27.1804263328159,2.827963150062662
Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion,32.01067205520479,12.739476565669216,1.2974096910088784,44.681087916873416,0.3615024111024151
Signaling by TGF-beta Receptor Complex,31.994609105290362,8.411059090674568,0.8098579537411177,37.320235956774404,0.43631950378832507
Role of ABL in ROBO-SLIT signaling,31.986151359613842,25.507435665559065,4.1295233367557,16.991783253117948,11.60339947370883
p53-Dependent G1/S DNA damage checkpoint,31.98158847876279,16.523132938513985,4.7330126292377726,29.444019513407554,2.1224025260246884
p53-Dependent G1 DNA Damage Response,31.98158847876279,16.523132938513985,4.7330126292377726,29.444019513407554,2.1224025260246884
Processive synthesis on the C-strand of the telomere,31.938938686871946,21.763042520247538,6.1907615575346115,26.004284293178532,4.649627671368149
NTRK2 activates RAC1,31.924315562031982,20.20181414461491,1.9874038771264535,28.563775596997427,2.768573554169556
Nicotinamide salvaging,31.844244199723928,9.69391391780841,3.646197531390506,21.51668828285512,5.6424148563039305
Formation of HIV elongation complex in the absence of HIV Tat,31.838173885656335,17.04835815111572,2.9962256320313054,29.651945020925584,3.5399569776108457
Synthesis of bile acids and bile salts,31.83305141705539,12.848229384384167,0.5551482953617056,29.659337460171148,2.0383869990775016
Formation of HIV-1 elongation complex containing HIV-1 Tat,31.815787466159225,17.19102304633458,2.966845975965665,29.78975448217589,3.4789302693099
Tat-mediated elongation of the HIV-1 transcript,31.815787466159225,17.19102304633458,2.966845975965665,29.78975448217589,3.4789302693099
HIV Transcription Elongation,31.815787466159225,17.19102304633458,2.966845975965665,29.78975448217589,3.4789302693099
RHO GTPases activate IQGAPs,31.75336569067085,17.084782189517682,6.209278174111816,25.20500638798491,3.4275654622957576
TRAF6-mediated induction of TAK1 complex within TLR4 complex,31.679659010146885,17.876373698500007,2.0904344960451526,29.642420578983465,2.45271306861399
NOSIP mediated eNOS trafficking,31.626820120285405,17.668956313850245,7.522269214608562,18.32629652306802,11.413441306897317
Downstream signaling events of B Cell Receptor (BCR),31.612266409698286,15.769386385853108,3.7879551860254104,29.590275686774433,1.9186213523627866
"BMAL1:CLOCK,NPAS2 activates circadian gene expression",31.568450288723245,9.670287381373333,2.649489190794246,29.251374109416552,1.9927371924030157
Recognition of DNA damage by PCNA-containing replication complex,31.560515048270346,18.78720687938486,3.330179078643019,30.335649598775486,2.4485615437949
Beta-catenin phosphorylation cascade,31.530410425104385,18.518974044297817,13.507129728593666,17.745099221916416,13.412106101160411
RNA Polymerase III Transcription,31.524921750056677,11.720530172825864,1.0689880895867843,34.275345432978696,1.08723559785587
RNA Polymerase III Abortive And Retractive Initiation,31.524921750056677,11.720530172825864,1.0689880895867843,34.275345432978696,1.08723559785587
TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling,31.413346353089217,19.228607583678535,6.6233226113207335,25.155086400876627,5.12290576642604
Formation of the HIV-1 Early Elongation Complex,31.258375562917696,16.279697209760936,2.815031325278564,29.909361625737528,3.0340776925169606
Formation of the Early Elongation Complex,31.258375562917696,16.279697209760936,2.815031325278564,29.909361625737528,3.0340776925169606
Transcription of the HIV genome,31.23780403076731,17.043039576844194,3.248349373581556,27.54324410129211,4.12498758515013
Nuclear Envelope Reassembly,31.217404295778394,14.267869247024644,9.30305501790096,20.861787039319516,6.276164318255716
Initiation of Nuclear Envelope Reformation,31.217404295778394,14.267869247024644,9.30305501790096,20.861787039319516,6.276164318255716
RHO GTPases activate CIT,31.217404295778394,24.879143164511905,3.9461321892248464,33.68927617574622,2.482342493046154
Cell-extracellular matrix interactions,31.184650963958703,10.028834327671685,3.6460859609880703,23.73278310232813,4.639153654519052
Diseases associated with N-glycosylation of proteins,31.134107246877104,23.059290740418678,8.411305440267467,17.66789656504548,11.12803149414452
VEGFA-VEGFR2 Pathway,31.119664683567628,12.84335398989764,0.4039756299143708,35.86447282889363,0.3031998743066087
Loss of MECP2 binding ability to the NCoR/SMRT complex,31.053730719409167,22.98299914417284,15.004127610318605,16.3605694232276,12.064644787782836
Vitamins,31.024338261110763,17.348773750045737,0.3648537383419295,38.83633958996229,0.4443889346434341
FGFR2b ligand binding and activation,30.929081040626745,8.893388687515024,4.600288661707833,45.80633463339019,1.6041033232822712
Metabolism,30.922156556477628,10.448765847530725,0.5949426413780697,32.479313270565676,0.8746609817642605
TBC/RABGAPs,30.90309518250049,17.894865911734158,0.6802775390039276,36.41317996699041,0.6098947767636395
"Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation",30.78519718392728,17.310272955171463,22.658291819815208,11.112031841625356,16.919751904925455
Passive transport by Aquaporins,30.695897645389387,11.362879429929222,9.800940772185365,22.248691059302512,7.885543297746235
Toxicity of botulinum toxin type F (BoNT/F),30.503783667425846,23.925493585581986,16.5970491547956,19.234449682386565,11.896589594803949
Toxicity of botulinum toxin type D (BoNT/D),30.503783667425846,23.925493585581986,16.5970491547956,19.234449682386565,11.896589594803949
Removal of the Flap Intermediate,30.414439003871905,19.479955310175452,4.635963949252755,27.110722648944616,3.284809301897875
Phase II - Conjugation of compounds,30.397852689159226,13.08550118381707,2.1364469908298127,31.334184619058835,1.0914776813024936
NOTCH2 intracellular domain regulates transcription,30.23245828415189,13.572020221637644,1.0217664264658273,28.043290469820178,2.5489664319234855
Mucopolysaccharidoses,30.22699861604785,12.15011702351749,5.551440269339073,22.365901193926568,5.020053420471635
EPH-Ephrin signaling,30.186937776632515,11.017034622383632,3.295833845063216,24.110039041544557,2.937551014103069
mTOR signalling,30.1473648317358,23.541741070321446,15.491106755765252,16.888785998106506,13.220948271940857
PI Metabolism,29.99331957914971,22.337609013626672,3.7901437591905385,21.13754091632968,6.45073926720609
Abortive elongation of HIV-1 transcript in the absence of Tat,29.99331957914971,21.272059813182384,4.500315148631739,27.853243911263387,3.773258256226509
IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation,29.98006736232971,17.215376971907016,2.1210697963152074,28.15306453164716,2.3142722604191333
APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint,29.920427912549155,16.30890310729508,6.414770889126368,26.328865562127053,2.566342372812082
Retrograde transport at the Trans-Golgi-Network,29.873234126591406,8.222446463937581,1.0879096188898352,26.94605611048908,2.3478404838817646
RNA Pol II CTD phosphorylation and interaction with CE during HIV infection,29.87109263501415,11.814599224539041,1.317432552254169,29.011778022213022,2.2540354701192205
RNA Pol II CTD phosphorylation and interaction with CE,29.87109263501415,11.814599224539041,1.317432552254169,29.011778022213022,2.2540354701192205
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells,29.837690408085447,11.986194444811598,8.113534315011243,19.966804639941103,7.609472291844063
TRAF3 deficiency - HSE,29.826763138185875,15.276099433443346,1.3964799561749677,29.05061609708491,3.026254033804821
"Activation, myristolyation of BID and translocation to mitochondria",29.782392158871165,13.246633035266091,12.9714160335138,14.749343016991174,9.94815363088761
PIP3 activates AKT signaling,29.755906864234177,13.60521817438686,1.8290420610190106,29.563191243208728,1.300071035710505
Regulation of PTEN stability and activity,29.696495166550847,16.613257875100473,4.427823484448241,27.429049391696882,1.9063439365005095
Toxicity of botulinum toxin type G (BoNT/G),29.63897167657189,25.430993707300367,15.465780178337655,17.725889635373946,10.92654446935505
"TET1,2,3 and TDG demethylate DNA",29.31464548827132,16.169764510719247,11.154162513816443,18.592689218448626,8.250559135129622
Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE),29.232543070518613,17.184790505596837,2.7382477729408787,20.0930943790013,4.746642922045714
Binding and Uptake of Ligands by Scavenger Receptors,29.22581306078025,20.509993617667355,9.877978154672533,15.180981722571294,10.37692532410713
Extension of Telomeres,29.151539371589777,18.87846805404241,3.328662225859671,28.364003657744707,2.0648063534323433
Interferon alpha/beta signaling,29.026709172676235,18.502318600947568,3.6741610170605865,26.43170056059208,2.2563739968318637
RNA Polymerase II Pre-transcription Events,29.003733627692796,14.695912968444334,2.7682175126977695,24.979213796918593,4.161915836134649
Alanine metabolism,28.992060427239352,11.220511099762344,0.43653136971107886,30.975857386791496,1.7786535146237097
Attachment of GPI anchor to uPAR,28.98129256329311,12.379992820988702,2.3046991781178763,18.644235309903447,8.131682003587558
Signaling by high-kinase activity BRAF mutants,28.944339553449637,10.3700062803108,4.646982155408105,21.03781190212814,4.150638129598529
Cdc20:Phospho-APC/C mediated degradation of Cyclin A,28.863220290637514,15.699502608236934,6.064254724207667,25.42838342943423,2.4389771202713466
Regulation of insulin secretion,28.83265090414378,11.662809435413813,0.7867536362773937,30.587853168155206,0.6481195101252005
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,28.80885208314691,7.892453217591067,1.3310002303503028,43.173835886637605,1.8535001691075583
Acyl chain remodelling of PI,28.801719692766934,4.997537850219115,2.5685157739186018,36.28019731538453,0.5500853324090093
Cytosolic sulfonation of small molecules,28.66553168126142,12.344085102366407,1.0593189248646564,29.51749961864198,0.7645437852787506
Lactose synthesis,28.632824657049735,15.753181882066473,1.7242723191326346,29.38249904694977,1.8939515280442365
TCR signaling,28.617187143429522,16.108184675098254,3.1170521297293887,23.753201303259992,3.3095868502574852
Hedgehog ligand biogenesis,28.467122678157622,15.38933107774651,4.5573503888692155,25.850192550716507,2.0137625135250605
Interaction With Cumulus Cells And The Zona Pellucida,28.39786476343423,7.91740583872265,16.441043481416596,5.449235491143248,30.38026749938358
CDK-mediated phosphorylation and removal of Cdc6,28.322889528367885,15.411804073149128,5.697011720344274,25.19671138615601,2.240421263999648
Plasma lipoprotein assembly,28.27566234611284,20.034639855233763,9.824890358253704,16.496175374674337,8.587463280833886
"GABA synthesis, release, reuptake and degradation",28.16389471623921,9.950126128867696,1.2057900382953568,31.538276910586376,0.720045561439159
Sodium-coupled phosphate cotransporters,28.132371655369045,5.891280007529949,1.3626273853667201,30.80740357071307,0.805810162347486
Formation of xylulose-5-phosphate,28.111093491477135,13.652182293776278,1.2923819226939752,37.39087871199209,0.4947910948744614
O-linked glycosylation of mucins,28.00809234124535,12.455167382727284,0.9988111359766554,25.91872049071478,1.625411502054602
MyD88 deficiency (TLR5),27.98198195192819,13.514416980046326,6.194052714113074,13.9547013720514,9.412615983244896
Defective LARGE causes MDDGA6 and MDDGB6,27.966083709827775,10.720553600121262,11.091852995963121,19.31980340880437,7.1810347547532185
Transcription of E2F targets under negative control by DREAM complex,27.82397056772378,16.207519694566667,2.156565739051159,34.143191081562094,0.34275868884754024
Digestion of dietary lipid,27.696347716079377,15.973935420907438,14.410260856657802,10.361896421418212,19.492968363008785
Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS),27.605140682642627,20.265379142285454,7.874276555077972,15.007579015676685,9.0477298394674
Activated NOTCH1 Transmits Signal to the Nucleus,27.596400964990934,13.644510939334696,0.6665609875025266,22.63073665402962,3.2547823303487737
Intracellular metabolism of fatty acids regulates insulin secretion,27.58898354863198,3.542442837220645,0.3581041243829822,27.532517219797803,1.1226757037585198
Metabolism of polyamines,27.512470352665165,14.516050767597298,4.758686783301968,24.615589388061682,2.094895634864846
Synthesis of Prostaglandins (PG) and Thromboxanes (TX),27.452318690920595,16.00801616009559,0.8433357939912163,24.196622152382016,1.9787982782035172
Signaling by FGFR4,27.38916262890197,4.972019990084773,1.3764416560663908,33.541230859811385,0.43017379799793654
Degradation of GABA,27.33177919081575,13.697896099548064,9.394527512639902,13.680016465199113,13.296702675701562
Signaling by NTRK3 (TRKC),27.299859848898986,9.756916781844268,0.4314876974565033,29.36770822346688,0.8455049455325464
Defective SLC7A9 causes cystinuria (CSNU),27.215079776327613,10.997075385023019,3.355119785117016,15.624576128487844,7.816846157155417
Defective SLC3A1 causes cystinuria (CSNU),27.215079776327613,10.997075385023019,3.355004028013317,15.624934122270139,7.816846157155417
Defective CD320 causes methylmalonic aciduria,27.177110740726956,20.302193412400968,3.843798513340416,39.60361433424007,1.1198246947923705
RUNX3 regulates NOTCH signaling,27.15445720848141,12.376688713651655,0.9988111359766554,24.901688163050203,2.2345582882413817
Aggrephagy,27.12526322248995,15.084009196957885,0.6673585604435966,30.15914079436574,0.5186401217088579
Translocation of SLC2A4 (GLUT4) to the plasma membrane,27.0642381978548,18.550478241838288,9.902212366195451,16.86647597024347,6.246634917779182
Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters,26.97758781828789,10.978882622047653,0.554240569440456,28.095009723980485,0.7505853052270949
Diseases of Programmed Cell Death,26.942467098290134,5.40362541329133,3.254133652053254,38.30704060551821,0.6870055430294759
Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function,26.942467098290134,5.40362541329133,3.254133652053254,38.30704060551821,0.6870055430294759
Activation of NF-kappaB in B cells,26.925567546176765,13.81371172967656,3.648143908131159,25.278549911054885,1.6590374122815934
Synthesis of PIPs at the plasma membrane,26.9156309215514,15.714828789699235,1.4263086619754604,20.46079150287343,4.079663117836029
Biosynthesis of DHA-derived SPMs,26.893957333409436,8.375844148870698,0.9560742237031398,23.352808651038288,1.9163247418320004
PPARA activates gene expression,26.882722122742564,8.792691429316946,0.8650515816469804,28.719726890956817,0.7758072190414405
DNA Damage Bypass,26.87366156277674,16.166883898084308,5.386955210370535,23.56007987869117,2.8523431143064206
Processive synthesis on the lagging strand,26.810757116873123,19.779930973133546,4.6112630689518745,23.30812541302047,3.3444848383023937
CREB1 phosphorylation through the activation of Adenylate Cyclase,26.744026891827474,13.658261228692654,2.142447212727137,26.90957174611655,1.6773030930154906
CDT1 association with the CDC6:ORC:origin complex,26.628486203768094,14.575104088642087,4.889243821194342,23.930784905995072,2.008080041137925
Scavenging of heme from plasma,26.54946375531213,19.111427544507613,10.261915888990186,13.088206364858081,10.539848914780963
EGFR downregulation,26.469268024913546,5.221732949269716,0.39187226655669904,21.367835306037964,2.309418873659918
Dual Incision in GG-NER,26.399595288836824,11.15376228931755,1.8951641398733479,23.92536466646323,2.8745843402705695
HDL assembly,26.399595288836824,11.55435404551452,1.0910138617769267,26.19680512401156,1.4724201773811758
Formation of annular gap junctions,26.29040532159185,20.109915991112935,2.088557923064166,17.69769818735243,7.143447273666143
DNA Damage Reversal,26.259972241284878,21.39030647297333,7.036764124039187,15.552268095084424,9.79842252393319
Tat-mediated HIV elongation arrest and recovery,26.24121052477375,19.31455662642082,3.6674715403944695,24.224929301647432,3.6361153473174816
Pausing and recovery of Tat-mediated HIV elongation,26.24121052477375,19.31455662642082,3.6674715403944695,24.224929301647432,3.6361153473174816
SCF-beta-TrCP mediated degradation of Emi1,26.211235082980075,14.153363724810257,4.32636182438576,24.05700042032277,1.8203502438036296
The IPAF inflammasome,26.205293016621063,7.6986540081130705,1.1302958039057536,25.135574006973215,1.7032712709435887
Cellular response to hypoxia,26.16076441388119,13.41323082484843,4.552681037065314,23.508064728252343,1.9890256313126713
Estrogen-stimulated signaling through PRKCZ,26.149685577130803,9.793785960785216,0.5168410769404862,27.234907437585445,0.8549145629239903
LDL clearance,26.08166464113491,9.678023618340363,1.214650922442702,27.94654858708413,0.8636269886132798
Glycosaminoglycan metabolism,26.053492851134337,7.148179791812149,1.3468937936181862,23.807433744931547,1.7786535146237097
Regulation of IFNA signaling,26.043719574040338,19.014966079088524,5.813218761017338,17.148165773239953,6.768801121636345
Heme biosynthesis,26.03480281501562,6.149395392659587,2.0610064003462134,20.784909049211716,2.05067178407929
Abasic sugar-phosphate removal via the single-nucleotide replacement pathway,26.017766678284097,19.31478486071736,1.6641512506556946,18.10327849394288,5.691293125243198
HIV elongation arrest and recovery,26.000796432611896,18.93555629338584,3.6395452623641855,23.849332856732875,3.6773487506165004
Pausing and recovery of HIV elongation,26.000796432611896,18.93555629338584,3.6395452623641855,23.849332856732875,3.6773487506165004
RAS GTPase cycle mutants,25.99188572031934,8.162070586928797,0.8677038283176188,24.067464278146502,1.6996371168725044
G2/M DNA damage checkpoint,25.899341389858083,16.33350136498006,5.455451004010933,23.205128451046804,2.2572221331347984
Transport of organic anions,25.823992161105437,15.35760759910464,6.954101599118389,16.15416708145421,6.5248817718064265
Regulation of lipid metabolism by PPARalpha,25.810856355494316,8.93880339042481,1.004739356374463,27.49768100690897,0.8004177057157984
Interaction between L1 and Ankyrins,25.800702214036903,14.547405736103643,16.150155089243768,13.461587841176433,14.64745332412533
SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs,25.43613631174841,14.629361255114771,4.646982155408105,22.480839583043846,2.4412044976607206
Degradation of beta-catenin by the destruction complex,25.368230394535843,11.883561843100873,3.225246063028202,24.110480574886168,1.380252980847614
Opioid Signalling,25.31137237025993,9.560799942128902,0.30856973520484066,25.899861771335278,0.6570686920775501
Resolution of AP sites via the single-nucleotide replacement pathway,25.30258557658353,7.93031702015438,8.321314877346953,13.669319116561725,7.316074154400992
Netrin mediated repulsion signals,25.215092661544016,13.327036359555473,0.5421500450684088,24.809201278437722,1.737820378801719
Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha,25.197073169129354,13.183297489783936,4.5581390633886185,22.622876243100514,1.9244837203812901
RIP-mediated NFkB activation via ZBP1,25.19250978801697,12.110858911248892,1.5107204673981083,25.420545405335638,1.2824163209179862
PTK6 Down-Regulation,25.048178064249598,6.686799361601579,4.555311183962105,39.587733488237866,2.3151324698898748
HSF1-dependent transactivation,25.045724384868397,10.335984476400396,1.4142973095944877,16.982603418481343,5.486038822881941
APC/C:Cdc20 mediated degradation of Securin,24.98588974771741,13.824877579407966,4.873854870824268,22.703971392953186,1.849256961534421
Transcriptional regulation of white adipocyte differentiation,24.9696280217439,13.13019832634934,1.7753250253303288,22.9074382580393,2.8750768192694296
Semaphorin interactions,24.956718007004348,8.223877860036541,0.6945432083688281,23.176995981787897,1.0008553320494433
FOXO-mediated transcription,24.902006847861525,10.784614127869965,1.4778089070810076,26.215772529130938,1.022909713354651
Processing of DNA double-strand break ends,24.89078554791227,15.686168449309218,4.218767510058531,23.700492140879167,1.7194859784701026
IRAK4 deficiency (TLR5),24.87998418645445,11.477117527620718,4.377500678047476,14.289974225803508,6.560584309084479
Binding and entry of HIV virion,24.82869719086175,12.279534822540542,1.0463224609611401,21.85922233881192,2.0808627135741182
Transcriptional Regulation by TP53,24.81624083485667,17.668956313850245,4.396312530457221,20.267588657831897,4.824413277813254
TP53 Regulates Transcription of Caspase Activators and Caspases,24.788777517958824,7.681269303495544,0.9585759595399996,22.352553615257392,1.7504382068323874
Negative regulators of DDX58/IFIH1 signaling,24.77258020707383,18.04870587975282,1.9860191916835186,26.336340576900948,1.4859830374036231
IRE1alpha activates chaperones,24.76972082962475,13.566208179875927,5.2694119783645315,20.91918262238545,3.5975108666656976
Energy dependent regulation of mTOR by LKB1-AMPK,24.7568619642036,16.88746900535494,12.774949531992945,11.86406973236873,12.512338036304545
Mitochondrial tRNA aminoacylation,24.74775463659259,10.181997184493433,0.7363189076594359,25.15365835526689,2.062825737326762
Condensation of Prometaphase Chromosomes,24.705762081549892,19.829694709894504,0.47447427299603273,32.27504254486524,0.4235348977452469
YAP1- and WWTR1 (TAZ)-stimulated gene expression,24.603140012292506,3.012363872665288,0.3758642609608114,24.40297087798103,1.0513768795020093
Ubiquitin Mediated Degradation of Phosphorylated Cdc25A,24.59791016765714,12.917389329265099,4.060920857978195,22.6632020864528,1.6772428295660493
p53-Independent G1/S DNA damage checkpoint,24.59791016765714,12.917389329265099,4.060920857978195,22.6632020864528,1.6772428295660493
p53-Independent DNA Damage Response,24.59791016765714,12.917389329265099,4.060920857978195,22.6632020864528,1.6772428295660493
Response to metal ions,24.565175541212554,18.735442098981075,0.6396358546558094,23.508064728252343,1.3273668817752442
Adrenaline signalling through Alpha-2 adrenergic receptor,24.549051413692553,28.891877062701372,9.10206092984952,15.183919717696398,8.108593792811558
Proton-coupled neutral amino acid transporters,24.491901270048796,18.30622371250471,3.6217840728117374,22.97048958986315,2.274874554547359
CD28 dependent PI3K/Akt signaling,24.461309033870606,14.10043360070955,0.6037484753952053,29.456637466252282,0.3602282881572775
Regulation of RAS by GAPs,24.400955937917967,12.412895747311472,3.3347181885414336,23.482079043249414,1.3429716407937944
Caspase activation via Death Receptors in the presence of ligand,24.365050497081516,13.489222300291544,1.9218397522553419,22.110542143777813,2.0225238692011485
FBXL7 down-regulates AURKA during mitotic entry and in early mitosis,24.360973026065405,13.053765352242841,4.2020520357991575,22.253269162799572,1.72946238989945
TP53 Regulates Metabolic Genes,24.35772168396991,12.759351226987748,3.962971706642286,16.052355736717665,6.242380588704849
Signalling to RAS,24.34744843373553,9.078021933533444,2.4173628519961565,18.47554833120351,3.1991578676055217
tRNA processing in the nucleus,24.27115587416826,17.690011970619565,1.131887671327273,29.482543102737484,0.6832551023698775
Budding and maturation of HIV virion,24.24894739622896,16.326844468425016,8.70981994006358,12.191757378574119,11.430128245065843
Negative regulation of FGFR3 signaling,24.210273856570254,3.485261262107716,0.9642650706823959,25.34974295378239,0.5443034038771837
Signaling by TGF-beta family members,24.207855494623995,5.247138651778549,0.4900261328250771,27.853243911263387,0.36666941133378234
Metallothioneins bind metals,24.181972157888172,18.882491174039558,0.6177393649519872,23.447127964440924,1.2469938975557697
Trafficking of GluR2-containing AMPA receptors,24.047635756653197,9.580091448565396,3.1143814108149144,16.225520565179433,5.512403880464111
RUNX1 regulates transcription of genes involved in BCR signaling,24.019790109115114,18.11975411312265,7.723817428609341,14.013909518257254,8.002792961828114
p130Cas linkage to MAPK signaling for integrins,23.989501623385294,11.84943552592586,24.650985304688266,6.15260802274354,19.65798578344623
Inflammasomes,23.95104123917109,7.361504213024957,0.8245019294045521,21.876067155810546,2.135872765565205
Hh mutants abrogate ligand secretion,23.67384133247263,12.64082936553492,3.738440743944946,22.04553463314558,1.5308179351721312
Chylomicron assembly,23.648661074117115,17.909373341380793,9.289424558768909,13.788443446788405,8.159898706612216
Stabilization of p53,23.63488246307963,12.422228189000455,3.3773096292177502,22.62151103693179,1.3515075110415755
XBP1(S) activates chaperone genes,23.609723240145364,13.131249830103604,5.000058620524083,19.998986168188193,3.4526750441300886
ABC-family proteins mediated transport,23.5098761646184,13.363288860921717,3.499672918797118,22.508542292965746,1.35043833069263
Dectin-1 mediated noncanonical NF-kB signaling,23.475866911215505,12.161091384933405,3.566286560813145,22.10277009965203,1.4449010151736774
GLI3 is processed to GLI3R by the proteasome,23.38885164219823,12.159575847738806,3.727684559802987,21.731886815874677,1.554964908321623
Pyruvate metabolism,23.386072947394375,8.219398414629142,2.4495242877580323,22.31999381467735,1.6868957591626754
VEGF binds to VEGFR leading to receptor dimerization,23.323515740218756,14.610486723853496,2.337692832449941,9.802542584082493,11.213375754500973
VEGF ligand-receptor interactions,23.323515740218756,14.610486723853496,2.337692832449941,9.802542584082493,11.213375754500973
ABC transporter disorders,23.31750867092521,13.643708283657281,3.5916316150923957,22.237675471458857,1.3484551290533058
ROBO receptors bind AKAP5,23.293330898244974,9.800465630495077,0.7236123257169845,27.226792537158644,0.37559087583016726
Vpu mediated degradation of CD4,23.152299237596353,12.558066670584642,3.6145666469403728,21.6647530756079,1.4833933476391397
SUMOylation of transcription factors,23.116546219466688,9.65042759695191,1.2461664322697459,36.8383555730263,1.9498630722272432
Signalling to ERK5,23.037444734661356,6.38923604924934,7.726535012713228,13.242536668182245,7.495193568649186
Signaling by FGFR4 in disease,23.023449064785467,6.366808406286597,0.8167601399255455,28.74746972073569,0.3608273136650573
Formation of Incision Complex in GG-NER,22.984189736910906,10.122130172944894,0.6279479562789664,22.743932976143906,1.7269129819414877
PCP/CE pathway,22.97582249027554,12.49144696780808,3.635338526805787,21.308009977866345,1.5344553561147085
VLDL assembly,22.82179881197988,16.94965471513955,8.3961098888188,11.43711296518327,9.63324710262534
Other semaphorin interactions,22.804276633281045,16.299647305950344,3.9148946105658617,19.12843755967235,2.793496759127946
SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion,22.689465159014397,12.281056082600825,0.8062391476215041,23.31139164784465,1.4955419250290602
Regulation of RUNX3 expression and activity,22.653684056654406,12.349865421208156,3.328662225859671,21.690124889674443,1.3029013865276953
RNA Polymerase III Transcription Initiation,22.55037944061466,6.289444504738958,0.7349973313411992,25.06220125039179,0.7699340051504172
Regulation of TP53 Activity,22.52225027147449,14.8871045559471,2.156565739051159,23.316542471410507,2.070778522451748
Ubiquitin-dependent degradation of Cyclin D,22.472334143061268,11.902976509185509,3.6281961465125803,20.92361823406991,1.436464579721156
Degradation of GLI1 by the proteasome,22.428809934321432,12.001257577828847,3.603103023659627,21.03425716900348,1.443460361471967
Interleukin-6 family signaling,22.31063104789204,3.923404731318371,0.8144214361140394,25.26582282086479,0.4522734784007199
WNT5A-dependent internalization of FZD4,22.28620837996701,6.840224552428711,2.3710457490171986,19.473460051251205,1.5656261004809133
POLB-Dependent Long Patch Base Excision Repair,22.2726479226827,17.297611393047895,6.859301677118231,15.744120900002265,4.52906530217952
Signaling by plasma membrane FGFR1 fusions,22.243317754396006,3.7652488191005804,15.073036756192685,6.932274782817038,19.027499332523625
"PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases",22.19844713669905,7.8762315191531105,0.45530169360667255,24.099050959638195,0.5108164292088877
Fibronectin matrix formation,22.151655965244935,10.741276461576343,6.661319913080801,16.100507207656896,4.9384757257438885
Metabolism of porphyrins,22.117886798094187,6.221646583964827,1.1293135667218954,19.424215359811008,1.417824571859307
NIK-->noncanonical NF-kB signaling,22.11400830696466,11.425605557505,3.2706305809398573,21.17873163403466,1.2592094508737504
Breakdown of the nuclear lamina,22.10777157970638,10.880602106548116,0.3011528803716599,27.71532554564079,0.4974576778040813
Nef mediated downregulation of MHC class I complex cell surface expression,22.087980311331766,10.816952760406224,0.5701426963693734,24.665728233569933,0.42919004519622217
Downstream signaling of activated FGFR1,22.01522172195255,9.161622811451004,1.0580478157036264,19.436183697345328,1.8599556148866299
SMAD2/3 Phosphorylation Motif Mutants in Cancer,21.950273579935896,4.864066210274956,5.10287933132511,9.567030381130254,9.779523160163917
TGFBR1 KD Mutants in Cancer,21.950273579935896,4.864066210274956,5.10287933132511,9.567030381130254,9.779523160163917
FMO oxidises nucleophiles,21.94058768741091,13.810784260176577,6.231627192654532,11.614170464567623,7.5544331425922
Glutathione synthesis and recycling,21.94058768741091,11.4106830328253,26.64841138870134,6.307406136614525,20.035731631482264
Regulation of ornithine decarboxylase (ODC),21.928504126941718,11.695188906256202,3.578527143806191,20.61785807935043,1.378548649100608
"Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1",21.85743548944026,19.870962810233856,1.5552313127487454,23.36362381448069,1.3454060428698837
"Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2",21.85743548944026,19.870962810233856,1.5552313127487454,23.36362381448069,1.3454060428698837
Nitric oxide stimulates guanylate cyclase,21.706937323218586,8.107747871266113,3.6982086680910657,9.210679956808203,8.894491754620926
Disinhibition of SNARE formation,21.668850995087766,10.105841995136517,0.40278599378806695,23.072452757497366,0.5743811966452491
MHC class II antigen presentation,21.534916615401965,12.764739903303926,1.9294194690262076,17.842602091001364,2.8063876269569095
Acyl chain remodeling of CL,21.533417264805024,8.385457319258776,2.457677663562393,19.720144603138895,3.2792019700125
Downstream TCR signaling,21.43819535964895,11.923390655340512,2.25847986322245,18.47678233410467,2.2824059046696576
Erythropoietin activates STAT5,21.396488237506684,5.7375611862642115,6.534495314313677,35.214912260991944,2.8506350852977964
Transcriptional regulation by RUNX1,21.37142749653877,14.077092812808612,6.09870117311445,18.10327849394288,2.5084992362628737
CHL1 interactions,21.31049990147934,9.80803441647307,4.006314863111553,12.704211418089326,4.94638177161386
TRIF-mediated programmed cell death,21.24465598863987,13.164118677622293,1.9718502360308239,19.641196528240602,1.6828853703574445
Hedgehog 'on' state,21.235852543219107,10.558452953153514,3.5916316150923957,19.619658380797627,1.4410628984855194
SHC-mediated cascade:FGFR1,21.234364029567807,9.016156118534386,0.5016579242834711,20.522026511411838,1.1974201461128948
Early Phase of HIV Life Cycle,21.129074540086112,13.796976842953745,10.408193892590266,12.877971584351533,5.9325599153339414
Degradation of GLI2 by the proteasome,21.09420012350363,11.251843217913425,3.489088398586819,19.811408376424808,1.3545631357706933
Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding,21.034447738907087,18.147545121078842,5.964575765137111,18.137163431606435,2.4781624528547295
PTEN Regulation,20.96139667240545,10.022297819627914,3.0023752793710035,19.385231039608634,1.5627871124419954
Activation of NOXA and translocation to mitochondria,20.917496841985017,6.100168860113144,0.9555950237433137,28.911763581699425,0.6366354940360579
Degradation of AXIN,20.858384536035707,11.355421042610436,3.5331766239195126,19.524144060853693,1.3613017951636621
Assembly Of The HIV Virion,20.8077385029157,2.9695491834162953,0.45005290820036453,21.73504662785855,0.7354808486511886
Cross-presentation of soluble exogenous antigens (endosomes),20.798648649860343,11.231732738618685,3.131239497580859,20.364501226503045,1.084057641495815
Vif-mediated degradation of APOBEC3G,20.760251719342673,11.377803298574944,3.5406257425458665,19.424215359811008,1.3353812829420417
AUF1 (hnRNP D0) binds and destabilizes mRNA,20.759922650193136,10.993273299282906,3.49676717698265,19.342027911368792,1.3469306101591285
Regulation of Apoptosis,20.698001581564263,11.280972323385955,3.4629371349342235,19.44774700766562,1.3064849133876462
Death Receptor Signalling,20.57060630988316,11.5848902438559,0.35596665133686506,23.12119023699374,0.9401813104061166
Suppression of apoptosis,20.50784258518201,12.858857591025242,8.72982718732662,11.295781900709164,7.675953248139443
Extrinsic Pathway of Fibrin Clot Formation,20.467835158330324,13.573610776826586,2.4287070072008428,10.672943104947644,6.321674590718395
Hh mutants that don't undergo autocatalytic processing are degraded by ERAD,20.404856336443135,10.977200399674574,3.3971466506513095,19.304858338552783,1.2609614680336572
Degradation of DVL,20.366083100913862,11.137450079456066,3.570550533165523,18.944735175778263,1.3666782625554645
Potassium Channels,20.348431516195028,9.904478751338678,3.1687735318036867,14.080589032759478,4.513328264178026
Vitamin D (calciferol) metabolism,20.331164133150345,14.268961991096763,2.2916670678381807,21.119199452437275,0.5673018358321015
Autodegradation of the E3 ubiquitin ligase COP1,20.301865777713065,10.974341954013493,3.349440125968012,19.24294558671748,1.2406172604798305
Regulation of activated PAK-2p34 by proteasome mediated degradation,20.28837857162631,11.007306068239025,3.3723113285630832,19.14669898460959,1.2577512811838771
Autodegradation of Cdh1 by Cdh1:APC/C,20.244461211882125,11.013937341128816,3.6958410636677383,19.168820706752633,1.2653466652542957
Reversal of alkylation damage by DNA dioxygenases,20.22386048268772,17.66415062170451,5.312589732496723,12.753682464859047,7.398312797829063
MAPK family signaling cascades,20.218281066408824,7.460053990905207,1.0507257490123132,20.291664217384497,0.7898626953267313
MAPK6/MAPK4 signaling,20.111132389142128,10.051538337861974,3.081038669289239,19.36084042097247,1.1572246546666707
UCH proteinases,20.09135020242325,12.1931951487877,3.7961903331730644,19.135652369557953,1.3353812829420417
GABA B receptor activation,20.027156813978422,14.648243446383589,2.463513064037027,16.96265142155454,3.441401222835426
Activation of GABAB receptors,20.027156813978422,14.648243446383589,2.463513064037027,16.96265142155454,3.441401222835426
Axonal growth inhibition (RHOA activation),20.00555069648727,15.477634275746562,1.1185507638894316,21.808229482179076,1.130421281285062
Activation of gene expression by SREBF (SREBP),20.002241860227862,12.732310904982121,37.83361851098307,3.3632331038397396,27.26302092562754
Activation of the TFAP2 (AP-2) family of transcription factors,19.907228266024767,23.480420067072554,11.732078604373122,10.342468215603661,11.160714258142871
p75NTR regulates axonogenesis,19.86039216377429,15.439359325407814,0.5572919770336826,21.267118910281123,0.8879479412332261
Costimulation by the CD28 family,19.85932728902101,12.188694566664301,2.104402297496794,16.08885696273137,2.7443705326667747
Disassembly of the destruction complex and recruitment of AXIN to the membrane,19.82778108717776,8.859911936665508,6.105837801394893,12.93274102548549,6.805821716958641
Negative regulation of NOTCH4 signaling,19.660985323371044,9.789101807293394,3.8729368054618116,18.258985576572762,1.4268103747290348
"Unblocking of NMDA receptors, glutamate binding and activation",19.658077193547363,14.58644011407733,18.91588395161765,8.264151738876608,12.432126992112492
Developmental Biology,19.537350552355715,5.0976030512059705,0.48020486112513006,22.67147657467356,0.32134835144689006
Interleukin-9 signaling,19.4261974837459,14.44938809844491,2.033736405637645,16.204451157904238,1.9080486191968868
Loss of Function of TGFBR1 in Cancer,19.310238442191615,6.157706456009775,1.4019136538529033,13.385198617492941,2.7548083069925093
PI3K Cascade,19.28134459311453,21.450191235189127,34.44280003525202,1.8253949747758067,33.14733614931761
Type I hemidesmosome assembly,19.275171563203955,1.1386932264453984,1.0813598426545152,18.87963809704567,0.8571560198983253
Regulated proteolysis of p75NTR,19.26246166388428,7.816061308645308,0.47145232220188105,22.59881175312016,0.4236666849052503
FRS-mediated FGFR1 signaling,19.26246166388428,7.602278850417857,1.1042768774341272,16.386064082326897,1.879778571343209
TNF signaling,19.249337231086127,9.779105168713485,0.3619097884506194,22.562686858498378,0.7065968765929775
Pregnenolone biosynthesis,19.172983733863155,9.322508402880358,3.9662784816806185,28.57783820564807,1.6550478896828056
Intestinal saccharidase deficiencies,19.1452909612984,6.050985641325379,3.635338526805787,13.56595766754309,4.332422797168178
Frs2-mediated activation,19.143518434284424,9.809839896742329,0.6362845790668108,16.526907423541367,2.4392414326655825
Attenuation phase,19.09251825475078,8.051052467512987,1.1240083029023433,12.554499055232613,4.6775351239979
Defective AVP does not bind AVPR2 and causes neurohypophyseal diabetes insipidus (NDI),18.947093192810268,10.94492739575308,4.646982155408105,14.289974225803508,4.5620900593387805
Neurexins and neuroligins,18.92863879864713,8.816016515038298,0.3392521208089207,16.840618896266058,2.008080041137925
TLR3-mediated TICAM1-dependent programmed cell death,18.91926000518535,8.620968757668251,3.6734376237930517,12.253080553183148,4.13939288831263
Regulation of mRNA stability by proteins that bind AU-rich elements,18.89936939842228,9.399339442513185,3.2757853846635614,17.523710253641372,1.2009478902235944
Generation of second messenger molecules,18.89905900555838,11.79379371966698,2.2223503468236623,14.801026801032977,2.966857645559788
S37 mutants of beta-catenin aren't phosphorylated,18.889577989709863,11.666059445402231,11.84996211438543,9.023919116598924,11.28453015161554
S33 mutants of beta-catenin aren't phosphorylated,18.889577989709863,11.666059445402231,11.84996211438543,9.023919116598924,11.28453015161554
T41 mutants of beta-catenin aren't phosphorylated,18.889577989709863,11.666059445402231,11.84996211438543,9.023919116598924,11.28453015161554
phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex,18.889577989709863,11.666059445402231,11.84996211438543,9.023919116598924,11.28453015161554
Misspliced GSK3beta mutants stabilize beta-catenin,18.889577989709863,11.666059445402231,11.84996211438543,9.023919116598924,11.28453015161554
S45 mutants of beta-catenin aren't phosphorylated,18.889577989709863,11.666059445402231,11.84996211438543,9.023919116598924,11.28453015161554
Sulfide oxidation to sulfate,18.873686520847308,8.898258003601828,4.153222054790964,34.277400998098024,4.052503157527034
TICAM1 deficiency - HSE,18.852371426935093,11.379034439844498,1.4901968442823892,15.50877341506055,3.959014801719831
Pyruvate metabolism and Citric Acid (TCA) cycle,18.813345353036834,6.66110961819823,0.6362845790668108,21.41558993369993,0.5496334303717175
GABA receptor activation,18.676599202581624,13.717744311500006,2.683153838767061,15.38272186653203,3.586806392485222
Synthesis of 15-eicosatetraenoic acid derivatives,18.604308872974336,3.2939742526420535,8.10764006333923,38.50612255219195,4.645621680037108
TNFR1-induced NFkappaB signaling pathway,18.56339463404912,8.59527612072439,0.3216585184148938,21.16171667619722,0.8074010102977233
Beta oxidation of butanoyl-CoA to acetyl-CoA,18.55805843354611,11.143885545818065,1.4682300655308071,15.024443055183202,1.9569191584484948
Asymmetric localization of PCP proteins,18.53405841666656,10.604865614163757,3.3344079458817286,17.533856309778113,1.1830516783423832
Regulation of TNFR1 signaling,18.35477897521061,9.006799490491785,0.38101940464729,21.436318699826582,0.7074188239972526
NR1D1 (REV-ERBA) represses gene expression,18.31094021984348,24.37506070285239,7.360093355287174,11.258037094906255,6.759303787388129
ATF6 (ATF6-alpha) activates chaperone genes,18.226219686083272,16.883947323504533,0.4243561301563083,15.799710334001507,2.7548319509119894
Fructose catabolism,18.18929193993971,7.787155132570605,0.9935785427368697,17.049817773407753,0.9400859145080097
HIV Life Cycle,18.161989703501174,12.246292196107861,3.095332249544583,13.415944895187485,4.485617507139775
SHC-mediated cascade:FGFR2,18.130805764109212,6.113955835108307,0.3834906387308268,17.949417240894775,0.895970841523291
EPH-ephrin mediated repulsion of cells,18.061032636773835,5.900415608904074,0.3259929096440647,18.746786369525847,0.38330328777479666
Serotonin and melatonin biosynthesis,18.033476664521594,6.897733794940258,2.4391656425142934,13.499143744377335,4.521495314293953
Neurophilin interactions with VEGF and VEGFR,18.024684512078952,6.811660483797768,0.3998434972780604,14.822961281960453,2.3180848350699286
Effects of PIP2 hydrolysis,18.004933728388004,4.56718525452027,4.555640866586008,34.471403723196055,4.174365184776842
Prolonged ERK activation events,17.97459636244832,8.166717875623203,0.5235092819771942,15.103750177820872,2.5298967216086896
MET activates PI3K/AKT signaling,17.930878049460276,3.812667734622154,0.33146155573811753,17.472150659231822,1.293972110519025
Defective DHDDS causes retinitis pigmentosa 59,17.923522354991594,7.957930465247203,2.7382477729408787,16.13745451590105,1.3785461544958766
FGFR2 alternative splicing,17.842903187884918,7.8584491459698125,1.8634352459598034,16.4666541990056,1.5656261004809133
Interconversion of nucleotide di- and triphosphates,17.806028898005476,13.821153131787545,3.5916316150923957,17.223825289235357,1.4268211779601399
"Plasma lipoprotein assembly, remodeling, and clearance",17.7895646152969,6.323670215394533,1.5129306460794374,14.101260021995762,2.068794770836038
Glycogen synthesis,17.777322168307695,4.475071238887251,1.4287584454316062,25.990874914218132,0.7922548326882058
Signaling by NOTCH4,17.772105899621163,8.133695748039646,3.8042248729126746,16.301784382384373,1.394521503988878
Signaling by WNT in cancer,17.75741241449599,10.6475575101373,9.726181299778954,8.982434086589763,9.69992342204746
TNFR1-induced proapoptotic signaling,17.745882717694553,7.104527496743181,0.6813919834036907,22.49468888621098,0.4287042165531129
Defective CFTR causes cystic fibrosis,17.70070226546778,10.478619755803434,2.7189438478286854,17.815954979517315,0.8308581960240461
ZBP1(DAI) mediated induction of type I IFNs,17.54134278524238,7.9692862247201806,1.0103191433874659,17.494467185481,0.9899818307721548
Metal ion SLC transporters,17.453269582057974,9.003593924847461,7.055922122506004,7.826036865799656,11.169516011467277
Regulation of localization of FOXO transcription factors,17.44149638979319,10.054490028786857,2.352177905926194,18.468464316973332,0.8004177057157984
Glycerophospholipid catabolism,17.415130217260323,29.92156695724623,4.452738595737173,12.704211418089326,4.53874142442754
Translesion synthesis by POLK,17.325306913006386,7.690446720354878,0.34964271796770063,20.267588657831897,0.46041397812442664
Activation of AMPA receptors,17.22604735560143,16.615009667326955,10.146525378630681,9.472338410884827,6.995762552716332
"Glutamate binding, activation of AMPA receptors and synaptic plasticity",17.17603719960582,6.491487534907095,1.109848549115084,13.924424405081146,2.424284299642645
Trafficking of AMPA receptors,17.17505545584453,6.490419003581026,1.109848549115084,13.924424405081146,2.4242596314667706
Late Phase of HIV Life Cycle,17.075899025911063,11.311607950264401,2.8629318739144303,12.554812366687656,4.347502368692029
Signaling by FGFR1 in disease,17.06666691564744,8.41291865488225,1.1063598281466098,18.209613244466556,0.7898626953267313
RNA Polymerase II Transcription Pre-Initiation And Promoter Opening,17.012011678389616,7.300932306883758,1.3560510698609531,14.634932036597373,2.1544272816601993
RNA Polymerase II Promoter Escape,17.012011678389616,7.300932306883758,1.3560510698609531,14.634932036597373,2.1544272816601993
RNA Polymerase II HIV Promoter Escape,17.012011678389616,7.300932306883758,1.3560510698609531,14.634932036597373,2.1544272816601993
RNA Polymerase II Transcription Initiation,17.012011678389616,7.300932306883758,1.3560510698609531,14.634932036597373,2.1544272816601993
HIV Transcription Initiation,17.012011678389616,7.300932306883758,1.3560510698609531,14.634932036597373,2.1544272816601993
RNA Polymerase II Transcription Initiation And Promoter Clearance,17.012011678389616,7.300932306883758,1.3560510698609531,14.634932036597373,2.1544272816601993
rRNA modification in the nucleus and cytosol,16.92361733072408,13.473220461815911,8.580570339980678,9.572866463489484,8.682251254792803
HDR through MMEJ (alt-NHEJ),16.90860954322405,16.848037466150558,7.531847528270306,11.64073990755234,4.91006838676425
Translesion synthesis by REV1,16.84917389358957,7.556197881513779,0.3216585184148938,20.030758690750655,0.41299899816503166
Biosynthesis of DHA-derived sulfido conjugates,16.836642669306194,6.6887945059928615,3.2048337892974916,10.937574225725735,4.545404395824167
Biosynthesis of maresin conjugates in tissue regeneration (MCTR),16.836642669306194,6.6887945059928615,3.2048337892974916,10.937574225725735,4.545404395824167
Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4),16.822320297694112,11.193331326823829,3.7206610088947323,12.871445638355896,3.704213876808614
Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5),16.822320297694112,11.193331326823829,3.7206610088947323,12.871445638355896,3.704213876808614
Constitutive Signaling by NOTCH1 PEST Domain Mutants,16.822320297694112,5.371116040147108,4.071624431639635,13.015778506281316,2.3797459526549285
Signaling by NOTCH1 PEST Domain Mutants in Cancer,16.822320297694112,5.371116040147108,4.071624431639635,13.015778506281316,2.3797459526549285
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,16.822320297694112,5.371116040147108,4.071624431639635,13.015778506281316,2.3797459526549285
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,16.822320297694112,5.371116040147108,4.071624431639635,13.015778506281316,2.3797459526549285
Signaling by NOTCH1 in Cancer,16.822320297694112,5.371116040147108,4.071624431639635,13.015778506281316,2.3797459526549285
MET activates PTPN11,16.739549724227906,2.8621836914458143,0.48020486112513006,18.161572936580473,0.687354065829706
DNA replication initiation,16.727057553386537,14.045998110217226,3.1170521297293887,15.182087206862617,2.1544272816601993
Telomere C-strand synthesis initiation,16.727057553386537,14.045998110217226,3.1170521297293887,15.182087206862617,2.1544272816601993
Synthesis of bile acids and bile salts via 24-hydroxycholesterol,16.645888759187272,9.139736363201646,1.20168754939902,13.747599816212245,2.369490694255995
ERK/MAPK targets,16.416306626916978,5.442137254081157,1.8234309612464459,11.155660589565954,2.238550864275589
RUNX3 regulates p14-ARF,16.37325396300804,4.042029928967846,2.071965179550343,9.518906149799871,5.057727389554263
Platelet sensitization by LDL,16.326899518395084,7.294273808889779,0.5117021864738902,19.65282171387233,0.4138555087879341
Beta-catenin independent WNT signaling,16.3188880523661,7.919599993085881,2.070765426801056,16.59636639244008,0.7228032223912745
Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon,16.29073344091148,11.818322275557867,3.0429160741791845,17.043427512903854,1.5864096201222384
Synthesis of diphthamide-EEF2,16.245841474526078,9.847700286719851,2.4461566121958143,17.32349735902324,0.8631492866079128
Translesion synthesis by POLI,16.225455345815547,7.236532634614403,0.302677795635335,19.576618385918735,0.38073551574296294
Defective ABCA1 causes Tangier disease,16.225172363572497,14.436069629446067,4.01759231223603,9.869542171995917,5.048772450940037
Mitochondrial iron-sulfur cluster biogenesis,16.21651690711093,9.091278946551212,0.7257682366366507,14.85464356058776,2.58035155854195
Cohesin Loading onto Chromatin,16.214559315627277,10.407974680021855,7.213213731406613,6.601654346157503,9.427895135182125
Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding,16.0829696126747,14.742560519110803,0.540267257824827,22.874327505281858,0.718749261436277
Infection with Mycobacterium tuberculosis,15.993462686809849,8.513109513734797,9.126080103661986,7.455047742079497,7.741227527124578
GRB7 events in ERBB2 signaling,15.987199464572667,2.547368939901749,45.71627457841246,53.426254743678456,21.70650082550523
Mitophagy,15.956687871189338,13.767536102037184,0.6149218904114501,22.995219618920032,0.8086192324568399
TNFR1-mediated ceramide production,15.924548058659829,5.886719649139582,1.0819226092143386,21.75366072811194,0.35470279882343686
Metabolism of serotonin,15.805086907076147,5.498043929054016,3.8669313814400006,16.1974467474992,0.8542570341408741
Depolymerisation of the Nuclear Lamina,15.786642440947196,14.102318045796014,12.411383747555824,10.031819758643849,5.511104361409356
p38MAPK events,15.569853858939783,4.796355438105431,2.135455213988234,10.721442681946078,2.58035155854195
ATF6 (ATF6-alpha) activates chaperones,15.569253386965979,15.435980968872395,0.8273161956851022,12.359868160764858,3.3445021676281517
Signaling by MST1,15.563079565614643,11.659377889882197,2.342663616120687,27.60790976952624,2.417965866022705
Bicarbonate transporters,15.530372744482353,14.884064934775747,6.355090977015048,7.3142606228510685,8.803896351703287
Inwardly rectifying K+ channels,15.509478932428394,11.653276031721255,1.6017945189667162,12.993868645080093,2.7178830107606653
FRS-mediated FGFR2 signaling,15.494485923529544,4.811197740079631,0.944797267893987,13.217997089125873,1.478069134326272
PTK6 Regulates Proteins Involved in RNA Processing,15.471002908104401,3.2229439990845203,5.748197729064346,27.28336413261077,3.044858255658158
Entry of Influenza Virion into Host Cell via Endocytosis,15.300312876943678,15.885901666336078,9.82888846155301,11.833255193948764,3.174267808176044
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,15.299394024189937,12.948733971208926,1.565119769350864,16.728546618027973,1.0534227044298532
Neurodegenerative Diseases,15.298150006206289,12.948733971208926,1.565070975918285,16.726584659059835,1.0534227044298532
Global Genome Nucleotide Excision Repair (GG-NER),15.268980138036735,9.510495848874159,1.2752556193752862,12.358880689961934,2.8535393850719015
Activation and oligomerization of BAK protein,15.258651258023974,14.520960559077253,3.210577876660855,14.161547606465554,2.30770014311522
Activation of Ca-permeable Kainate Receptor,15.177761905598102,12.274744575836838,2.4399182736290923,14.401552886747398,2.1654099413234444
Ionotropic activity of kainate receptors,15.177761905598102,12.274744575836838,2.4399182736290923,14.401552886747398,2.1654099413234444
Phosphorylation of CD3 and TCR zeta chains,15.16908261691532,9.665414000538576,1.873486335529612,11.905232187563918,2.489623681637727
Downstream signaling of activated FGFR2,15.06517063775564,4.722924555946552,0.7610379862764661,13.341103219374714,1.2419173291486998
Signaling by NOTCH3,15.062003595661327,9.587789629742451,1.0576297696019574,11.16237409218786,2.7874114433474215
TRAIL  signaling,15.046272398232047,3.8645129072973483,4.026949000640547,6.912176625377414,7.354400646486988
HSF1 activation,15.007381110800463,6.107575043517791,0.8433357939912163,9.631940265625653,3.8903186990386747
HSP90 chaperone cycle for steroid hormone receptors (SHR),14.921039650946689,8.18285249073953,1.6350790971936109,8.781298934159995,5.223955679101104
Terminal pathway of complement,14.917247661927476,5.618575572549419,3.0811624821074144,13.359432973067042,2.3051472345210025
TP53 Regulates Transcription of Cell Cycle Genes,14.87821039937006,14.38531141260912,6.869349783673222,9.986667277575624,5.705592583965321
Interactions of Tat with host cellular proteins,14.875384561905253,3.3100040509983804,0.5415434346282648,19.787609221816556,0.43545812574136683
Vasopressin-like receptors,14.858795663719981,7.424184662998248,1.045509865985066,15.115396962219856,1.4257020888705065
GLI proteins bind promoters of Hh responsive genes to promote transcription,14.856611337139823,6.226174097090603,0.32579708341890484,15.336439204469144,0.39367405797654503
Signalling to ERKs,14.839233827310098,5.556984784537469,2.7841758912875227,11.657472671751915,1.821917560646632
Intrinsic Pathway of Fibrin Clot Formation,14.837530260283224,4.86302405424064,0.478886341278531,12.190104721767192,1.1285158299723657
Plasma lipoprotein remodeling,14.696922826280131,6.7669269615965195,0.5774299579032113,14.895303052788805,0.652021346651332
Signaling by NOTCH1 HD Domain Mutants in Cancer,14.660785917340753,7.636282664756444,0.4825111937496815,13.743710730225631,1.1100244067631015
Constitutive Signaling by NOTCH1 HD Domain Mutants,14.660785917340753,7.636282664756444,0.4825111937496815,13.743710730225631,1.1100244067631015
Transport of Mature mRNA derived from an Intron-Containing Transcript,14.657981992114118,9.07996448228926,1.8352257233840092,15.368308135141813,0.7241613789632364
Synthesis of PIPs at the Golgi membrane,14.634217753347722,12.992195731991382,3.8661943457047636,10.1354083348491,4.947013840842318
Synthesis of glycosylphosphatidylinositol (GPI),14.633003422608283,10.509244682857123,1.333152228153535,12.715824860041465,2.73561018506053
Viral RNP Complexes in the Host Cell Nucleus,14.55634978283193,8.757725703292044,0.6545177650882638,10.692430910296599,2.705559640941582
Phase 3 - rapid repolarisation,14.509581783407901,12.222578943983887,1.6928169159226516,11.349154599888262,2.6219563545719082
Response of Mtb to phagocytosis,14.504265324844429,8.282619039459329,8.991974570754552,6.5636910091842235,7.624042880975816
Biosynthesis of protectin and resolvin conjugates in tissue regeneration (PCTR and RCTR),14.498159926415859,5.157337602065051,2.5173764904716043,9.51555301731549,3.881677240510971
NOTCH3 Intracellular Domain Regulates Transcription,14.490476434117744,4.660019383093391,0.4081677562209306,16.55174686057587,0.6181381819647531
p75NTR negatively regulates cell cycle via SC1,14.40885152419356,2.386855471557892,4.043539428095065,6.9678688484992755,4.7898090497698815
Regulation of pyruvate dehydrogenase (PDH) complex,14.377434592679986,2.4646567187888033,1.4063648954924073,14.108862541733064,1.0685945190460466
RNA Polymerase I Transcription Initiation,14.330348319598246,7.326634284625712,2.694041483448695,11.906196894197057,3.2555769681040334
SUMOylation of intracellular receptors,14.209147342185389,3.6560130128186876,1.4858314671260717,20.38643640409675,0.9029720614723399
Propionyl-CoA catabolism,14.036547670563795,9.602943791932383,1.0123925591429226,14.885987417171007,0.611725867858768
Creatine metabolism,13.848374012982502,18.767384999573135,13.944260606885415,4.168115020149019,12.803073772133104
Chromosome Maintenance,13.826539191892318,13.517580485942595,4.813738245687339,12.668835686799275,1.7786535146237097
Invadopodia formation,13.815812924563861,7.354445419760158,2.713358041835215,8.976461680666763,2.9876941323329707
Nuclear Events (kinase and transcription factor activation),13.77800013942467,4.131773580973573,1.5421503214201475,9.89151184727889,1.626618380520848
Negative regulation of TCF-dependent signaling by DVL-interacting proteins,13.758375707844515,0.3851162891996827,2.477546920930014,26.138349306848184,3.188292280561971
Deubiquitination,13.688887235663437,6.257416520765426,2.007628769854747,13.892352978245443,0.7436567086234336
Translocation of ZAP-70 to Immunological synapse,13.680209932022358,8.726808859088004,1.7310283238432258,10.682878994340443,2.341077439148807
Formation of Fibrin Clot (Clotting Cascade),13.551831975476393,4.323024314941181,0.5357861943873757,10.569349390404364,1.2086291710771204
Signal transduction by L1,13.53954189072346,12.559729419170559,1.118167303147463,21.35434481804696,1.2965719379371676
PD-1 signaling,13.520858212023882,8.772583068470238,1.6364368563291327,10.780943815882791,2.196672330294417
Lectin pathway of complement activation,13.478297837120017,7.350246853316052,1.5536632899806773,10.24992045194618,2.421660310275885
Dual incision in TC-NER,13.440363385685313,6.986430833671507,1.0030645630057013,12.068985898491977,2.0658091421169935
Formation of TC-NER Pre-Incision Complex,13.405214707297139,6.865362834044275,0.8260393698139696,12.456304092501696,1.6998533763551236
Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant,13.376600223410243,6.337211762396437,0.3205657160448412,11.759888618792017,1.2274980190240492
Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant,13.376600223410243,6.337211762396437,0.3205657160448412,11.759888618792017,1.2274980190240492
Stimulation of the cell death response by PAK-2p34,13.376600223410243,13.701341200680098,12.320683567580755,8.351773055220074,5.5331650883002235
Uptake and function of diphtheria toxin,13.366362313155175,10.717498316021821,4.05141627828771,13.957203502570552,0.9868946525796656
Translesion Synthesis by POLH,13.34462687162917,7.175822411972621,1.7098577491690554,14.667729555393773,0.6544930720109592
Inositol transporters,13.328957639057075,6.34882700505178,9.596652976871665,3.5651054012218073,12.151838882670727
TGF-beta receptor signaling activates SMADs,13.296680741278761,1.5806149673424812,1.1871175111293417,20.51631304870569,1.5329644904605793
RAF activation,13.28466353695856,4.5962271862229445,0.35483587419745133,14.70775039624249,0.3762983158012004
Synthesis of PS,13.205149866694274,7.047208162383746,0.3865771554078182,13.969436565909836,0.9579240345046235
GP1b-IX-V activation signalling,13.200998648585154,9.198536653819541,1.0103052560736918,13.16052213456124,1.2355565018107593
Signaling by TGF-beta Receptor Complex in Cancer,13.16678101478909,2.0793216503819822,1.7098577491690554,16.14288687303343,0.7359591536798449
Apoptotic factor-mediated response,13.140563395697283,2.9573296550049086,2.144054843175699,22.99080513146741,2.1544272816601993
Defective B4GALT1 causes B4GALT1-CDG (CDG-2d),13.118871560588978,9.168950346025428,2.389739123810269,10.246887553831156,2.674304333409779
Glycine degradation,13.070692627718476,7.221612334093486,3.808297705136659,11.263491634821586,2.639808150574283
Neddylation,13.058185207726464,5.368073307132044,1.4780988847634158,13.957203502570552,0.50193003648249
SHC-mediated cascade:FGFR4,13.011616350086152,3.328365445502589,1.06856695175589,16.854939755096588,0.4961589206181643
Synthesis of Ketone Bodies,12.910644663929917,8.79376221699911,1.0553916702937105,18.258985576572762,0.822787527053252
Defective ST3GAL3 causes MCT12 and EIEE15,12.887815799911966,9.154939013992287,2.1551116869984233,10.267717757974086,2.5193069494668947
Signaling by NOTCH,12.75658613834033,7.098536598594525,5.460841644072861,10.435538659043067,1.7969609400434512
Folding of actin by CCT/TriC,12.726223821721138,10.998321698551935,5.307188052498413,8.7666215185767,2.5084992362628737
Antagonism of Activin by Follistatin,12.71212166942222,11.6900533540891,0.8446297783314508,19.614076735913212,0.7321624629259939
SUMOylation of DNA methylation proteins,12.709235442827422,8.927590224007261,0.47340467577279743,11.005643060503441,2.482801945113451
Sensing of DNA Double Strand Breaks,12.703104907646972,9.287756955600155,1.7815987488729972,8.717022498693895,1.860163474220899
Thyroxine biosynthesis,12.691079459697029,1.8081715595857124,1.7463145168982215,7.751888948673973,2.676895301057699
Transport of Mature Transcript to Cytoplasm,12.667277486035369,7.091987854393414,1.0148454703940186,14.539939206190457,0.39372215031568
Organelle biogenesis and maintenance,12.659685404126812,5.79225439551173,0.5965015227583651,14.681054392389802,0.4261320540091072
Prostanoid ligand receptors,12.646798779299381,7.0873097921431425,0.30117107649969654,10.00998909022093,1.0535186188250762
Smooth Muscle Contraction,12.484399642914568,2.5123887026083933,2.194614677684409,6.926093202671449,2.848454560247836
Uptake and actions of bacterial toxins,12.382386510547478,6.053727239910978,2.556743084189365,11.930452256487634,0.822787527053252
Histidine catabolism,12.293562946715914,10.633174698345242,1.8863908654956865,11.428683812793627,2.078873328754937
betaKlotho-mediated ligand binding,12.25915120583603,12.30505293422754,24.219656712376516,0.343446735581373,26.314641363705253
PDE3B signalling,12.08534898208324,8.401820113841794,1.9795435322138841,9.30114756141433,2.8506350852977964
PKB-mediated events,12.08534898208324,8.401820113841794,1.9795435322138841,9.30114756141433,2.8506350852977964
MET activates STAT3,12.082256171189835,13.383156668473926,4.9441638654244695,6.676046095882864,4.395908730912998
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion,12.016043301664949,9.830789507148676,6.006854316144395,7.18765689817111,5.737555580618755
Gap-filling DNA repair synthesis and ligation in TC-NER,11.99320160693118,6.809278600086995,1.009221084423837,11.052889441001906,1.7945959727758418
2-LTR circle formation,11.986687647505677,4.826313771629071,4.190952914036787,7.424740625644198,3.2548004636753745
Rab regulation of trafficking,11.984752937889164,3.3194874415796485,0.6022092965499696,14.360869147320118,0.3047930263374876
Lipid particle organization,11.980243462800512,9.915657291210934,3.170025893598769,10.972199053401084,2.1388921930485614
ALKBH3 mediated reversal of alkylation damage,11.949437482323448,16.89393455998092,12.008453975776476,3.2720326299585842,12.330802280186814
PKA-mediated phosphorylation of key metabolic factors,11.86168550094068,4.3261423975652535,2.7189438478286854,8.702734357655977,2.30770014311522
Post-translational protein modification,11.842979454733792,3.8555311407002013,0.5096775448655684,13.752591645218985,0.31139862790700823
Lysine catabolism,11.825425456840355,6.21241790502335,10.153018628324173,4.077452052307807,8.170855892263555
CRMPs in Sema3A signaling,11.821516621587632,2.2306443027528755,3.0437759585695057,16.0702122102872,1.378548649100608
Defects in vitamin and cofactor metabolism,11.79489801258279,7.042918650415186,0.5598404269774361,15.785863672877083,0.7647153779502217
RUNX3 regulates BCL2L11 (BIM) transcription,11.74112072736953,1.054078373939569,4.057355815562714,18.59434663713787,1.1845765663158643
Receptor Mediated Mitophagy,11.686342506613016,10.615992509321119,1.4600231765252483,19.691218961783346,1.700109154249757
FOXO-mediated transcription of cell cycle genes,11.676248613078098,1.608937762019473,3.3782070764301584,18.498500038063707,1.5257229703636606
Adrenoceptors,11.623600588803614,14.938211177646542,2.9333664864964493,12.298295312488555,1.2734206088640971
Ketone body metabolism,11.62282524647874,7.983819110556798,1.2586123773555389,16.632713286154203,0.821811216435826
RHO GTPases regulate CFTR trafficking,11.600943311762205,9.941798544585689,0.3516145576397604,13.110521081296246,0.7940871021427758
Negative regulation of MAPK pathway,11.530241422556696,3.851940850686432,0.551992639157947,10.86501122644424,0.757721541396768
Lysosphingolipid and LPA receptors,11.529189601726454,4.911161029579436,0.4611852760166811,9.07189024468913,0.893095832573829
Interleukin-17 signaling,11.528137587187002,3.6612825886774547,0.7907353002825664,9.93280711279435,0.7648869525816987
Activated NTRK2 signals through PLCG1,11.391257505686132,13.906020730316392,21.184388547396512,2.51305877441514,15.890970044263325
Regulation of gap junction activity,11.334841084873423,19.01771247168703,1.5155629639700727,13.094817582568677,0.8321453720680119
Diseases associated with O-glycosylation of proteins,11.183153285630302,6.061967739540404,1.121798508617945,6.519489360167851,2.6228774398157064
Establishment of Sister Chromatid Cohesion,11.08603146607743,8.427876741418856,7.253184687649317,3.702124423827891,8.311193723250582
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol,10.93172865653169,5.880300900438399,0.722327253577044,9.350344772897268,1.5786837172706911
Loss of phosphorylation of MECP2 at T308,10.897469512476443,1.5253519296089744,0.5972297723760623,14.991099838390868,0.3992447875707668
Zinc transporters,10.810056802145192,5.541996496166636,6.1858037178273095,3.9398036792116056,9.505183737268572
WNT mediated activation of DVL,10.806337750564692,10.216206452295982,1.4465438075980828,19.02608538557716,1.9080486191968868
Oligomerization of connexins into connexons,10.788064970502113,26.78576776308346,5.568981213783877,3.700900987603762,7.940464283434112
Transport of connexins along the secretory pathway,10.788064970502113,26.78576776308346,5.568981213783877,3.700900987603762,7.940464283434112
NOTCH3 Activation and Transmission of Signal to the Nucleus,10.744042191381725,7.184105792868494,0.4366378380695516,8.494418205387236,1.8793847647663326
Transcription-Coupled Nucleotide Excision Repair (TC-NER),10.707936143825101,6.24204665110441,0.8891128798497567,9.519154409832055,1.7632864381205096
Insulin receptor signalling cascade,10.682745561517534,1.504516926192115,8.259626325071437,25.497369203241913,6.409836702096807
Interleukin-6 signaling,10.682745561517534,0.9663965673649996,2.124323868474077,13.622594897682193,0.5405672563065734
Defective ABCC6 causes pseudoxanthoma elasticum (PXE),10.657644679809167,3.4470113224700127,0.9678234447061183,14.755638283148691,0.4040862640313417
Formation of apoptosome,10.585402037182678,3.969911203247042,1.0813598426545152,16.833494492366334,1.4077848205529044
Regulation of the apoptosome activity,10.585402037182678,3.969911203247042,1.0813598426545152,16.833494492366334,1.4077848205529044
Defects in biotin (Btn) metabolism,10.527373593663276,7.20915852616644,0.6319505884589949,14.144832524301838,0.6061538471225594
Signaling by BMP,10.487650347990957,12.686527258086057,6.422534016798911,4.877604975148144,7.446280731713971
Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase,10.417933867955883,9.154939013992287,5.042177667429851,5.839460604938531,4.751926484315359
MECP2 regulates transcription of genes involved in GABA signaling,10.37736687097163,3.7342339874230026,5.798373059134929,5.218358980773228,5.672251086405557
"Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA",10.375322277312192,12.095971649961175,1.456931179040101,13.420164671366415,0.37142320622006086
Antigen processing: Ubiquitination & Proteasome degradation,10.336167296260776,3.9571059691548385,1.357718176451605,10.667329733676377,0.48967318044695246
Synthesis of bile acids and bile salts via 27-hydroxycholesterol,10.332008916303169,6.594421683488789,0.7073091128048805,9.200898304758992,1.511485665863626
MAP kinase activation,10.288448938787793,3.269855685525184,0.6793409724471154,9.06646307964174,0.6589120261824899
IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR),10.280681902099907,4.761336442640445,1.288802269690473,7.3983112027635825,2.6752359467702984
IKBKB deficiency causes SCID,10.280681902099907,4.761336442640445,1.288802269690473,7.3983112027635825,2.6752359467702984
Prefoldin mediated transfer of substrate  to CCT/TriC,10.234602253697735,10.542291157914459,3.9133070991724055,9.24320980370191,1.490677110771837
RNA Polymerase III Transcription Initiation From Type 3 Promoter,10.197043830223063,2.6409117197356267,0.3648744196109361,12.10582214921712,0.3568165722822283
"WNT5A-dependent internalization of FZD2, FZD5 and ROR2",10.189761538749584,3.658058830317849,1.3560510698609531,8.84582801306764,1.0882760711003596
Phosphate bond hydrolysis by NTPDase proteins,10.17407612980464,8.586775560716346,0.7446084336862697,12.711379827742158,0.4755758233344445
Toxicity of botulinum toxin type C (BoNT/C),10.15236903533183,10.622038544581377,21.25779548521141,0.3653564398763503,25.545699715765526
IRAK1 recruits IKK complex,10.137762729386056,6.159081537085965,0.3080266603198522,7.179568818774896,2.2345582882413817
IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation,10.135220015577731,6.158220752878619,0.3080266603198522,7.177594781632887,2.2345582882413817
AKT phosphorylates targets in the nucleus,10.134249832347418,4.345338292528533,1.6492225876095667,18.89229870192881,2.556994411188503
Synthesis of dolichyl-phosphate-glucose,10.108138441344416,6.065565236959928,2.794553007983574,5.625315923012889,3.5201024074423533
Calnexin/calreticulin cycle,10.099581801858847,1.1534804419625837,6.152728172291413,2.9571129365874946,8.395433535520676
"Activation, translocation and oligomerization of BAX",10.09809013509636,10.074975613578538,1.785222234010528,10.294115709238145,1.1714246117176281
FRS-mediated FGFR4 signaling,9.997464586130617,2.174297491064072,0.5217810441385035,11.716023071351975,0.31887792798238673
Hyaluronan metabolism,9.985057455605144,1.1548499232351206,0.5086677519142287,5.673992817026428,2.185481352852512
Cytosolic sensors of pathogen-associated DNA ,9.911169602439076,2.975668314611406,0.5267413935784039,12.474666777094868,0.4984297113410463
Glycogen metabolism,9.874244204211406,3.4980354844107837,0.8077515555803368,13.850241985337377,0.7071610347217723
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),9.851329527118288,5.442137254081157,2.6545500927529724,4.0027310969746175,3.129461617017984
Toxicity of botulinum toxin type B (BoNT/B),9.845213322893988,4.2747763691514296,3.1747260826689967,4.407761559265392,4.267242494672159
AKT-mediated inactivation of FOXO1A,9.766474623733679,4.627334863566686,1.806023435848593,19.457167401559474,2.982325523631195
COPII-mediated vesicle transport,9.658655654489117,9.97765781684228,4.331388331119116,5.188180279779763,4.860090289546357
Formation of editosomes by ADAR proteins,9.645105288664585,2.6105347640885905,0.8374516692332686,14.332018732787702,0.4579902833683326
C6 deamination of adenosine,9.645105288664585,2.6105347640885905,0.8374516692332686,14.332018732787702,0.4579902833683326
mRNA Editing: A to I Conversion,9.645105288664585,2.6105347640885905,0.8374516692332686,14.332018732787702,0.4579902833683326
Defective CHST6 causes MCDC1,9.633188747487978,7.3228242694293435,2.5779640582206342,6.8451063963732866,2.6752359467702984
Synthesis of Dolichyl-phosphate,9.61924005727216,2.751934670415788,10.48456920797716,29.731293878477526,10.129936325232288
N-glycan trimming in the ER and Calnexin/Calreticulin cycle,9.604028243731836,1.2156820230540615,5.621238745294266,2.894883670067698,8.102595819264119
LDL remodeling,9.59213879074865,5.8179396121209646,0.36027998883733897,10.675692962433125,0.5816469789149179
ER Quality Control Compartment (ERQC),9.591964827076797,1.0549956941977892,6.09870117311445,2.746012321085843,8.221359148182069
DNA Repair,9.560248775652266,4.917406348365069,2.6144463850758,9.00242184731446,0.8660834242005404
Diseases of Base Excision Repair,9.521993093374533,10.835858374955853,1.8951641398733479,10.140868009512218,0.40372360908474114
Inhibition of Host mRNA Processing and RNA Silencing,9.520045142913325,4.295489149635917,1.8281423408668005,6.967432733493229,2.5084992362628737
Signaling by Leptin,9.467204021663576,13.579410140721341,28.57568688664131,0.8768816941343789,20.68169988822694
SLIT2:ROBO1 increases RHOA activity,9.282645756800706,4.590778575898477,0.3435822181567863,6.370230897357309,2.3051472345210025
Downstream signaling of activated FGFR4,9.23773965532174,2.003059055079309,0.7649809508242461,11.683435678587044,0.46614096858861137
PERK regulates gene expression,9.197679896496622,10.111280407814794,2.633998608309769,7.737630038709128,2.454705726619155
Zinc influx into cells by the SLC39 gene family,9.193365576551798,4.384846244311554,5.097339962591029,3.462807218927505,8.06250548865657
VEGFR2 mediated vascular permeability,9.193365576551798,2.480740805254138,1.3150745217548738,12.940353013395976,1.1678067738176199
Protein localization,9.175282928282517,5.165122646631771,1.5980093505924362,4.736144216956137,4.222825210798765
Postsynaptic nicotinic acetylcholine receptors,9.115774555269,3.650832414601665,3.3171992512874433,4.917313373644992,3.483179270823303
Highly calcium permeable postsynaptic nicotinic acetylcholine receptors,9.10421259220529,3.4800925931184445,3.7727631308488268,4.87917192752244,3.7096766399696897
Acetylcholine binding and downstream events,9.071135693335247,3.6421332620998683,3.3290924757926725,4.888817624297013,3.4783685834964437
Myogenesis,9.068006391192604,2.1951251049102307,0.3516322364725837,10.740929084737946,0.6303177112253529
TFAP2 (AP-2) family regulates transcription of cell cycle factors,9.06092378233904,6.289097983198925,12.503686176810033,22.80768470778028,6.713398753367235
Biosynthesis of EPA-derived SPMs,9.026451463642704,1.5680453814641662,0.5662331344129978,10.375773809004166,0.35054349862887657
RUNX2 regulates genes involved in cell migration,9.016921751616739,3.1416120000545256,0.32811794467057315,14.819633456543169,0.745204751884035
Carnitine synthesis,8.978603857010617,7.621120469585889,9.487235535419755,2.2646323093565193,9.728869671866969
SUMOylation of immune response proteins,8.963204273878453,6.100168860113144,2.51262998368035,4.717199373535952,3.9275432004312814
ARMS-mediated activation,8.894395605072857,0.9952699921803773,2.1587123202816065,10.784378036005496,0.35054349862887657
Inactivation of CDC42 and RAC1,8.835616309656976,1.8901227089274018,0.829105339940064,8.739234513153997,0.8151815286162876
Loss of Function of SMAD2/3 in Cancer,8.743302400930899,0.368897018836893,4.298903599607818,13.668631087194733,1.845888090312775
The retinoid cycle in cones (daylight vision),8.687226912098648,4.96061287667392,1.4537998585833956,6.27267044778315,2.214052831148012
Rap1 signalling,8.614971784152896,8.01869482348806,3.280898636167203,3.827530078480659,4.420033449452862
KSRP (KHSRP) binds and destabilizes mRNA,8.580688428760801,8.693249277629311,2.669890576926403,9.205207462545413,1.1100244067631015
Ub-specific processing proteases,8.571655441038478,4.552528952275228,2.398649105154078,8.640864393916921,0.5916224910390321
"Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2",8.553516293638822,3.8016604480014493,0.3090312066047385,11.530660301597774,0.46124988199809275
Aquaporin-mediated transport,8.513384732179619,3.6996326232991383,1.0855253249459818,9.443504067372807,0.4353202194536908
Synthesis of active ubiquitin: roles of E1 and E2 enzymes,8.502956226761013,11.786681434108646,4.277986126181539,6.713199418650054,2.532803973667786
Intra-Golgi and retrograde Golgi-to-ER traffic,8.451990252241448,9.602943791932383,5.145599511155794,4.981515241667438,3.992876767776632
Signaling by NTRKs,8.424234728633184,1.6826826471334655,0.9743464719255287,7.876726263852924,0.5926803705738717
Activated NTRK2 signals through CDK5,8.401275902559263,2.7400177196841473,3.8797911944361294,1.9063205978874458,8.735923082037205
IRF3 mediated activation of type 1 IFN,8.394481182423585,2.8984330923940065,0.5800039923479415,4.424131414112878,2.615806772447227
"Defective CHST14 causes EDS, musculocontractural type",8.31148322857346,4.636230653025208,0.5786818952933397,9.059597085537526,0.7311526376693159
FGFR1c and Klotho ligand binding and activation,8.300716795687302,3.794629131640534,4.508371749126684,4.434548738609756,5.803333070219664
NTRK3 as a dependence receptor,8.289957863551718,7.967085057583425,2.466666540912159,6.022789478453658,2.500361881688217
Multifunctional anion exchangers,8.21407807175905,3.607878887845669,1.3468937936181862,5.883173947751592,1.7869958451502432
Protein ubiquitination,8.197284746305408,4.6737327540408735,3.6821653308310793,6.57042131068261,1.2871506301929776
Urea cycle,8.11392712326788,7.241641470423908,0.722327253577044,12.256763576777047,1.5658202597628301
Pyrophosphate hydrolysis,8.106095115151478,2.73031021272779,4.216135452066182,3.9003537331802094,2.8061096544691315
Laminin interactions,8.068952232685264,2.1961262277879214,1.1759736463313795,5.339374231230879,1.4557285910438955
Synthesis of PIPs at the ER membrane,8.060214546288549,10.539492213940717,5.3443226693314605,2.9628115805249267,6.672401839911659
NOTCH2 Activation and Transmission of Signal to the Nucleus,8.01785498997995,4.653484535189203,0.8016512223414746,7.0881440919352094,0.9450749023390017
Biosynthesis of D-series resolvins,7.996650349920441,1.3072036239995872,0.4373751805742269,8.840758325911228,0.41564475800458783
eNOS activation,7.97709288399331,3.3371513581334904,2.1155559489283573,3.0394487236574443,3.9275432004312814
MAP2K and MAPK activation,7.943493210143453,1.739497504351938,1.4640619547575304,6.11139753833596,1.1107976294130835
Biotin transport and metabolism,7.938515810019434,6.141955814901677,0.8144214361140394,11.409523531284659,0.7914568489895957
Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits,7.918069687858082,7.150627651775951,1.0526402502523076,6.825955449601189,1.7719200858923048
Activation of G protein gated Potassium channels,7.918069687858082,7.150627651775951,1.0526402502523076,6.825955449601189,1.7719200858923048
G protein gated Potassium channels,7.918069687858082,7.150627651775951,1.0526402502523076,6.825955449601189,1.7719200858923048
Defective GCLC causes Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency (HAGGSD),7.914250851034585,3.182286139254873,0.9107756807065548,12.109145465993926,0.8312745053470038
Meiotic synapsis,7.912502886702749,1.1861630078271739,0.9565630192164274,7.9759314810962705,0.5965944282249691
TRAF3-dependent IRF activation pathway,7.887544677834355,7.401600247295958,2.8398399290539458,7.980183275921367,1.35992111008814
"TICAM1, RIP1-mediated IKK complex recruitment",7.812279922015795,1.8638497082855057,0.4370506189497131,8.281669626902417,0.37582644616584465
Signaling by Retinoic Acid,7.810316952513276,0.8625923512363967,2.2829844769101717,13.493135791937751,1.926761412982025
Muscarinic acetylcholine receptors,7.787812049860174,3.291683008452174,1.3614188950570487,4.8725211514949205,1.6075103597184202
Defective Mismatch Repair Associated With MLH1,7.7809290441621535,4.516395958323401,1.3646946233649306,7.295880263027107,1.1346383320665594
Defective Mismatch Repair Associated With PMS2,7.7809290441621535,4.516395958323401,1.3646946233649306,7.295880263027107,1.1346383320665594
Metabolism of nitric oxide: eNOS activation and regulation,7.776235140623492,3.1632997194255514,2.055137066853028,3.0229106914533994,3.689821381619345
Biosynthesis of aspirin-triggered D-series resolvins,7.672094209895525,1.2205137870419813,0.4446287133285934,8.722900639657738,0.3654772477727824
The NLRP3 inflammasome,7.641671982890182,1.646519094640783,0.6647440034786273,8.136527047375964,0.5610281628972237
Ceramide signalling,7.629352086758298,4.310603546627296,1.1925380133251666,7.530220462309342,0.35822111712773297
Epigenetic regulation of gene expression,7.626964668553642,2.5828469467852435,0.5455844120057768,5.441875131176316,2.2074645263699484
5-Phosphoribose 1-diphosphate biosynthesis,7.619165828124692,1.6027258445515704,0.6568869979403237,14.38358916631505,1.2249340531588953
Methionine salvage pathway,7.545727223821525,2.8354815700724214,2.6711996024451623,2.0657174949752624,6.580001468902519
Biosynthesis of E-series 18(S)-resolvins,7.514454994890367,1.2632119363118188,0.4249916394403177,8.389846617237215,0.39846119573665056
"Base-Excision Repair, AP Site Formation",7.481912256654674,1.168720024234668,1.0305925102538935,7.729476717457514,0.5284353037808306
Adenylate cyclase inhibitory pathway,7.4435425059142215,6.707740980755735,6.189908166993054,4.867130214248893,3.335728520319481
Regulation of gene expression in beta cells,7.4170527653997596,2.311908000471313,2.580255449787512,16.623633926595,4.071371438787542
Deadenylation-dependent mRNA decay,7.415815061382652,6.865735610727021,3.6710762080976327,5.208360128821407,2.793984136322108
FGFRL1 modulation of FGFR1 signaling,7.400806773551918,5.569858847017701,0.3101679088202268,13.236940878139066,0.8439363731964818
Ficolins bind to repetitive carbohydrate structures on the target cell surface,7.3514847661554255,4.026338061449795,2.522626340090234,3.506117402917218,3.4163744133858462
Recognition and association of DNA glycosylase with site containing an affected pyrimidine,7.315762783374183,1.129469005837333,1.0309035612949558,7.546364499044201,0.5251801112784908
Depyrimidination,7.315762783374183,1.129469005837333,1.0309035612949558,7.546364499044201,0.5251801112784908
Cleavage of the damaged pyrimidine ,7.315762783374183,1.129469005837333,1.0309035612949558,7.546364499044201,0.5251801112784908
NRIF signals cell death from the nucleus,7.304170317531335,5.709403187212434,0.449373927031062,4.616478827842766,2.160939091179619
Chaperone Mediated Autophagy,7.229956685911696,2.545943040656245,0.3011528803716599,7.563712394521006,0.43255967188429634
Signaling by Activin,7.212305268645769,0.5462107823950575,1.0689880895867843,8.994433584700463,0.43618115697545257
Formation of Senescence-Associated Heterochromatin Foci (SAHF),7.195551888563294,4.752035906754665,0.38574166997933496,11.099243249079802,0.7793113600760612
Biosynthesis of E-series 18(R)-resolvins,7.160047546127902,1.1805976159749367,0.4329112585651733,8.23021552058781,0.35293999899684225
Mitochondrial protein import,7.150550796950272,8.973918450993851,1.6100011452582597,8.074381969330876,0.6423112930520763
Cleavage of the damaged purine,7.144522641872802,1.0802464163398522,1.0015583253276443,7.331183861504897,0.5288854824759675
Recognition and association of DNA glycosylase with site containing an affected purine,7.144522641872802,1.0802464163398522,1.0015583253276443,7.331183861504897,0.5288854824759675
Depurination,7.144522641872802,1.0802464163398522,1.0015583253276443,7.331183861504897,0.5288854824759675
Estrogen-dependent gene expression,7.1235037449182395,1.2699113077480992,1.3153398958595703,7.19218095165948,0.5431518847871895
Processing and activation of SUMO,7.122295572089415,2.5408843923512183,0.3521848823518743,11.056690506636087,0.5828063460284988
TICAM1-dependent activation of IRF3/IRF7,7.1063075474306245,5.832231143230702,2.5385794852040013,7.136221028476496,1.3373529652420642
MyD88-independent TLR4 cascade ,7.057399931165612,1.9876736056034503,0.3011528803716599,7.020288465298399,0.36176063381650303
TRIF(TICAM1)-mediated TLR4 signaling ,7.057280744126447,1.9876736056034503,0.3011528803716599,7.020288465298399,0.36176063381650303
FGFR1b ligand binding and activation,7.0139462251553475,2.6913433606042947,12.85977690951741,1.783109611626635,8.793832151844827
Packaging Of Telomere Ends,7.0077892307680445,1.0533658539905164,1.0278038220887697,7.250488178901448,0.5018400706013267
Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives,6.981607154368677,1.290326116086593,0.3521848823518743,7.386733461264304,0.5375654286111713
Vitamin B1 (thiamin) metabolism,6.95612195820628,6.998490879523351,2.592826518864471,3.333396637067118,3.5074314130430713
RUNX1 regulates expression of components of tight junctions,6.938620311416079,9.168924242121378,0.5861961603249937,10.507003584790807,0.37699077529789354
Threonine catabolism,6.9275698835404285,3.494640955603601,9.124829602829235,14.658858817804992,2.7881307370844084
Highly calcium permeable nicotinic acetylcholine receptors,6.919741138838553,3.134516460581316,3.4215703274485065,3.6770596412598158,3.2124680277606688
MASTL Facilitates Mitotic Progression,6.89993677372639,2.8919458807850966,4.574921380704077,6.935209021421453,0.6509126772636458
STAT6-mediated induction of chemokines,6.887424392152209,2.8899422183941814,2.7065077173320473,3.381329746025577,3.160503506964602
Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells,6.883677498554001,3.465021220933952,0.7635372753475504,5.85627013641825,1.0268717408712396
Type II Na+/Pi cotransporters,6.879291166560966,1.5810038988673605,0.3799803900476081,8.136527047375964,0.30275878323513294
Nef mediated downregulation of CD28 cell surface expression,6.867012539229866,3.2905025087762767,0.704612924976491,6.704425146767456,1.0184843921769837
Deactivation of the beta-catenin transactivating complex,6.846225625955727,1.680837598956105,6.25561376080465,12.867663556787608,3.4471758147338267
Dermatan sulfate biosynthesis,6.840575351838579,4.926605055679461,1.8532844604436738,5.329682550632583,1.389703176889741
Signaling by NTRK1 (TRKA),6.81430823350847,1.423675889149841,0.5629973339828988,7.493495873530449,0.31521958564392155
Recycling of bile acids and salts,6.749998057048423,1.6359619331632786,1.8918362311776926,14.339267200965512,2.1909714987642475
Clathrin-mediated endocytosis,6.738689617273186,2.312336209039493,0.3422995104035593,9.312107952571406,0.6328796556436518
Interleukin-7 signaling,6.717902078105163,8.113197447595585,7.773700747547707,3.255329234838905,4.642223302630566
Glycogen breakdown (glycogenolysis),6.672550490998501,4.356087462936115,0.32738758747246477,7.4020046445502725,0.3425521130943106
Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells,6.658794763251652,7.550970178076458,0.5391234445876828,4.707721044342286,1.1808083570765782
Activation of BMF and translocation to mitochondria,6.595065720297405,8.503829934552812,6.865040051906974,4.312558038244349,2.87385533319464
O-glycosylation of TSR domain-containing proteins,6.594748288108444,1.92381673416748,0.6109912518444587,4.441335200319923,0.9905911259372867
ERKs are inactivated,6.594430667895481,1.6082964443626844,2.6129841351587464,2.0800883960541663,3.9081901612555656
Biosynthesis of DPA-derived SPMs,6.580862177231641,1.2569280432241123,0.3648537383419295,7.069316930356606,0.5072823901487686
Biosynthesis of DPAn-3 SPMs,6.580862177231641,1.2569280432241123,0.3648537383419295,7.069316930356606,0.5072823901487686
Defective B3GALTL causes Peters-plus syndrome (PpS),6.5540966288981855,1.7471351391125138,0.5829530924563076,4.492442843797962,0.9091359635099083
MECP2 regulates transcription factors,6.490702962216541,4.91574269132787,0.34906580331871484,3.994106281668956,1.9429384633042075
Defective HLCS causes multiple carboxylase deficiency,6.46805913240548,4.2835397364692405,1.0246421939628265,9.906560565126535,0.9877547712027035
DNA Damage/Telomere Stress Induced Senescence,6.464029069096949,0.915189553083583,1.0892564846872115,6.5094043280340745,0.5162179862148601
G alpha (12/13) signalling events,6.453809022558381,5.257625869287802,5.972663487517539,2.8989610272504827,2.7098074951541826
Interleukin-1 processing,6.445453278117439,1.1975904680800618,2.3586712097550557,10.675103189349976,1.1836068278834402
Generic Transcription Pathway,6.410965461447038,2.11550854497535,0.587807141064294,6.911742623189073,0.35389735944975265
Cytochrome c-mediated apoptotic response,6.410243935775692,2.1671311433592484,1.74139948135113,12.560253977032685,2.2849194464020024
Signaling by NODAL,6.410138962243522,0.9720219686909475,0.6606212036772714,4.168971310983382,1.461482688724425
Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD),6.3644855389704915,4.1308725326659825,0.6173071945687245,8.806485702034058,0.5572472953360188
Synthesis of PIPs at the late endosome membrane,6.281121476956948,7.2992152817323985,4.543056919816589,2.8570925064659654,5.011135920208151
GABA synthesis,6.278783616274525,8.799439601999143,5.0561206672455645,3.0885219360818925,2.69926021647579
Negative regulation of FGFR2 signaling,6.252484599530646,0.36885055591456395,3.6767277491955466,9.774080033523042,1.666113123758484
"Sodium-coupled sulphate, di- and tri-carboxylate transporters",6.222400025386796,0.7012657575892249,0.3968467371968264,4.2762527312501835,1.6075103597184202
Synthesis of PIPs at the early endosome membrane,6.190173721889845,7.45083375546424,3.745686734734658,2.782521840643933,4.438835738202293
Activated NTRK3 signals through PLCG1,6.153611388004648,10.536923572222118,17.5549074091274,1.012892106872949,9.880613377658326
RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known,6.132614429311016,5.981845712623186,0.5162596893295713,9.562927012792564,1.0811371731338055
Biosynthesis of DPAn-3-derived maresins,6.127499074735733,1.1264427827583237,0.45178684791317153,6.295602197439535,0.59286005124303
FGFR1 mutant receptor activation,6.120380367269036,0.6219408540568258,0.8907349629055175,6.096833928791017,0.6012074002865293
"Formation of the active cofactor, UDP-glucuronate",6.108657432244899,6.54329512686963,0.8793472384390814,7.662328238010682,0.38673465706298504
Regulation of TP53 Activity through Acetylation,6.084145404121663,5.12124464234298,0.7640956837444205,4.901586316020254,1.8466443378325075
Biosynthesis of DPAn-3-derived 13-series resolvins,6.061981546984129,1.1142669098677198,0.45178684791317153,6.222860588123634,0.5940569456126532
Presynaptic nicotinic acetylcholine receptors,6.056000867149161,2.6297492409630343,2.5388502168356166,3.229631091794198,2.5494319521375135
Pre-NOTCH Processing in Golgi,6.050522393030451,4.759854909179711,1.140691562227441,6.091774693843089,0.5112371691681351
The canonical retinoid cycle in rods (twilight vision),6.039669260903068,9.517291320269422,8.358516115760832,2.1458577302461825,5.785128414268351
Post-chaperonin tubulin folding pathway,6.029224660057946,1.8414415838577087,3.882002697317372,7.6633216937505,0.5162179862148601
ESR-mediated signaling,5.9985365947259295,1.2719464576994142,1.0576127535045796,5.326726636150988,0.8026260240191225
Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus,5.938098036303531,2.1715432743177923,1.1170561199732518,5.239894343452537,0.328376802398534
Erythrocytes take up carbon dioxide and release oxygen,5.921745017393154,1.2934299793893065,2.9750256141402542,4.569068241623897,1.7160677180179542
O2/CO2 exchange in erythrocytes,5.921745017393154,1.2934299793893065,2.9750256141402542,4.569068241623897,1.7160677180179542
HDL clearance,5.914562223355849,2.5911227780173816,5.371720817685434,15.550000004518777,4.139376066187672
"Adrenaline,noradrenaline inhibits insulin secretion",5.912894788008773,1.0145690940388268,1.2275911667854373,8.150301725746498,1.1072084103888702
Erythrocytes take up oxygen and release carbon dioxide,5.9000144233092975,1.3103746040135018,3.039111863387598,4.488775841758715,1.771003842386643
Regulation of TP53 Activity through Methylation,5.896776663753161,4.38990630650167,1.378425342112187,8.188977942092865,0.5363082888357518
RNA Polymerase I Promoter Clearance,5.876653941597488,1.3809416129654737,0.45192789645580894,4.745632499793737,1.2240767481192119
Dopamine receptors,5.871658304063433,1.5545648805459182,2.6409169301047624,3.7412288472654844,2.10747221416897
RNA Polymerase I Transcription,5.847668279798947,1.386252615305686,0.45915790674912704,4.70957021003208,1.2219280353096003
SUMOylation of transcription cofactors,5.819436881527877,4.475071238887251,1.9607789832835305,3.273588636596965,2.940201888788142
Defective CHSY1 causes TPBS,5.809787677067929,4.589921576309724,0.43710163146410264,6.148695228492712,0.7353641776117883
Synthesis of UDP-N-acetyl-glucosamine,5.790994882977154,5.838789453294234,0.3384220280213273,7.238524707581317,0.40941014014848237
Sterols are 12-hydroxylated by CYP8B1,5.764853900011479,5.967186775803047,0.8144214361140394,5.46850818370563,1.24945824918109
Regulation of TP53 Expression and Degradation,5.697402938620535,3.600025388479075,4.201286913850106,2.777592251501561,2.4123733476426286
Processing of SMDT1,5.693071772765943,1.359194874733131,8.98810347260475,3.1961980983794276,2.907687965489505
PTK6 Expression,5.677180717151697,6.013966604035617,0.3075705183136266,5.312712152979453,0.3123129692681539
Suppression of phagosomal maturation,5.64574902618927,5.042683436708889,0.4411516621516239,3.0958149494488336,2.48166533900982
Neurotoxicity of clostridium toxins,5.642975551278966,2.6834741915978984,0.3011528803716599,13.288250304932646,2.23729629538995
Events associated with phagocytolytic activity of PMN cells,5.624286343898899,4.138588808996382,0.3337283669927169,6.8208170039970595,0.505888188632121
Biosynthesis of DPAn-3-derived protectins and resolvins,5.612136322435071,1.0744157774541427,0.4678495651117931,5.837256836966097,0.5633325122160637
Retinoid cycle disease events,5.606608789100759,6.9359022875846374,10.38818221617325,1.6188946732281568,6.55996626312424
Diseases associated with visual transduction,5.606608789100759,6.9359151732663555,10.38818221617325,1.6188946732281568,6.55996626312424
Common Pathway of Fibrin Clot Formation,5.596008584515305,1.9553702467879066,3.5916316150923957,7.684573945732026,1.1270354788076853
Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components,5.587137575716198,4.238193398037406,1.9341478618108168,6.471662394334857,0.4296864336168273
Inactivation of APC/C via direct inhibition of the APC/C complex,5.586670875745593,4.238193398037406,1.9341478618108168,6.471008095489745,0.4296864336168273
HuR (ELAVL1) binds and stabilizes mRNA,5.559893839023526,0.3220198588600886,0.3890483968060758,5.623607206892416,0.3562864942613076
STAT5 Activation,5.54496830927002,4.532604447506898,8.882006763686944,1.5277165845513416,8.479491127249531
Collagen formation,5.542603070366552,1.7927442924324442,1.7103791562334647,4.343680125324375,1.2529498675461146
Pre-NOTCH Expression and Processing,5.528842115462454,1.032370026180022,1.435561097828604,5.96421005562115,0.3988527509772136
Negative regulation of TCF-dependent signaling by WNT ligand antagonists,5.514720777289037,3.626675328055922,1.1252808217145436,4.1517084283740795,2.1572993182918676
Synthesis of Leukotrienes (LT) and Eoxins (EX),5.510278363157914,1.4071184421086091,0.30117107649969654,5.762293561709492,0.4897587555780545
TGFBR1 LBD Mutants in Cancer,5.498264829191118,3.401933202955649,0.3251325616611387,4.176002683292796,0.47130258846413425
Enzymatic degradation of Dopamine by monoamine oxidase,5.428771742981833,1.7416330914368077,7.708642161775589,2.0632846109029743,4.395891886472819
MTF1 activates gene expression,5.400159457513312,0.9399961411648202,0.8239078413008708,2.938276448327761,2.1609614327097058
Regulation of TP53 Degradation,5.39633146180115,3.4303660260930124,4.077775625691406,2.596452543849699,2.372694348930702
Intestinal hexose absorption,5.39381606827745,3.33596113170734,0.3968467371968264,4.265571308126847,1.6219980880179694
Gene expression (Transcription),5.3677334322489285,1.8617015911898211,0.3964493633457036,6.462889561168997,0.39335545298682717
Inhibition of TSC complex formation by PKB,5.357570811783151,2.3591520970386943,0.5818980353000259,8.9269921252745,0.938644794329063
Regulation of thyroid hormone activity,5.303143875820686,2.454244064646505,5.426465415903005,1.2970724761758736,4.5099997195071255
OAS antiviral response,5.283967012224871,4.220426954755202,2.3172310578299173,4.914700134302671,1.0621349759752847
Synthesis of PA,5.2600220510106634,2.8049821411942832,0.8704494976527886,5.807738994083144,0.5485581859814622
Pre-NOTCH Transcription and Translation,5.215510796199249,0.9120545770356585,1.226572754836616,5.368673668241081,0.4553520349245476
Formation of the beta-catenin:TCF transactivating complex,5.135742647821219,0.6669072680181632,1.3334572185818612,5.443825796586174,0.37920699273879965
Uptake and function of anthrax toxins,5.095798158847076,2.6286211610163845,3.060066163337203,2.2772208209144043,1.9347823174720846
DNA Damage Recognition in GG-NER,5.086284922970597,7.947788975990791,2.0464492040099027,2.8641091770499534,2.969304105662339
Josephin domain DUBs,5.042213092254193,3.952097140983269,2.1606254245530865,2.519730250145598,2.373779468800653
Keratan sulfate degradation,5.01778800442297,4.517800210721202,2.1654425952321117,2.8709365235635125,2.492263178394154
Chondroitin sulfate/dermatan sulfate metabolism,5.016278689052007,1.4591788161533306,0.8435020693270656,3.4937673578240473,1.1845765663158643
NFG and proNGF binds to p75NTR,4.96124832380327,2.9883961781636397,0.6372525928105914,3.7193571587734047,0.6442189220924821
MET activates RAS signaling,4.949370317670065,6.298910529551417,0.5129817002943465,5.796454507495095,0.31179965628145334
TRAF6 mediated IRF7 activation,4.949125541100056,6.065227640842084,3.58501760922187,4.264894423374779,1.7285606828395113
ABO blood group biosynthesis,4.92601832802407,1.6530720992045569,1.2378291071109047,4.658286999737899,0.3782071093506654
Prostacyclin signalling through prostacyclin receptor,4.908665906950905,4.55079207235604,3.4067940899728706,2.9079494733953744,3.9269642558493167
Transcriptional Regulation by E2F6,4.899525304194026,2.4393353119296397,0.5372266799065973,4.1862749936913435,0.7898626953267313
Respiratory electron transport,4.896615244631889,1.8306974142231305,1.3162501286647434,3.1420963162869144,1.7534784865563748
PI3K/AKT activation,4.832236866876041,5.78153454752655,10.938915515982861,0.4208651490605755,10.911603373007127
Nuclear Receptor transcription pathway,4.8291736917976955,6.464422550679665,0.9291773916561836,8.708325361815122,1.0184843921769837
Disease,4.828228806595916,1.375224136882929,0.5800039923479415,6.724371615116067,0.7914568489895957
MAPK1 (ERK2) activation,4.811594978602118,9.695268378002146,4.78838541124251,1.909733567509073,5.0206862866676465
Synthesis of 5-eicosatetraenoic acids,4.793410676463338,0.4576100224635301,0.721873107289117,7.3983112027635825,0.6332980188474437
NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10,4.792645967690644,5.077749136320926,1.4740358400543967,5.441875131176316,0.8168257656792994
Thromboxane signalling through TP receptor,4.778360672649939,4.235536837093316,0.8618755598125487,4.684182536177008,1.8782267147052678
Sodium/Calcium exchangers,4.763398243337542,1.6007736581524847,1.9274870397517414,10.275370616796701,1.1988245767269354
Adenylate cyclase activating pathway,4.739024289916842,3.98156044627521,5.4305771776322045,3.505529026561871,1.9285012243458926
Vitamins B6 activation to pyridoxal phosphate,4.716634859433729,3.98156044627521,1.3645398124524506,7.194921722503092,0.33408222073191784
MET activates RAP1 and RAC1,4.715878420368052,5.307410902162199,3.002497175855605,1.551998585636365,3.806268203230637
RNA Polymerase II Transcription,4.695634798122474,1.6879965205833853,0.5293131139866498,5.163476224399024,0.30105694012921036
Nucleotide Excision Repair,4.679774809133098,3.4373244648606933,0.5247504200581485,3.718387172784962,1.4268103747290348
RAB GEFs exchange GTP for GDP on RABs,4.667408256549941,0.34321898709378523,0.37940200262453416,6.6093804306482244,0.8004474126168174
Complex I biogenesis,4.6505636043994185,0.9711079730296733,1.6486435384015796,2.62237904388681,1.7766611130972327
Long-term potentiation,4.572543536918047,5.3113947340816985,9.635798042299301,1.5939563610844139,5.355634833139584
Processing of Capped Intronless Pre-mRNA,4.570946896091116,1.0000157853199128,1.109848549115084,6.593689875055368,0.7353641776117883
ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression,4.501296178029184,0.5465713046917133,1.4327418887723389,5.079627333156761,0.3091178841326243
Base Excision Repair,4.4440238871245645,0.511353771485986,1.333152228153535,4.615967426796532,0.42479001750216616
Beta oxidation of hexanoyl-CoA to butanoyl-CoA,4.430656830745615,3.6027009877397593,0.30117107649969654,4.180851813316438,0.3031998743066087
Translation,4.414285901241201,5.518443373478345,3.056619206299765,2.903662735930444,2.586653593529498
RA biosynthesis pathway,4.412723860050423,0.5131617489523295,2.7898716624958517,9.441784939002856,2.658857613729098
TCF dependent signaling in response to WNT,4.343230312162602,4.5962271862229445,3.330683992469275,4.1037531592741745,0.6323287638567042
Apoptotic cleavage of cell adhesion  proteins,4.3420172214130135,1.5585785838245902,2.3710457490171986,8.05547551600014,1.9832148583066072
RUNX1 regulates transcription of genes involved in interleukin signaling,4.319844688164927,3.422091966013541,2.0211321117316436,2.886940069078642,2.1544272816601993
Assembly of active LPL and LIPC lipase complexes,4.308675917214969,2.763500154424266,5.293974495138192,2.2374376048123046,2.9867082986273235
Glycogen storage disease type II (GAA),4.2907342465377925,1.6901853543468557,1.1127799268036584,4.986872045654079,0.4993228882111474
Biosynthesis of DPAn-6 SPMs,4.281756356705489,1.5882417504146034,0.8107824662002432,5.201585422931637,0.5230671182394184
Class C/3 (Metabotropic glutamate/pheromone receptors),4.276918398738224,3.6042104095096557,1.2145669812534456,2.684129979878835,2.424523277316024
ChREBP activates metabolic gene expression,4.275551643649735,2.0720684972479053,0.8144214361140394,4.477800903928914,0.566283935621404
Neurofascin interactions,4.273359340850617,1.8428625202328355,4.40928863323867,1.1765019666633492,3.751077772608355
Transcriptional regulation of pluripotent stem cells,4.272818600042833,5.074333912349364,1.5150179310572662,3.048427406106668,2.0322770119640787
Negative regulation of FGFR4 signaling,4.2495268877750965,0.8191201920537555,6.792837060102153,10.872582066837778,4.37442780338531
FOXO-mediated transcription of cell death genes,4.246848696531164,0.9778493227677897,1.2145669812534456,4.709254775101011,0.4539235865696334
rRNA modification in the mitochondrion,4.233321780255148,1.6470883014339506,2.6286371130539368,2.9809489823097937,1.1157539743685903
RNA polymerase II transcribes snRNA genes,4.2321275726016125,2.738089981870035,0.8144214361140394,4.554593412801245,0.3912495204891879
Association of TriC/CCT with target proteins during biosynthesis,4.194235447617925,2.3075312298399746,1.1363366758925413,3.2514616410147235,0.8811379624568897
Vasopressin regulates renal water homeostasis via Aquaporins,4.189453999632272,1.5415396764333642,1.77797959531822,5.258544766802765,0.8633472976647485
RNA Polymerase I Promoter Escape,4.162995728096508,0.8595417203064385,0.4816590781856437,3.1926993619580295,1.0338458799485686
"Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)",4.104738728682062,0.940055694694969,1.0349301197774667,4.638107098903865,0.6239715682459132
Reuptake of GABA,4.091625540626942,0.8982541328677967,7.3387785180931875,10.921078088605451,2.8928883306678306
Axon guidance,4.07338622616478,0.5843579951182797,1.1368824876524413,5.443688079059613,0.9277035647634851
ADP signalling through P2Y purinoceptor 1,4.051020773600678,4.09556545881095,1.5195723601496263,3.2704770099456018,2.6205866546295273
Voltage gated Potassium channels,3.9988809178559976,4.489619753661681,1.46537164584598,9.336630167413299,1.6788806286847642
Defective LFNG causes SCDO3,3.998526355597109,3.970648878878559,0.3521848823518743,2.8514685923179597,1.052408167186234
Galactose catabolism,3.9865564601569763,0.9307984089595599,1.379584432203462,2.3449273414581517,2.1144340407481255
Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3,3.986361613375169,0.4467234274716637,1.4600231765252483,4.570283273198579,0.317432546385211
Digestion and absorption,3.953966629974807,1.9274710563627102,0.6147422451691067,4.5817852456905594,0.7452191952852509
Removal of aminoterminal propeptides from gamma-carboxylated proteins,3.951716417275474,1.2461545907503675,0.7256281557219295,2.6757494233794437,0.56030519623756
Mitotic Prophase,3.9515233267282484,5.191487539683765,3.639025402057824,3.4971109621499132,0.9424553313435527
Amyloid fiber formation,3.9402645226042536,0.49602227157201767,1.3757378744878168,4.29486609565695,0.33024451242649866
RORA activates gene expression,3.927762149049684,0.7785151144526111,3.154727317845803,8.561604472445275,2.656799254286851
Negative epigenetic regulation of rRNA expression,3.9192182291682824,0.9484854497938796,0.44350583889477724,2.853972290471562,1.143968643611592
Modulation by Mtb of host immune system,3.9061245257803523,3.254060841963232,0.5985494792076033,2.609178212562409,1.2657831474577788
Transcriptional Regulation by VENTX,3.882706504752719,4.131253233848168,1.560956635130685,4.664253557700302,0.9434097386099083
Scavenging by Class B Receptors,3.879853903469286,2.9340751891899974,0.9833813907559621,4.455607829834618,0.3785758240053585
TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain,3.878881340811375,5.2630229329010705,3.667692397829638,2.1836078091133038,3.196382736363823
Sema3A PAK dependent Axon repulsion,3.8780653818320183,0.35266042633141886,5.918142186399098,6.6324119581985,2.0157380308451867
STING mediated induction of host immune responses,3.868801006414978,0.31619143239092085,0.4656186910279262,4.298441526457401,0.43680827661421384
RHO GTPases activate PKNs,3.856895052106528,0.363243390188187,1.683280598550132,4.3895633240928404,0.3259789688362038
Defective Mismatch Repair Associated With MSH6,3.8418937860596376,1.904338840579013,1.5163576860702352,2.1321368909227867,2.0557675241752054
G beta:gamma signalling through PLC beta,3.8396814456438078,4.550528645142267,2.0857844709256272,2.5693699524500913,3.035581004768794
Asparagine N-linked glycosylation,3.8360690805764004,4.870124413925511,3.1086651462332187,1.3166301545432528,3.937938197439483
Mitochondrial calcium ion transport,3.831992077707875,0.9459839062944086,7.051273935917335,2.538163034734956,1.688652602044213
Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum),3.828383870603206,10.716069011875925,0.3527098382519007,4.934288357164145,0.5816469789149179
Extracellular matrix organization,3.8213606493787933,0.9115353701412368,1.2488618872868116,2.5377013997386992,1.0608504810509518
vRNP Assembly,3.8123285194992884,1.5128897543474114,1.5940758562366886,2.2589433809750035,2.227779577822269
NOTCH4 Intracellular Domain Regulates Transcription,3.805786838111088,4.093517844294781,0.43853620684101813,2.692898871299668,0.9232094424460631
Sperm Motility And Taxes,3.7916716997790947,2.547368939901749,37.61963161341848,28.41184847322334,23.547715339472408
RUNX1 regulates transcription of genes involved in differentiation of HSCs,3.779283255881343,4.819498535762918,3.882002697317372,3.1702520973487243,0.8455049455325464
Regulation of HSF1-mediated heat shock response,3.773390609785276,2.021155448084101,0.3435822181567863,6.667543124467965,0.9029720614723399
SUMO is proteolytically processed,3.739981750465492,0.7984462995809856,0.4373751805742269,4.73094045277956,0.385358870856878
PI5P Regulates TP53 Acetylation,3.730598786609476,1.1350945457938377,21.618466022646892,12.409736086884037,6.192135549581915
Regulation of TP53 Expression,3.7258212182704744,0.48674647689169454,0.7206332244570129,4.640634233556212,0.627251899073267
Arachidonate production from DAG,3.715999785310031,0.5355808357582463,0.7983034758824493,4.092751524613726,0.925119282310657
SIRT1 negatively regulates rRNA expression,3.699173752171681,0.4276331771998932,1.482045622547015,4.277223452274236,0.3416938629198997
Signalling to p38 via RIT and RIN,3.6985354377383772,1.1075809560315817,3.5105557905625213,2.4222634521960664,2.1407151336267365
Localization of the PINCH-ILK-PARVIN complex to focal adhesions,3.6930958545350028,0.4041106045429621,0.9576538630745804,3.301892161994739,0.6099276204695838
Metabolism of Angiotensinogen to Angiotensins,3.670603962877176,0.5634605844551969,1.012086229105097,7.675659234392334,1.1093603488552288
PRC2 methylates histones and DNA,3.670603962877176,0.4162941458503192,1.5506565661186118,4.258261335402952,0.3414884307663402
"Metabolism of ingested SeMet, Sec, MeSec into H2Se",3.6411825336153916,3.886161117541001,0.6271076492796305,3.3834253087937776,0.8549145629239903
NoRC negatively regulates rRNA expression,3.6382842424035227,0.8104621586040164,0.49071072506532587,2.688846897837646,1.0535186188250762
N-glycan trimming and elongation in the cis-Golgi,3.634632109925259,1.3080785190604758,2.979454049229793,1.112802179317305,4.06476209970347
Cargo concentration in the ER,3.6234395396343153,3.098784119102811,1.1032266733683054,2.2973189650070966,1.8359906966346284
RNA Polymerase I Promoter Opening,3.616557284505508,0.3778102865837495,1.5182768312499737,4.208480373746179,0.346952298081506
Regulation of PTEN gene transcription,3.6102843185705145,1.656989943624009,0.31995616836548524,3.663121887316221,0.548577583443586
Tandem pore domain potassium channels,3.6070996630323044,7.613733787985907,1.6284621897654572,4.940867198650605,0.4148263388312538
Defective DPM1 causes DPM1-CDG (CDG-1e),3.5997818645978796,1.248799723018544,0.41000458332322975,3.2404749626789533,1.0152669754467594
Defective DPM2 causes DPM2-CDG (CDG-1u),3.5997818645978796,1.248799723018544,0.41000458332322975,3.2404749626789533,1.0152669754467594
Defective DPM3 causes DPM3-CDG (CDG-1o),3.5997818645978796,1.248799723018544,0.41000458332322975,3.2404749626789533,1.0152669754467594
Synthesis of dolichyl-phosphate mannose,3.5997818645978796,1.248799723018544,0.41000458332322975,3.2404749626789533,1.0152669754467594
RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function,3.588351577177083,0.35814336185485923,1.6588343603470463,4.165550863770593,0.3418395143070111
Abacavir transmembrane transport,3.579636189494465,2.00559386286102,3.1472260171385797,4.161280724952935,1.0705488030609034
DNA methylation,3.564506803598011,0.36888952381615364,1.5209936347750252,4.133263832287418,0.34777113778726726
NF-kB is activated and signals survival,3.5638842156496,3.215444256711736,0.38649466971275664,1.7717938711043724,2.143538546147445
MET Receptor Activation,3.5574403162896058,1.3459308190131636,4.76852623786423,10.692430910296599,4.831287800798626
Biosynthesis of maresins,3.5472780774717134,0.9394634745030349,0.5334538124297945,3.0414130596981996,0.37625741003802804
Signaling by MET,3.53966105904884,1.0356472754828212,1.0580478157036264,2.793790860817817,0.7758072190414405
Transport of fatty acids,3.5354720891326004,2.5545062593438854,0.39691850496484987,3.486984178945064,0.31321864192710464
Opsins,3.518817613250468,3.041866781097395,1.0029542869995145,3.662160501029661,0.6620336265185481
Potassium transport channels,3.456226101958321,3.367758579101763,0.8144214361140394,2.5173805145526984,1.4958748015864196
TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation,3.431291104077001,1.7521376526014993,1.8502794806676377,7.6284161270467,2.337898157661902
Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA,3.419873105877491,7.026633845556781,0.501646318945267,5.650522079315549,0.535697527192663
Gamma-carboxylation of protein precursors,3.4198531557228646,1.2690916256649516,1.9941823346273253,3.71527821494918,0.6351649174373537
Alpha-defensins,3.406854386834016,2.4925189828837278,0.5972297723760623,3.2334834048663645,0.6325566199336933
Hormone ligand-binding receptors,3.404213213912975,0.6088220989094831,1.705925451638703,6.384741020938875,1.0705488030609034
NCAM signaling for neurite out-growth,3.3731121371740165,0.9555277731566331,0.697214486426221,2.2922760538471394,0.6892613112601944
Digestion,3.3560225155863246,1.7416330914368077,0.602384224150823,3.9092311385481513,0.7313725428841457
SRP-dependent cotranslational protein targeting to membrane,3.3510949074387044,4.102625662554556,3.231128310531847,2.3724421936590248,2.0137853938119803
SUMO is conjugated to E1 (UBA2:SAE1),3.3490567533092426,1.31880612372228,1.2377997740241984,3.9721704075680693,0.49640713751981214
Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling,3.3484618814538427,8.068065343342326,9.316520891941959,0.4794324508489261,5.048139536501273
Cellular response to heat stress,3.3379214134134747,1.7237934643659143,0.34964271796770063,5.887219643409916,0.8942196979718594
Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA,3.3360319731124544,3.605071527227252,0.3772818340113561,3.031544587542512,0.31321864192710464
Meiotic recombination,3.323071298999475,0.35452259565564853,1.4602320970467075,3.749006137803153,0.3075013423580355
Glycogen storage diseases,3.3220486660157236,1.7872473791972752,1.1092083533128958,4.684182536177008,0.691425207066795
Pink/Parkin Mediated Mitophagy,3.3088324528557984,2.02538940006678,0.49660038193652783,3.8947787352901355,0.32880383414848163
Presynaptic function of Kainate receptors,3.29393026924284,4.00669132352515,1.9122116086077738,2.1846760731787755,2.8491816190913006
Miscellaneous substrates,3.252601724189279,2.6159680064257236,2.143288996430618,2.7814197817568087,1.8670252682930089
Deadenylation of mRNA,3.243650546112818,4.566626330596727,3.1943071657873494,1.9190171538607925,2.717401587752488
Reproduction,3.238819180864923,0.3092037999928343,1.4190537168500044,3.4771162567300413,0.3435079913840157
Tachykinin receptors bind tachykinins,3.2325771580947404,2.5131997886233184,0.6086629501862351,3.700466977673732,0.7572311486827389
Activation of AKT2,3.2291690795995964,1.077038246788267,3.5694248230136947,8.34603330602665,3.3229084502311315
Phase 1 - inactivation of fast Na+ channels,3.228165607599699,0.6577004965911991,4.209091214657066,6.539268593569041,2.153399346438868
RUNX2 regulates genes involved in differentiation of myeloid cells,3.227020923191805,0.508503746147892,2.0101214467627986,2.143616491793515,1.728539957135793
Late endosomal microautophagy,3.218110888787422,0.5646826537696065,1.751793650599897,5.897454260337438,1.4675858227640985
Meiosis,3.199924284245673,0.30635451100771066,1.4551823279093563,3.5178323761038195,0.3208181078390671
Nef Mediated CD8 Down-regulation,3.1904951974666393,0.4576100224635301,0.72292113051122,3.6665592395351996,0.4217026039992977
Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD,3.1819232138963094,0.5043846961751056,4.649316782796345,6.504640580292706,1.7246041103835197
IRAK2 mediated activation of TAK1 complex,3.1662289213015544,3.2806973440879186,0.429253206070198,1.6246012683319597,1.9033345925287475
TCF7L2 mutants don't bind CTBP,3.164259800333262,1.7986850806355286,0.8303910358975485,1.8165052358945701,2.6005254154259596
Tight junction interactions,3.1546119607323466,1.7927442924324442,0.5086544504323771,1.3303794151924935,0.9563402881118954
Pre-NOTCH Processing in the Endoplasmic Reticulum,3.1224596086065284,3.5311159266196475,0.3171965199465965,2.1156186810612483,0.9949758076130072
MAPK targets/ Nuclear events mediated by MAP kinases,3.101399596233047,0.3788637085243597,0.5663272651043514,2.1065259687245264,0.5193986564181582
AKT phosphorylates targets in the cytosol,3.1005608849578823,1.1004300892283514,3.75324952965967,11.817052215781922,6.959055157527953
Peptide chain elongation,3.0975118570881404,3.847949037608426,3.3894711058377953,2.143616491793515,1.9927371924030157
Mitochondrial ABC transporters,3.097502305455964,1.0841898330520574,2.6316347140134653,0.4395151232729515,7.137186261284728
NTF4 activates NTRK2 (TRKB) signaling,3.0947311254197927,9.76800767461586,10.750204375993224,0.32123555122258113,9.603086193259795
Viral mRNA Translation,3.0914095742979693,3.83312130490421,3.4313358642105958,2.1149616824302493,2.0287645861768357
TWIK related potassium channel (TREK),3.08560910971604,0.9717764156858067,0.30117107649969654,1.884710546717972,1.0184843921769837
Inhibition of replication initiation of damaged DNA by RB1/E2F1,3.074714830463108,5.10541681895534,4.1983195105428015,1.0331915153662423,3.7738265678091407
Lysosome Vesicle Biogenesis,3.074714830463108,0.7384672231862905,0.47679781845884267,4.403547248397846,0.9447333238573032
Response of EIF2AK4 (GCN2) to amino acid deficiency,3.0745679752087884,3.905478483728521,3.4674128464671123,2.0726352348260084,2.082066377898107
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),3.0564279902616653,3.834554371633907,3.3418225053371446,2.084338946272875,2.0344342671571405
Nonsense-Mediated Decay (NMD),3.0564279902616653,3.834554371633907,3.3418225053371446,2.084338946272875,2.0344342671571405
Biosynthesis of specialized proresolving mediators (SPMs),3.0395873419961603,0.4543364886834994,1.8390520720133416,4.276930686176833,0.7098314965314833
Eukaryotic Translation Termination,3.029204971333842,3.7918713366280037,3.30185472629767,2.0811225108530587,1.99760369174195
RHO GTPases activate KTN1,3.026470447006727,1.277959411148231,1.5134753447043534,1.9560520571429885,1.052408167186234
Lysosomal oligosaccharide catabolism,3.0210135314465427,1.0744157774541427,0.6403045588161843,2.3463229923859106,0.7220689136460723
Vesicle-mediated transport,3.009580857629295,0.790752081769087,0.49064131472218797,4.051339151346949,0.6311139355460611
Recycling of eIF2:GDP,3.008079243504119,4.2830047759397765,7.734422887116433,0.3679848289458622,8.313100998285817
Elastic fibre formation,2.995319666803503,0.887665520443598,1.067035866131486,1.9892564152677037,0.878264440771537
LGI-ADAM interactions,2.952663515384021,1.7952685344774295,0.45010857985166164,1.7561189299992017,1.2480075352830111
Eukaryotic Translation Elongation,2.952389729817322,3.7292550514030385,3.257243016510097,2.055757135469909,1.9471672821939765
Transcriptional regulation of granulopoiesis,2.9523846611791176,0.3267591259145193,1.4913535868332635,3.289241728110687,0.32134835144689006
Telomere Maintenance,2.9504980574292263,0.31662659492462947,1.1111489486772066,2.6516953468505466,0.5311505169568769
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),2.9384144664850034,3.7789910403217237,3.3315763106556777,2.012706034166384,1.9836213949680324
Beta oxidation of octanoyl-CoA to hexanoyl-CoA,2.912467924249561,11.0444275091264,10.438530650283639,0.5689985588879214,5.486038822881941
G beta:gamma signalling through CDC42,2.90899731423444,3.3857983704328154,1.5940758562366886,2.0929684929724788,2.4522568349180824
PTK6 Activates STAT3,2.9069946540885705,1.4471713859736943,4.3126212105322,6.719275857826853,3.1898356405366695
Selenocysteine synthesis,2.905925194071553,3.756000034867552,3.401576231652839,1.9764093093232185,1.9774138380303643
Cargo recognition for clathrin-mediated endocytosis,2.9003298398410657,1.1290493498736187,0.6886857660449912,4.908348462456958,1.0168342502977765
Platelet homeostasis,2.8895596793995297,2.777675145594713,3.0739968681917875,1.6676448297469242,3.1657739787297365
Integration of provirus,2.8567306785871383,1.818311668547251,4.43924129765688,0.9077610353192908,2.932751236326877
Regulation of innate immune responses to cytosolic DNA,2.848950356747233,1.2337868541806325,0.4366378380695516,3.2277581333542926,0.4088685100788581
NrCAM interactions,2.8142874747156967,3.540050618151906,12.49292364976152,0.7432488495853147,9.709760404672549
Listeria monocytogenes entry into host cells,2.80592043837491,3.0307771726719914,1.4751847610990647,1.4487732915868312,1.9950855195068642
VLDLR internalisation and degradation,2.790400357551838,0.35814336185485923,0.8483689634159015,1.731081669151529,0.6366354940360579
Selenoamino acid metabolism,2.7902712404115233,3.6730214206201475,3.4334233676675283,1.8419295043338515,2.028160143958851
Termination of O-glycan biosynthesis,2.7824656958676237,4.379827835475458,0.4949396376631105,3.690439243359765,0.5468152008333141
NGF processing,2.7640424578784635,1.168720024234668,2.0464492040099027,0.36295438423634885,4.394668343495258
Expression and Processing of Neurotrophins,2.7640424578784635,1.168720024234668,2.0464492040099027,0.36295438423634885,4.394668343495258
TFAP2 (AP-2) family regulates transcription of other transcription factors,2.75783155843944,0.8181051296800186,2.7870094861059607,9.267926656438993,4.015523785815782
Cellular responses to external stimuli,2.7525332402985527,0.5143364091527235,1.1644674924573881,4.3138198494152435,1.1399803486093136
Heme degradation,2.75008119086272,3.1822202984257855,0.47067879589608963,3.1481611877310494,0.4166064540847217
Interleukin-38 signaling,2.7436309368210337,2.2758336675047524,0.9581808019689676,2.301960317622631,0.7084463141974062
Metalloprotease DUBs,2.7419571273770322,0.4513369479082604,0.6788352395610051,1.9654693793998221,0.8074723692335924
GTP hydrolysis and joining of the 60S ribosomal subunit,2.738480133942468,3.8745861564238893,3.6826835985903217,1.7849767435014257,2.0955122826098975
Peptide hormone metabolism,2.7213801192838205,3.101232819774217,1.6905001392381738,1.3467916967297018,2.903845735758938
Intracellular oxygen transport,2.7149693689203853,1.8747115140979402,2.910262899674995,4.312069963488137,1.1974201461128948
Metabolism of RNA,2.7088235384048027,3.3690811146078525,1.7451712429579467,1.4887100855881084,2.257657975669539
Cap-dependent Translation Initiation,2.7071024578586926,3.9122176552248167,3.656417938151247,1.765524811190087,2.097732805601
Eukaryotic Translation Initiation,2.7071024578586926,3.9122176552248167,3.656417938151247,1.765524811190087,2.097732805601
Coenzyme A biosynthesis,2.694134842057365,1.002864002539492,0.3029218407274461,3.0126542145811483,0.36166299755556786
HDACs deacetylate histones,2.680630108921959,0.3298592378951207,1.537317122134059,3.0876641064155836,0.3250938507504807
Histamine receptors,2.679871011561978,4.384846244311554,1.2326334536126655,1.6636094541305457,1.3078300265812104
Interleukin-36 pathway,2.674153364261206,4.557509793126304,0.8365041298129705,2.6608808690788246,0.6265539651547631
Mitochondrial biogenesis,2.6679352696450827,1.3482676244337297,0.5074602333728826,3.7514146957135397,0.4027931936870381
Defective MMAA causes methylmalonic aciduria type cblA,2.657545138201135,1.250871825275107,2.0610843794281823,0.9870952154540484,2.8802976544252106
Defective MUT causes methylmalonic aciduria mut type,2.657296927020231,1.2508393238638666,2.0610843794281823,0.9869123543188033,2.880317164707935
"Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.",2.6561624855105137,1.0811344247456298,1.0229582412860905,1.6183588548008303,1.293972110519025
Nephrin family interactions,2.6445472471605536,2.2277288189231865,1.315490624399085,1.573578716528518,1.869101779845723
Defective ABCG5 causes sitosterolemia,2.6445472471605536,1.5497922661172032,0.35305822000905557,2.6841673853986943,0.8636269886132798
Defective ABCG8 causes gallbladder disease 4 and sitosterolemia,2.6445472471605536,1.5497922661172032,0.35305822000905557,2.6841673853986943,0.8636269886132798
"Biosynthesis of A2E, implicated in retinal degradation",2.627288083584376,4.6737327540408735,7.656091482950855,0.6378880986799083,4.897312816230156
Apoptosis induced DNA fragmentation,2.6094662498657315,1.5264467583490224,5.768594748154965,1.5438789416391803,1.4635686083325794
Acyl chain remodeling of DAG and TAG,2.6085958096007267,4.816030910877936,1.8534921481896378,0.6877418422790106,3.161520764203545
Loss of Function of SMAD4 in Cancer,2.5873689404620017,4.442417144349417,7.358922308941202,9.386657904118666,6.015820760922543
SMAD4 MH2 Domain Mutants in Cancer,2.5873689404620017,4.442417144349417,7.358922308941202,9.386657904118666,6.015820760922543
SMAD2/3 MH2 Domain Mutants in Cancer,2.5873689404620017,4.442417144349417,7.358922308941202,9.386657904118666,6.015820760922543
L13a-mediated translational silencing of Ceruloplasmin expression,2.57803401591021,3.750606965003134,3.63196984923173,1.678106024553467,2.03758699719801
Crosslinking of collagen fibrils,2.5658633804267867,0.8053331707120563,0.962460582665376,2.0316286896240614,0.701344334879983
Metabolism of vitamin K,2.562646053683831,0.8787448914461042,0.8374516692332686,4.377450612351298,0.4553520349245476
Digestion of dietary carbohydrate,2.5517546376417766,1.239577089224191,0.38083952886763384,3.3734893298798396,0.4637673030630462
Oxidative Stress Induced Senescence,2.5431119706869687,0.35339150796938046,1.6499326474632572,2.808741048652782,0.32138050931755024
Insulin processing,2.533377414049618,0.8570932044231342,1.555834716591438,2.4752110610990306,0.4280650129219496
E3 ubiquitin ligases ubiquitinate target proteins,2.507833575091478,2.0852623299050337,2.5638827641668644,2.2599015293193396,0.5263106208015303
Toll Like Receptor 3 (TLR3) Cascade,2.501967956792263,0.49581358663947434,0.5117021864738902,2.6487117514322773,0.4495144824222066
"Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)",2.4861033551034297,2.834702560307816,1.3077279503991008,1.2728724240832903,2.074921786159395
"SUMO is transferred from E1 to E2 (UBE2I, UBC9)",2.4769819675141016,0.8873865112000736,0.396155642675885,4.051618926790502,0.6043684039257982
Defective GALNT12 causes colorectal cancer 1 (CRCS1),2.476142373840856,5.036659299058096,0.3666962807978159,3.059555026951664,0.4553520349245476
"Gamma-carboxylation, transport, and amino-terminal cleavage of proteins",2.463051824693589,0.7908921902763316,1.2323837293357756,1.948264546210665,0.3138591740037029
Formation of a pool of free 40S subunits,2.463051824693589,3.5490785185079305,3.551576972606907,1.5953627099191223,1.9923299536284524
Prevention of phagosomal-lysosomal fusion,2.460639871555979,3.1587718840597643,0.5096775448655684,0.988097979638401,2.0673996035507427
DARPP-32 events,2.4421524522386857,0.5762556368732114,2.1109538513886457,3.4999392222245738,0.7444039639506577
Citric acid cycle (TCA cycle),2.4225432048783584,0.3192229468682071,3.3171992512874433,5.96036514873098,2.4891639563881727
Signaling by NOTCH2,2.416196241357259,1.565249056961332,0.3538510339260741,1.8077658402977619,0.8405403308758135
Collagen chain trimerization,2.412015144010754,2.4921688273901754,0.6601276050565178,3.2826881045664447,0.3012851079054069
HIV Infection,2.4119096354420058,0.9164673077618735,0.36197983289376673,3.403998168718761,0.6816093627570474
Dimerization of procaspase-8,2.399393300124317,1.307090716501273,0.4654330054285831,2.200959665354306,0.34947571721462184
Regulation by c-FLIP,2.399393300124317,1.307090716501273,0.4654330054285831,2.200959665354306,0.34947571721462184
CASP8 activity is inhibited,2.399393300124317,1.307090716501273,0.4654330054285831,2.200959665354306,0.34947571721462184
Sema4D in semaphorin signaling,2.390698645782281,1.1773651663914135,0.44003589379661207,1.391108214347545,0.6508713390259756
Negative regulation of FGFR1 signaling,2.3606678956090463,0.8346186093118084,5.486803787198746,4.755947976845342,2.350394753298679
Axonal growth stimulation,2.358199986473566,0.9795585392015913,4.146991339353878,4.194940126733773,0.9878583902552629
Amine ligand-binding receptors,2.334866348086322,2.559902855115607,0.4611852760166811,2.937915743964849,0.3101998452835675
Beta oxidation of palmitoyl-CoA to myristoyl-CoA,2.3104953939941764,7.461022618349698,1.7123110170996287,1.8128419358458936,0.5945878139635172
Positive epigenetic regulation of rRNA expression,2.310397251953797,0.437297254467591,0.4811140005332733,1.5887200234052097,0.9800454073968956
Synthesis of 12-eicosatetraenoic acid derivatives,2.280831576982259,6.717633504901405,1.1063598281466098,3.2008468622627966,0.5159581404208388
TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,2.263366026734775,0.62627226844646,1.0150687989028013,1.2392157587880908,1.1792702670672972
"Incretin synthesis, secretion, and inactivation",2.262809382617179,2.738970231823985,1.2797459004738436,1.1728163449039555,1.9890256313126713
Cellular responses to stress,2.2593661674731966,0.3841477484556066,1.2374387117452366,3.7114582443513338,1.2272153386157305
LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production,2.243031340039999,5.450200640664612,5.346652499747862,0.5305704163151521,5.135457928552585
Mitochondrial translation initiation,2.1937053758599343,1.290326116086593,1.0797148295732486,2.160550113712233,0.5347484494203771
Senescence-Associated Secretory Phenotype (SASP),2.191938564625904,0.5665458448113908,2.0103442066988606,2.678158242640963,0.4150944054946821
Transcription from mitochondrial promoters,2.191938564625904,0.9771775669885778,0.5341360005097259,3.6685827576241983,0.6332980188474437
DDX58/IFIH1-mediated induction of interferon-alpha/beta,2.183689931570987,0.9465790835117256,0.3910201188725575,1.280792445586436,1.0246957994117378
ECM proteoglycans,2.1808856049384304,2.2225368920467203,0.6473445317274693,3.1552088119814004,0.36127900287304615
Regulation of FOXO transcriptional activity by acetylation,2.1671349379766003,2.046253120173158,0.7352196646295075,3.2186439006689542,0.40548590073997465
Gene Silencing by RNA,2.1527608226530006,0.34479570897821094,1.4190537168500044,2.1525364692110625,0.38073551574296294
Non-integrin membrane-ECM interactions,2.1460560577022783,0.4252672260272263,1.3940647275300504,1.0612034459277393,1.268716515889019
Displacement of DNA glycosylase by APEX1,2.1354499819395967,1.4431321808165067,1.0840796903180263,3.5072235326150687,1.232816730416846
Regulation of expression of SLITs and ROBOs,2.133465728765866,3.13037235566631,3.0236172093004146,1.323836851531041,2.0045686302981425
Defensins,2.1321525033059663,2.4034432311309053,0.32661605577072517,2.4527877692452074,0.3418395143070111
"Cell death signalling via NRAGE, NRIF and NADE",2.123926417761008,0.5189959999995738,4.9070360013893835,4.84523055251276,1.4081064213743577
NGF-independant TRKA activation,2.123508005300651,5.447295740849968,16.730902886209744,1.4314317254581295,12.604405919856099
Activation of HOX genes during differentiation,2.1185535735099035,0.4714813915947906,1.3763653341893296,2.121591876318314,0.3194042263841258
Activation of anterior HOX genes in hindbrain development during early embryogenesis,2.1185535735099035,0.4714813915947906,1.3763653341893296,2.121591876318314,0.3194042263841258
Glycogen storage disease type IV (GBE1),2.1038177093245554,0.8607530564087936,1.030380035189562,2.4574711152254833,0.7251532147594216
RHO GTPases activate PAKs,2.096983758482504,0.4341798763975409,0.6673585604435966,0.458699131636643,1.5440175870144732
RMTs methylate histone arginines,2.0924814130381564,0.5087193790945616,1.9587544025595285,2.481055453956362,0.40360242979763616
HCMV Late Events,2.090632898092061,0.4049906399594692,1.0976323929152125,1.8885840686857582,0.48855099689017156
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks,2.0898886571410977,0.4479182257996348,1.6063591725165565,2.380222327207816,0.3061671844822638
Signaling by PDGF,2.071975916213159,3.1414277237828054,0.4816590781856437,2.1136574298320543,0.7060331080546908
Glucuronidation,2.064765731045812,3.8346022690427968,6.543755869173868,11.31548880289696,7.657081419993817
HATs acetylate histones,2.0641377363793496,0.3536670677264475,1.2855679240822009,1.8964690954711967,0.5284353037808306
IkBA variant leads to EDA-ID,2.06153887894128,2.834702560307816,0.9076659474574358,2.069813694861336,0.5442849979195741
Calcineurin activates NFAT,2.0565364823572425,0.9793718585958822,0.9816369717038584,2.906504599744258,0.3507552832609198
IRS-related events triggered by IGF1R,2.045978920044762,0.8340280896211025,13.554050247456512,11.53004104907955,11.305382712753588
Ribosomal scanning and start codon recognition,2.037735874291838,3.412444686478587,4.500315148631739,0.9011590153711773,2.8073418919600903
NR1H2 and NR1H3-mediated signaling,2.0324426213130984,2.67210051069664,2.936735899852229,5.994617351848218,2.6135425382410555
Pyrimidine biosynthesis,2.0207678771591415,4.450030128424244,1.21886416976331,1.6188946732281568,0.5663073444068246
Utilization of Ketone Bodies,2.0201498643547904,1.3927086762124425,0.49229970975655424,5.239118138506843,2.209523709603067
Negative feedback regulation of MAPK pathway,1.9969989844085294,0.6449563363097728,1.1946452173381603,0.8029581589298053,1.185264534663222
Mitochondrial transcription initiation,1.9931646377963277,0.8144938922452528,0.4855907227992278,3.6454892235523073,0.7898626953267313
Defective CUBN causes hereditary megaloblastic anemia 1,1.9861523033123747,1.1373818693836102,1.2033437157132003,2.740370904015377,0.715591717128066
Defective AMN causes hereditary megaloblastic anemia 1,1.9861523033123747,1.1373818693836102,1.2033437157132003,2.740370904015377,0.715591717128066
GPVI-mediated activation cascade,1.9858635702571634,0.7389487428184341,0.9798948005402465,2.1558205410819027,0.41299899816503166
Fertilization,1.980652183754922,1.3487534428040275,44.05337219880773,8.879661798361708,36.33866442181359
rRNA processing in the mitochondrion,1.9764102078279853,1.1650974815477784,1.609122383738962,1.5134848912237773,0.48617297114072794
IGF1R signaling cascade,1.9732406437819097,0.8262321403029036,13.75673444458175,11.481406861506265,11.515633692601897
Defective CHST3 causes SEDCJD,1.9698610947951773,1.6267023954497273,0.37363416916690956,2.59219648104694,0.3091178841326243
Negative regulation of activity of TFAP2 (AP-2) family transcription factors,1.9694677642358323,0.5621983304330612,7.876372436665152,10.302395459720557,6.8003551342399025
Biosynthesis of protectins,1.9571615282833053,1.2854281254062137,1.3557791588023285,1.3553577319939643,0.9214804187910656
G-protein beta:gamma signalling,1.94849949949834,0.54576750557853,0.6626057900933942,3.037007458084123,1.3780774958511308
Reduction of cytosolic Ca++ levels,1.9357429291267731,2.726375141545308,8.619611303480314,10.885866199391575,5.917302924071529
IRS-mediated signalling,1.9308224286265194,0.866616883002541,15.423911469749152,13.150040470505408,13.551612545444769
Signaling by cytosolic FGFR1 fusion mutants,1.9104815714685204,3.7685269756575748,13.272096054517096,0.6551258413363307,8.017727534531614
MET activates PTK2 signaling,1.9099939488633586,2.256018720439406,1.0618480214292942,3.0482153720428014,0.4808145791696699
"Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S",1.9090876992032035,3.3309200374270436,4.460570271415722,0.8351410928440427,2.747156639386763
TWIK-related alkaline pH activated K+ channel (TALK),1.8849321850601513,0.5668348818109491,0.980670111342491,0.4208651490605755,2.653838218669045
"Synthesis, secretion, and deacylation of Ghrelin",1.880920042357222,0.6833935406028083,0.37464885780719753,2.5173805145526984,0.5577921983961992
NTF3 activates NTRK2 (TRKB) signaling,1.8763950990344567,8.372968110605019,12.544113744603397,0.8291870301643426,9.272512309928116
Interleukin-33 signaling,1.873946827633469,0.796242919043476,0.32579708341890484,1.5570308127256924,0.5024242640653876
Cristae formation,1.8649899555839535,2.4021727179512804,0.6776486097606886,1.8444292137787768,0.5697380191370545
Collagen biosynthesis and modifying enzymes,1.8542059646025932,0.5902473989022939,1.1118088927970122,1.3502268111667663,0.7082905194575945
Anchoring fibril formation,1.8506452500375559,0.45411463926136597,0.6563217254134007,1.210180440335149,0.6847035957006862
Glycogen storage disease type 0 (liver GYS2),1.8496562323122956,2.3794098866611852,2.034255991637812,1.1982400198684389,1.9678165432375962
Translation initiation complex formation,1.8486675435688906,3.254060841963232,4.4334692044773005,0.8006646735510582,2.7213643203176177
Intestinal infectious diseases,1.831703760777356,0.35867356211926793,0.8273915602245113,1.8444292137787768,0.9854278276966791
Activation of BIM and translocation to mitochondria ,1.8267417408374527,0.3733948403487998,0.970820498694158,1.9667123010781695,0.30105694012921036
InlB-mediated entry of Listeria monocytogenes into host cell,1.8259655154125394,2.3240282425618504,0.8342661087457668,1.4037372358546059,0.6341355299555239
Synthesis of PIPs in the nucleus,1.8224386868597349,1.201161750377609,23.18602352673828,8.8356901043471,6.891907350696125
HCN channels,1.8152563954290122,0.4387200994507368,0.4243561301563083,1.0850766761936799,0.5994932951466331
Proton-coupled monocarboxylate transport,1.811032150234048,0.44445016992964065,0.33402839667041023,1.5451476892528795,0.687403238657585
Cell-cell junction organization,1.7994264575520953,0.3181624788095471,0.9607526889696916,0.8730037302827942,0.3925644925828893
Protein folding,1.7932066661403019,2.5230115540047007,0.5301633850399335,1.9193835350723873,0.5652030113417772
FGFR1 ligand binding and activation,1.7819705556341745,1.4284954025207595,0.3538510339260741,1.8308582114176097,0.47666871510864656
Mitochondrial translation elongation,1.7707762201446358,1.139249170910083,0.9996109524621648,1.7904757092803796,0.47502665555061707
Triglyceride catabolism,1.7667156051837212,0.6530667040257279,2.7464731862848217,0.8308740998712787,1.7969609400434512
B-WICH complex positively regulates rRNA expression,1.7559772382697971,0.3159810795375566,0.5800039923479415,1.2329601347132653,0.7532633475622338
PLC-gamma1 signalling,1.721934180031882,0.8337121549699509,5.995610264045588,0.33738284791582474,4.101744192487912
Melanin biosynthesis,1.7206985489852837,1.4908959315027108,0.5341360005097259,2.7379282068531228,0.36176063381650303
P2Y receptors,1.7058117489830231,0.8653332080820089,0.3216585184148938,0.8561095869473367,0.7793113600760612
Telomere Extension By Telomerase,1.698322235679842,1.1347398216566416,1.2746600105702557,5.497085885943854,3.033325660593655
"Formation of the ternary complex, and subsequently, the 43S complex",1.6870531948380718,2.978875271418388,4.3571585557441255,0.6908900515512738,2.719737936084454
Influenza Life Cycle,1.6861265985190166,2.781025532290559,3.133981514006097,0.9322643598073148,1.9857486448868518
G alpha (s) signalling events,1.680631635547093,0.6723782950720977,0.46252232136516036,1.1728163449039555,1.0507391974753921
COPI-mediated anterograde transport,1.6799485770459792,0.4714366721535742,1.5209936347750252,4.071172596322199,1.8730024120129072
Condensation of Prophase Chromosomes,1.6799485770459792,0.6513247599217414,1.8854733073411785,2.075339146275031,0.4510813000137288
Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC),1.6769872124335232,4.048485410186317,0.4329112585651733,2.2458944501102756,0.5602830934812779
Influenza Infection,1.6697695486964472,2.795636979291922,3.060066163337203,0.9356006278691362,1.9485149346127992
Metabolism of proteins,1.6672533648060337,0.35867356211926793,0.6497867651609955,2.7035477279904265,0.9855313032128811
Metabolism of amino acids and derivatives,1.6672533648060337,3.258368109417123,3.880528799168549,0.6935492077268665,2.7155471664378315
Influenza Viral RNA Transcription and Replication,1.666624136108633,2.801548439945613,3.2020584297972152,0.9393421455774676,1.933628406052575
Degradation of cysteine and homocysteine,1.6531778315793957,1.847136562717411,11.599075825638323,2.1109305307044117,14.131879063201312
Beta oxidation of myristoyl-CoA to lauroyl-CoA,1.6513032919366828,0.36314477200725065,0.3318279881511526,2.0741789172086835,0.5024242640653876
RUNX2 regulates chondrocyte maturation,1.6490461292093357,0.9550475438264393,0.7418172689210252,1.993885598728672,0.4637673030630462
Processing of Capped Intron-Containing Pre-mRNA,1.6219598166317675,0.6420703702392824,0.3076929253599861,2.481055453956362,0.6583805131540035
"POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation",1.6114748870649038,1.889581419361794,0.3467537635193883,1.8366890368425142,0.5053707494077528
TAK1 activates NFkB by phosphorylation and activation of IKKs complex,1.60707664782477,1.6228288453382733,0.8448871771311944,0.7665885778814613,1.5807041153454209
Hypusine synthesis from eIF5A-lysine,1.5894050652598752,2.1581438998443576,0.469612962771732,1.770751980923939,0.6087492339226197
DSCAM interactions,1.5768010048155718,2.205321820030033,0.6793409724471154,2.4004464085523884,0.3750311996453204
Insertion of tail-anchored proteins into the endoplasmic reticulum membrane,1.570221067434434,1.789247539287432,0.7250143258190411,0.5348769236291553,2.646818068629432
"Cobalamin (Cbl, vitamin B12) transport and metabolism",1.568874564712677,1.5525702262607544,2.9605557559049416,6.128392965911602,3.9863702994554036
Receptor-type tyrosine-protein phosphatases,1.5688338025239907,3.269855685525184,5.026873026981808,0.484164634505288,4.693832696068601
Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS),1.5635774066684025,3.8356325528665995,0.4709770221157833,2.1650233456650856,0.6087165537646984
Chaperonin-mediated protein folding,1.557125075269358,2.2637602913443216,0.6546465447096014,1.746645643800482,0.5131356834357804
ADP signalling through P2Y purinoceptor 12,1.5511520775717236,2.227313058856126,1.9587544025595285,0.8507986768055757,2.536129436840251
Physiological factors,1.5276046178842186,0.3030206971206215,0.34493217403610194,1.1718625738766446,0.5816469789149179
RAF-independent MAPK1/3 activation,1.5169431249366048,0.44904384179734347,0.32743910315495117,1.2043866584041183,0.3608273136650573
Signaling by ROBO receptors,1.513436305664815,2.7868066159912557,2.78887922285227,0.8673229532761252,1.9231455316497943
mRNA Splicing,1.506928590969422,1.8257379931602986,0.8031291845493435,0.8090112254405047,1.3270648432210137
mRNA Splicing - Major Pathway,1.5025275005173666,1.903159408897413,0.8198960020283355,0.8438003262043438,1.277102284161098
FGFR2 ligand binding and activation,1.4891689239012105,1.129469005837333,0.4461491809941075,1.7259291100099972,0.310831688463377
Synthesis of Lipoxins (LX),1.4830859804993728,0.7505634744939986,0.9220660091335706,2.2097596983387238,0.6081282256062109
Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT),1.4816105817975382,0.3177940503943064,0.3099151809002635,1.2845997977088421,0.6140871364025616
Plasmalogen biosynthesis,1.4786955896578116,1.7877661755065586,1.5107204673981083,6.630526982714756,3.8288975357099657
Downregulation of ERBB4 signaling,1.4630501447927051,2.2382152058723044,0.4677878500116078,0.5128057363418158,1.7839207667353778
Adenosine P1 receptors,1.4523974945407037,0.9469367790114354,0.3318279881511526,3.051672412780201,0.8538305963711061
Inhibition of nitric oxide production,1.4393984029837936,0.3101533615942335,3.171089774294666,0.827062630355048,1.0435852908656873
MET promotes cell motility,1.430261611114401,1.940108298535569,0.9318641762134944,2.3916538908872225,0.5288854824759675
Nonhomologous End-Joining (NHEJ),1.4261772090547358,0.5442882089739389,1.233765526169793,1.3004257344738444,0.43929827197742705
Constitutive Signaling by AKT1 E17K in Cancer,1.4253567320478537,1.5900846424041324,5.896622489362117,1.247391775164751,7.877599261411921
Rhesus glycoproteins mediate ammonium transport.,1.4228645068976946,0.3788637085243597,0.6214123884328568,1.6369954755234948,0.38400932131185134
TRAF6 mediated NF-kB activation,1.4214299215367265,1.5602550924253369,0.8704494976527886,0.5979876720329458,1.7170076499672646
TGFBR2 MSI Frameshift Mutants in Cancer,1.4127152803836154,0.577844284384918,0.3799803900476081,0.4212968588514527,0.925119282310657
SDK interactions,1.4049934290521395,0.49428509691027067,0.9479884694690267,3.004684494549548,1.0691077071023682
Activation of kainate receptors upon glutamate binding,1.4036583805020109,1.7593069144706974,0.6426113532403316,1.2143169486520935,1.2529498675461146
Rhesus blood group biosynthesis,1.3961413929323934,1.739497504351938,1.7434875387053146,2.713734957211101,1.0224142808376593
Synthesis of PE,1.3893427924532342,1.4833737513588736,7.306251546271232,6.11100323832143,5.805718801125423
Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA,1.3891448325242555,6.984014511579546,12.184568677597824,0.9647628267723477,6.7647650237866594
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),1.3840108933451316,1.0409483462801783,13.162214468188495,9.311863586187085,11.152879901236092
rRNA processing,1.3830354458631031,2.5125289281491665,3.0205597595198324,0.705651202288458,1.9754823335753375
Major pathway of rRNA processing in the nucleolus and cytosol,1.3615818394951782,2.479970571420622,3.1515997600862304,0.6884990430346223,1.962256321833077
Alpha-protein kinase 1 signaling pathway,1.3594193298943986,2.2974015209644776,0.38101940464729,0.574556114963805,1.4249091520385766
G beta:gamma signalling through BTK,1.3519643915738873,2.2399257242308943,1.4169739128755388,0.8841319843264323,2.143763562696598
RNA Polymerase II Transcription Termination,1.3503875461290236,1.6123789230315633,0.45656537255080754,1.4713293436733024,0.3457110899544325
Scavenging by Class A Receptors,1.3503875461290236,1.6470883014339506,1.5510843552638807,0.6125360336942925,0.9905911259372867
PKMTs methylate histone lysines,1.3501960130569426,0.5190567936371844,1.913849847963406,2.3679937946004905,0.4891117625868815
rRNA processing in the nucleus and cytosol,1.3423494737378046,2.4460512978445075,3.09316401447174,0.6787631847072835,1.9630402955026418
"POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation",1.3355466626349843,1.67183279091958,0.9162765240892798,2.3816315513138795,0.5048737333683029
Nucleotide-like (purinergic) receptors,1.331467511533548,0.8095090847586618,0.3422857276938284,0.9296462493446647,0.46491422988516146
NR1H2 & NR1H3 regulate gene expression linked to lipogenesis,1.3167108315954152,2.6519915757555426,3.408676922218721,4.759941518873672,3.42966558747989
Electric Transmission Across Gap Junctions,1.3133206366055787,3.2949084486383566,0.7972298446341737,2.2149866758101475,0.5926803705738717
Transmission across Electrical Synapses ,1.3133206366055787,3.2949084486383566,0.7972298446341737,2.2149866758101475,0.5926803705738717
Electron transport from NADPH to Ferredoxin,1.3086993722511606,0.6825584883677354,0.9902963235300871,0.47136134161805976,0.6210792484966776
Classical Kir channels,1.3077626148290875,0.7505901465037568,1.0199732849720942,1.4529647860331594,0.3824004396306066
Signal amplification,1.3044053339611734,1.4771329332514622,0.8975028751841918,1.001644730057096,1.7909734162913207
Release of apoptotic factors from the mitochondria,1.2973913315830528,1.458505736137028,5.635678878449123,0.4627173361045607,4.215833293811227
NTF3 activates NTRK3 signaling,1.2800630666772446,10.698852534524402,9.27346478034103,0.6607288509291755,5.456355103423039
Mitochondrial translation,1.278811492208745,0.8377809984904955,0.8273161956851022,1.356516958533737,0.3845839653515818
Glucagon-type ligand receptors,1.2736916487958572,1.424107292594257,2.1467969783929886,0.5219278979854484,2.507381088127921
Resistance of ERBB2 KD mutants to neratinib,1.2695260789900094,0.6128073827813979,4.6112630689518745,4.5202928799278,3.137678976671461
Resistance of ERBB2 KD mutants to trastuzumab,1.2695260789900094,0.6128073827813979,4.6112630689518745,4.5202928799278,3.137678976671461
Drug-mediated inhibition of ERBB2 signaling,1.2695260789900094,0.6128073827813979,4.6112630689518745,4.5202928799278,3.137678976671461
Resistance of ERBB2 KD mutants to AEE788,1.2695260789900094,0.6128073827813979,4.6112630689518745,4.5202928799278,3.137678976671461
Resistance of ERBB2 KD mutants to sapitinib,1.2695260789900094,0.6128073827813979,4.6112630689518745,4.5202928799278,3.137678976671461
Resistance of ERBB2 KD mutants to tesevatinib,1.2695260789900094,0.6128073827813979,4.6112630689518745,4.5202928799278,3.137678976671461
Resistance of ERBB2 KD mutants to lapatinib,1.2695260789900094,0.6128073827813979,4.6112630689518745,4.5202928799278,3.137678976671461
Resistance of ERBB2 KD mutants to afatinib,1.2695260789900094,0.6128073827813979,4.6112630689518745,4.5202928799278,3.137678976671461
Drug resistance in ERBB2 KD mutants,1.2695260789900094,0.6128073827813979,4.6112630689518745,4.5202928799278,3.137678976671461
Resistance of ERBB2 KD mutants to osimertinib,1.2695260789900094,0.6128073827813979,4.6112630689518745,4.5202928799278,3.137678976671461
InlA-mediated entry of Listeria monocytogenes into host cells,1.2456203693410592,1.8999860279259302,0.34384123983634635,0.5604511240852802,1.2309459967803873
DEx/H-box helicases activate type I IFN and inflammatory cytokines production ,1.2419632456738143,1.4846830621298641,3.3894711058377953,0.4682435645130596,2.214028717050807
Transcriptional regulation by small RNAs,1.238878730050233,0.7012657575892249,1.734591385737004,1.3856920949474834,0.3609586542188223
"TICAM1,TRAF6-dependent induction of TAK1 complex",1.225818311256317,1.8052718970144974,0.3075705183136266,0.5238331900087713,1.3135221550381737
NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis ,1.2251662664896905,2.5241100112942245,3.198594039163781,4.379699676340264,3.233191846908155
Mitochondrial translation termination,1.223872715044017,0.7781682879834699,0.8190486957398068,1.2935315534259202,0.38073551574296294
Activation of Matrix Metalloproteinases,1.2192966585770786,0.3736264641255049,3.2606169646303873,0.4489564939390919,1.8356025248693417
Acrosome Reaction and Sperm:Oocyte Membrane Binding,1.2145719321174977,1.1672222030682418,1.3310002303503028,1.4569842980359535,0.5053904943701537
Beta defensins,1.2096996784698115,1.8349542427092955,0.32680644650243634,1.4244846104246793,0.41140362517259643
IRF3-mediated induction of type I IFN,1.1794214251238637,1.3034944995857796,0.8800620482617946,1.8707028622811477,1.062020193134529
Regulation of signaling by NODAL,1.1778483635327475,0.38425842465789184,1.8171382216801628,0.3911694145010742,0.9401813104061166
Thrombin signalling through proteinase activated receptors (PARs),1.1603670488751567,2.0289773656925814,0.6164493089010099,0.9499584597562456,1.3996612632124164
Conjugation of benzoate with glycine,1.1592770937691352,1.485129754186024,5.274219435880922,4.32495678785773,3.718383722453198
Peptide hormone biosynthesis,1.1543131654622227,1.308698007193762,0.890733064696295,0.6660448872220308,1.6385600074985855
Transcriptional activation of mitochondrial biogenesis,1.1486680922094237,0.671936464176675,0.8351253272207549,3.276972988806652,1.7321280712759133
TRKA activation by NGF,1.1443492299447806,0.5526917872698565,1.3481701076969157,2.0540950632401604,1.4315591386509718
mitochondrial fatty acid beta-oxidation of saturated fatty acids,1.1421931710663757,1.336804565273369,6.899721294487664,3.6142037594397864,3.076947408612111
trans-Golgi Network Vesicle Budding,1.1390416044979017,0.5351365969221958,0.5404179874636535,0.5273295658486232,1.825327459902811
CREB phosphorylation,1.1326031516928377,0.3287970025647753,0.45192789645580894,0.6330672995592849,0.7222286174843721
Advanced glycosylation endproduct receptor signaling,1.1251968358224504,1.2403828323750241,0.8260393698139696,0.42655857401475356,1.6689113440361973
Signaling by WNT,1.1155454152072017,1.140606913519074,1.288428506145913,1.3158857736771599,0.4287042165531129
Chylomicron clearance,1.113123084225421,1.2156526514202488,5.158292687151696,1.8443142890477053,7.640217863818773
Olfactory Signaling Pathway,1.1096463805873875,0.3958472745214917,0.4494293998734788,0.6348867130552179,1.1336891688044965
PKA activation,1.09497611505754,0.4024063470319395,1.479126713779119,1.247391775164751,0.4250659006397461
Keratan sulfate/keratin metabolism,1.0924338331769756,1.0625938497848844,1.8476964110259246,3.30972114099129,2.5828463439144946
tRNA modification in the mitochondrion,1.090717710147474,0.6328733482355924,1.1853683279826994,2.0945218813860476,1.1837394218659651
"Regulation of glycolysis by fructose 2,6-bisphosphate metabolism",1.0884062200183455,1.4249981361626525,7.563666348019092,0.6381650767886468,4.161931493220662
Free fatty acid receptors,1.086843752237924,0.30710379284490663,1.3606790675542964,2.725591546632607,1.2932305991016388
Hydrolysis of LPE,1.0714036407830856,0.5223971319730782,8.315981951777433,4.42757187309945,15.000996437458197
Downregulation of SMAD2/3:SMAD4 transcriptional activity,1.0697842056776707,1.4880896288140177,0.47020436902612384,1.2499151039904741,0.41654901875648864
Chylomicron remodeling,1.0522265651366918,0.7964910353856443,3.0954562036986415,2.48864221139655,1.5889391503565737
Serotonin receptors,1.0487287985224307,2.7498791900074755,0.31135181078997815,1.0394073986482866,0.5547882254321002
Phospholipase C-mediated cascade: FGFR1,1.0448019242344895,0.9808441643949972,0.3392521208089207,1.155605128114173,0.3609586542188223
EPHA-mediated growth cone collapse,1.041393228535516,1.1627048810281817,3.5573199700276157,1.796816104114627,1.8328424011355573
MET receptor recycling,1.0367599341297482,2.0431263469105354,0.9485579739622007,1.567189647982201,0.5600859228665194
PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1,1.0315622193944858,1.9284776955347374,0.32451327608775654,0.5049125908552119,1.111597775799749
TWIK-releated acid-sensitive K+ channel (TASK),1.021420938278027,1.329184329269384,0.8851617099783272,1.5056579811558826,0.3094145423315657
Glycoprotein hormones,1.0130553666786786,1.230602389456843,0.7517448083274788,0.622702087283863,1.4724201773811758
Phospholipase C-mediated cascade; FGFR3,0.9950961600331844,0.8538139678274785,0.34153931098801044,1.1239844719183882,0.32386559205800214
Signaling by Hippo,0.9926402808925938,6.9359022875846374,1.0650023907072872,1.2688007181932908,0.569094077490071
Toxicity of botulinum toxin type A (BoNT/A),0.9836518843028862,0.42419958966720367,5.030354421030147,0.4320836972968092,2.309442912369026
Molecules associated with elastic fibres,0.9777869547064746,0.39980981430149404,0.8593229044174654,0.40727840697811585,0.7160106358367704
Glyoxylate metabolism and glycine degradation,0.9720838342145827,2.931243782444933,3.2192987103889648,0.8873525501633578,4.087392138790371
Infectious disease,0.9714748264915465,1.875339427264723,1.1929969181888394,0.4831096099458899,1.666822384622464
Sema4D induced cell migration and growth-cone collapse,0.963924971248121,4.795322189360898,1.1292935038868581,1.460567371036373,0.48128897853934355
Notch-HLH transcription pathway,0.9441222151179154,0.6216213267243536,1.5957717987076803,0.7254430279663231,0.59555966894387
HDMs demethylate histones,0.9358902781013093,3.98156044627521,3.9590260895377987,0.32013611478920634,1.699874020881843
"Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)",0.9281099555738983,1.1686276972624383,1.0334320481932306,0.5131261646665373,1.2529498675461146
Regulation of cholesterol biosynthesis by SREBP (SREBF),0.9274562282732374,0.8371335860984841,0.3337283669927169,0.31729822145612685,1.364833419636475
Hyaluronan biosynthesis and export,0.9249788559703113,2.1968323626450417,0.588045352154698,1.4908952409949325,0.3654772477727824
Ethanol oxidation,0.9249343624014791,0.3955467930656246,0.38574166997933496,2.8572913039829455,1.2612504957584867
Loss of Function of TGFBR2 in Cancer,0.920397889453046,1.3197220869354822,2.5486337242723835,0.4465030841963646,1.699874020881843
TGFBR2 Kinase Domain Mutants in Cancer,0.920397889453046,1.3197220869354822,2.5486337242723835,0.4465030841963646,1.699874020881843
NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis,0.9192107553253652,2.084582856015424,3.2234130378665324,3.601506552192366,3.2215741312618147
ER to Golgi Anterograde Transport,0.911189862317262,2.4765680144891085,3.1713994791012854,0.5969579995574412,3.2517297747923313
PI-3K cascade:FGFR3,0.9025488707451292,0.4169041999391484,0.4249916394403177,0.7219610515790367,0.5916224910390321
Role of second messengers in netrin-1 signaling,0.8980621875541088,0.45923897874036074,1.8244679980666112,1.902424555125438,1.544195307302685
Retrograde neurotrophin signalling,0.8929960001835636,0.5911635076141288,1.3468937936181862,0.9080802387204767,0.3300489150060912
RNF mutants show enhanced WNT signaling and proliferation,0.8745251560985823,0.42419958966720367,0.9338215236316649,1.247391775164751,0.4109989946382866
Fanconi Anemia Pathway,0.8735117988739461,2.009995506149082,1.984198637492828,1.3023280574382898,0.302372684268816
Myoclonic epilepsy of Lafora,0.8686006898379665,1.6123789230315633,0.3426804758995995,0.36913498803697214,1.0705488030609034
Organic anion transport,0.8573210507401486,0.7837900183343098,0.46060493159845256,1.0367608391443093,0.5288854824759675
Activation of the AP-1 family of transcription factors,0.8546516359744907,1.629586644626317,0.6341412553157445,1.303940818418951,1.1512665670086406
Aryl hydrocarbon receptor signalling,0.8513471519155112,5.036946224368672,1.1030011398715638,0.7208384901610058,0.5347320725515287
Integration of energy metabolism,0.8494582145433999,0.5211674076887636,1.5730637545443071,1.3401993066869546,0.9644769780735528
FGFR1c ligand binding and activation,0.8288546524883984,0.8505987268562785,0.5818672746232282,1.0598041384054506,0.36666941133378234
Negative regulation of NMDA receptor-mediated neuronal transmission,0.827944471293079,2.005213803809038,15.77232075527411,2.8797815988393456,9.616272078291841
Highly sodium permeable acetylcholine nicotinic receptors,0.8133011500370921,2.268388749303512,1.126345309607856,0.8884314424249404,0.5939816636465602
Regulation of gene expression in early pancreatic precursor cells,0.8133011500370921,1.0546641096433365,0.46002533157232356,1.752416648165791,0.7115266236399367
RIPK1-mediated regulated necrosis,0.8128397569047847,0.9591816884435412,0.8024844636677928,0.5131261646665373,1.1452001236488787
Regulated Necrosis,0.8128140786709221,0.9591816884435412,0.8024844636677928,0.5131261646665373,1.1452001236488787
Protein methylation,0.8102401775931263,0.8766552477559098,0.7463608505879357,0.4664961497058044,0.9498475064706665
COPI-independent Golgi-to-ER retrograde traffic,0.8047631369589815,0.6224877841552735,4.581478174558889,4.175335643107926,5.715813441578873
The AIM2 inflammasome,0.8041825638574666,2.2533019392643485,1.4234594324358887,1.9107086222433332,1.1023595256976257
Deposition of new CENPA-containing nucleosomes at the centromere,0.8026523358585435,1.1160314124414437,1.9499558234452736,0.7769594233504504,0.335581055523696
Nucleosome assembly,0.8026523358585435,1.1160314124414437,1.9499558234452736,0.7769594233504504,0.335581055523696
Defective B3GAT3 causes JDSSDHD,0.7984170203314117,1.434072576175723,1.4324170662494093,1.7220373498283235,0.9664431650106355
Blood group systems biosynthesis,0.7984170203314117,1.0765713061381914,3.857984587091748,1.8499234772452686,1.8193959950082592
Xenobiotics,0.7920783416298159,0.4271134925548931,0.3519789042094805,0.3641322044260825,0.317432546385211
FGFR3 ligand binding and activation,0.7907723765264156,0.7583192578561161,0.4366378380695516,0.9810690798087225,0.39113515546352123
FGFR3 mutant receptor activation,0.7886751124016235,0.7575167352103137,0.4366378380695516,0.9790118778897863,0.3912495204891879
FGFR3c ligand binding and activation,0.7882655033243935,0.7575125273526448,0.4366378380695516,0.9779981006198806,0.3912495204891879
Signaling by activated point mutants of FGFR3,0.7882655033243935,0.7575125273526448,0.4366378380695516,0.9788307833661102,0.3912495204891879
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,0.7788342674294205,1.419346140239154,3.708808069024841,3.62024837071877,3.3445021676281517
Transport to the Golgi and subsequent modification,0.7609815568411046,2.0269948162688145,2.4509323062352943,0.599257125915946,2.7702153840596275
NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose,0.745388205542703,1.6943260871753854,3.580864045603315,3.3668402723287003,3.560419444562648
RSK activation,0.7440217301672207,0.40366934371789676,0.4366378380695516,0.32206789896661986,0.8069952360431232
Nef Mediated CD4 Down-regulation,0.7333608974913299,3.8117746632958833,3.096074793837896,0.4838216912434582,1.443460361471967
Methylation,0.7267874691686094,0.6500070999866762,0.31135181078997815,1.8017554630347283,1.6128149146835673
mRNA decay by 3' to 5' exoribonuclease,0.7182970614452705,0.9390492396846408,0.6372525928105914,0.6799646505948175,0.38963245750439246
FGFR3b ligand binding and activation,0.7124985850308648,0.3179217903105324,0.6362845790668108,0.5192695088120328,0.5230671182394184
PI3K events in ERBB4 signaling,0.7124335726529266,2.263339462654298,1.4256654845054866,0.4177247264940158,0.9110264550216357
ARL13B-mediated ciliary trafficking of INPP5E,0.7117971561536655,0.9961357773893584,0.3056972786561963,1.5464171535603786,0.5906863820008933
"Defective AVP does not bind AVPR1A,B and causes neurohypophyseal diabetes insipidus (NDI)",0.6996325203708937,0.6650435160731982,0.348350246287274,0.5317286022484448,0.796916733409309
Cam-PDE 1 activation,0.6988928634359239,0.6469186602430389,0.5027795964046992,2.6694928200333536,1.559121861218423
HCMV Infection,0.6854219905907993,0.8595877088050409,1.4135380188177815,0.5591310804097505,0.436742970971476
Lewis blood group biosynthesis,0.6834138275406869,1.1678569778950714,3.9341110536670354,1.6743933873719046,1.8939515280442365
VLDL clearance,0.6802442909649759,1.5906388040295476,1.8825789138482494,0.44622971195913763,1.3782346795691403
NRAGE signals death through JNK,0.66994580748647,0.9307984089595599,10.39986946229771,3.6687486003806726,3.59886261514178
PLCG1 events in ERBB2 signaling,0.6698086562043081,1.0951774220805695,5.711148837972517,1.2472445818195381,2.9048159452543922
DNA Double Strand Break Response,0.6662997557196466,1.0973452611422785,1.8535596652930457,0.7428542104544392,0.33919191035113416
Integrin cell surface interactions,0.6647146194700261,0.8914321523292897,1.3438367854775057,1.432533186849875,0.745204751884035
"Transport of vitamins, nucleosides, and related molecules",0.6605170413036884,1.2443589304812899,5.6401281743298695,3.043059298326193,2.8491816190913006
Cellular Senescence,0.6540640405638728,2.5051436983378803,3.0286958777011783,0.47352905095316583,0.6864549607503035
Conjugation of phenylacetate with glutamine,0.6490511709618776,0.6533091250450352,0.9162812255059609,0.3029641538903767,1.301559588481589
NCAM1 interactions,0.6321422288800606,0.4352749983246074,0.7136006262142646,0.3126075564713015,0.5147100307946074
Protein repair,0.6249807309645978,1.4700498757911455,12.846529347527971,4.003564524213559,6.4775944499819325
PI-3K cascade:FGFR4,0.621739152911995,0.46610815159284846,0.9045718865602242,0.43895791672039175,0.5372933747614816
Activation of Na-permeable kainate receptors,0.6182487370428744,0.7017915390969747,2.25847986322245,0.3349624275231453,1.9439068743305516
Relaxin receptors,0.6164359622887785,0.37608873360528455,0.32743910315495117,0.4873105647332245,0.4751844999918368
Activation of RAC1 downstream of NMDARs,0.6149389117499314,0.5778665757629041,0.5709788223529808,3.438110618742437,3.2578714946465124
Hyaluronan uptake and degradation,0.604668856638869,0.6991862049767655,0.9089444722927498,0.626152964222532,0.7754154566700016
Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization,0.6043222556192303,2.093213203689431,5.168214582721162,0.7817178669597671,1.619436628793004
Formation of ATP by chemiosmotic coupling,0.6015152652993244,0.6816144738929709,0.3933931863779156,0.5746856431165414,0.3661227901021697
NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake ,0.6007613135769322,1.5882417504146034,3.6826835985903217,3.022223554841105,3.7033808069542493
Mitochondrial Uncoupling Proteins,0.5991678240995711,1.4071184421086091,25.12611489964641,7.255802201593944,18.12331582749276
The proton buffering model,0.5991678240995711,1.4071184421086091,25.12611489964641,7.255802201593944,18.12331582749276
The fatty acid cycling model,0.5991678240995711,1.4071184421086091,25.12611489964641,7.255802201593944,18.12331582749276
Degradation of the extracellular matrix,0.5954649547012463,0.5394280066316582,1.27903626583365,0.33477548074836055,0.6956149423228057
Phospholipase C-mediated cascade; FGFR2,0.5893524498343966,0.4760235618522335,0.551992639157947,0.7275167679837153,0.3883817973173038
phospho-PLA2 pathway,0.5886620494402778,0.622853262240979,0.9982183013070414,1.7849767435014257,1.5494920171591047
Signalling to STAT3,0.5799477026118605,3.0373219740349824,5.551509715977227,1.5567278114507883,4.83254315619558
IL-6-type cytokine receptor ligand interactions,0.5710722965943719,4.129094010845945,2.508944418785801,2.0337851077221747,2.4536013173801727
The citric acid (TCA) cycle and respiratory electron transport,0.5703507567942231,0.4097861600056029,0.7710244255339336,0.4011016541155644,1.0152669754467594
Signaling by activated point mutants of FGFR1,0.5383705042223403,0.6558550192645353,0.6768415281855785,0.7523796369433986,0.43631950378832507
RNA Polymerase I Transcription Termination,0.5307706193390318,0.9807181229668899,6.123200513355645,2.2754466848893475,7.057558836926538
Macroautophagy,0.5298566547738927,0.9477108618147354,5.098642774249977,1.9539480951960864,5.753946833804327
Autophagy,0.528033015367677,1.1563553328712433,5.081466121402817,1.9007223907603819,5.531502147261802
Activation of TRKA receptors,0.528033015367677,1.3072036239995872,9.673544384014555,1.7292514335197142,5.783089760727452
Defects in cobalamin (B12) metabolism,0.5258112226205444,0.4098090905142673,1.0148454703940186,1.4695804445583731,1.8881683492384667
Activated point mutants of FGFR2,0.5248813868364759,0.44862577456718533,0.6164493089010099,0.6850015612495727,0.4236666849052503
Toxicity of botulinum toxin type E (BoNT/E),0.5247472153287923,0.4543364886834994,4.768847342198343,0.4208651490605755,1.9184094148752155
PI-3K cascade:FGFR2,0.5234692766200688,0.34707169490355044,0.5666895042586965,0.42263002879745537,0.4923898621534528
FGFR2c ligand binding and activation,0.5170412560404632,0.4387200994507368,0.6144918296174009,0.6749867519889315,0.42247516288307246
NADE modulates death signalling,0.5152700805814778,1.7927442924324442,5.726018417047438,2.4737661755203137,2.9305813494937367
tRNA processing in the mitochondrion,0.5137339615436677,0.5576247371472102,1.1972694347945732,0.4829643783377355,0.35054349862887657
G beta:gamma signalling through PI3Kgamma,0.5104570839971123,0.7816232266161989,1.6093033877205944,1.4652258714661408,2.680324400591121
CLEC7A/inflammasome pathway,0.5100769645082931,2.9472269560791813,2.716236684940058,0.7311530375004737,2.124665382495909
NOTCH4 Activation and Transmission of Signal to the Nucleus,0.5008187132849533,1.077038246788267,1.5730637545443071,0.416684363122663,0.3195483609168483
Glycogen storage disease type 0 (muscle GYS1),0.49903454339473685,0.5592163339162634,3.0807899084372985,1.6299106029952217,5.071491488106311
Glycogen storage disease type XV (GYG1),0.49903454339473685,0.5592163339162634,3.0807899084372985,1.6299106029952217,5.071491488106311
Conjugation of carboxylic acids,0.49334988035913546,1.201161750377609,1.2008734008426614,1.7797301100829575,1.225791744622568
Amino Acid conjugation,0.49334988035913546,1.201161750377609,1.2008734008426614,1.7797301100829575,1.225791744622568
Assembly of collagen fibrils and other multimeric structures,0.47875237888270666,0.5530147910030782,1.3646946233649306,0.4161554646743214,0.7240012482665589
Conjugation of salicylate with glycine,0.47607485844932046,1.002240358428403,0.730562969811626,1.4487732915868312,0.8074723692335924
Regulation of necroptotic cell death,0.47559028185958985,0.7171055875648032,0.9336295469895964,0.4208651490605755,1.3223911194921631
Keratan sulfate biosynthesis,0.4755866560548701,2.7788445712764918,2.2862217785814987,1.1831255385959694,3.4783685834964437
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),0.46135502098901027,1.715165860490009,0.8858801206595116,0.30810397569469705,1.1119775398138882
HCMV Early Events,0.4603716986339555,1.2875514800677308,2.1782314406320182,0.5955147093926161,0.4721549446627174
PKA activation in glucagon signalling,0.4572172049319918,0.44445016992964065,2.277079888047687,0.6829822458070506,0.7021083998216334
SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes ,0.4515918437612378,0.577844284384918,6.919822197564078,2.2104377104848365,6.015534012732366
SMAC (DIABLO) binds to IAPs ,0.4515918437612378,0.577844284384918,6.919822197564078,2.2104377104848365,6.015534012732366
Vitamin B5 (pantothenate) metabolism,0.4515918437612378,2.175292124090033,1.0870743753128707,1.0774180878867954,1.4044999181827484
Phospholipase C-mediated cascade; FGFR4,0.4482776028268913,0.3955467930656246,0.7726433901301663,0.5551475623053611,0.34920222047835653
Regulation of PTEN localization,0.4482776028268913,1.0625938497848844,0.4249916394403177,0.7769594233504504,1.594326027122974
mRNA 3'-end processing,0.44397751478903696,0.9749305620248008,0.42090771502330504,0.4838216912434582,0.38967896381073347
ATF4 activates genes in response to endoplasmic reticulum  stress,0.4423192842860809,1.1975904680800618,0.6106015175419041,1.3632596872347225,0.680962794069554
FGFR4 ligand binding and activation,0.4388457736715916,0.39407473822598216,0.7907353002825664,0.5491009373787701,0.35411411027913875
Platelet Adhesion to exposed collagen,0.4330544407171257,0.6152410865701289,1.178894071528219,0.40727840697811585,0.3801673813180204
Triglyceride metabolism,0.43195900919091473,0.7139977617382485,3.5332954804325536,1.4467323065369095,1.9336040146150029
A tetrasaccharide linker sequence is required for GAG synthesis,0.42493905879450383,1.4461162022570742,0.98327401581884,0.4891190381706797,0.7519234480398794
Chromatin organization,0.41945233602299986,0.5351365969221958,1.0584826516990122,0.41540437054854634,0.4135321699986144
Chromatin modifying enzymes,0.41945233602299986,0.5351365969221958,1.0584826516990122,0.41540437054854634,0.4135321699986144
mitochondrial fatty acid beta-oxidation of unsaturated fatty acids,0.418958074129226,3.1855006681851448,3.6924469374552933,1.1740878522552949,1.3640642210035017
Glucagon signaling in metabolic regulation,0.418958074129226,0.6971438053341696,2.470871304337949,0.530128185680593,2.0003158357770903
Orexin and neuropeptides FF and QRFP bind to their respective receptors,0.4180524065947183,1.14410676749565,0.5069376172954021,0.7615127893921839,0.6011763511532562
RHO GTPases Activate ROCKs,0.4018014623503458,2.5883859630656056,0.4314384624685347,1.519525197646939,0.7897938783555166
Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane,0.39088625727643866,2.2298313137961747,1.275289099948996,0.6466715464663607,0.49997573091530434
BDNF activates NTRK2 (TRKB) signaling,0.3865769049753108,1.4476085880855865,4.863274474572522,1.460074729843961,2.96251183438576
Regulation of commissural axon pathfinding by SLIT and ROBO,0.3856548764314167,0.6696808268917437,1.4399567912161695,0.4627173361045607,0.37191304934298564
Diseases associated with glycosaminoglycan metabolism,0.3837554911172666,1.3796199377376288,0.4883224118955528,0.3115343584721568,0.5370214758527988
Mitochondrial Fatty Acid Beta-Oxidation,0.37734394016263023,0.9667009674689269,0.4855907227992278,0.4155810943577479,0.3744724514070178
Proline catabolism,0.3688437620273061,1.7521376526014993,34.008105368787255,14.897517840593693,31.48421892801543
MECP2 regulates transcription of neuronal ligands,0.36177872565906616,0.6396097777420019,0.6271076492796305,0.777631355252849,0.3062854195860401
Post-translational protein phosphorylation,0.35670383720170096,1.5666063160249588,0.5842461585114133,0.5025357188226104,0.870015209445096
Eicosanoid ligand-binding receptors,0.3563433547583297,0.7065920544922281,1.1120351852245292,0.510718335063644,0.534376975103325
"SMAC, XIAP-regulated apoptotic response",0.35373845833979534,0.4694784129207081,7.522559217225078,2.6942753022206016,6.274772178736584
Biosynthesis of maresin-like SPMs,0.35160847029669784,0.3608744609097119,1.1293135667218954,0.3232512519547774,0.6320059887956666
Syndecan interactions,0.347308533991502,1.1624778452953073,2.797480136913421,1.1083625499070415,1.743502909478661
Cation-coupled Chloride cotransporters,0.3467484748323558,1.3988800134145722,0.9104977632357261,1.0511502758037279,1.0865818210744327
Synthesis of GDP-mannose,0.34559504181397177,0.49642569557535693,6.474939014027129,1.7519618971069064,3.945804560787598
Defective B3GALT6 causes EDSP2 and SEMDJL1,0.34409888001012506,0.6981398826157971,2.183838344003368,0.891586058969129,1.607728172770564
Golgi Associated Vesicle Biogenesis,0.34409888001012506,0.6128073827813979,0.4923087941146736,0.831753972108556,1.3590006104843728
Membrane Trafficking,0.3430928026296903,1.157997023377974,1.3377728719731876,0.9244359536683845,1.874134823011108
Organic anion transporters,0.33908419562929837,1.3088080551635453,6.111264489361432,1.8376381079300348,4.809436518052298
"Defective B4GALT7 causes EDS, progeroid type",0.33661581130957835,0.7694018566133957,2.0259215963336135,0.9991448608587629,1.4751663474093408
PI-3K cascade:FGFR1,0.334775410491865,0.6297500178842086,0.322499678034276,0.31729822145612685,0.3076206672670413
Leukotriene receptors,0.3330113775628096,0.5802391000532168,1.2145669812534456,0.4127126762953268,0.5951647762071244
Collagen degradation,0.3329567696445631,0.6816760625754831,1.7159845478357674,0.7829819554736739,0.878264440771537
Activated NTRK2 signals through PI3K,0.3329567696445631,8.1101715753978,8.617736641264306,2.17397485356212,5.336525150461458
Scavenging by Class H Receptors,0.32126555878642005,1.2569280432241123,0.5838728806187785,1.001644730057096,0.5991875620244321
G-protein activation,0.3200211927170943,1.0782948798342276,1.3021074260627938,0.5148424013587082,1.656784273322647
CYP2E1 reactions,0.3170078642285994,0.39739229523170444,0.727094455933726,0.4208651490605755,0.6341355299555239
cGMP effects,0.31398424634648925,0.6049880922348563,0.6078528106746443,1.4085861443123275,0.8633472976647485
CS/DS degradation,0.30545878015466854,0.35519670891953803,1.0215557244692892,0.982557334560476,0.9960946453579234
Regulation of FZD by ubiquitination,0.304921596541315,0.693511042830642,1.7945339049148232,1.2463413904036509,1.6051316034131364
Chondroitin sulfate biosynthesis,0.304921596541315,0.3433057645232372,0.47596120337044234,0.5039614499585496,0.5053707494077528
Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE,0.3022301559421378,0.4422947282665161,2.8917321457235583,1.2037365298260845,1.4431305916428152
Defective MTR causes methylmalonic aciduria and homocystinuria type cblG,0.3022301559421378,0.4422947282665161,2.8917321457235583,1.2037365298260845,1.4431305916428152
